var title_f20_13_20688="Gastroduodenal Crohns UGI";
var content_f20_13_20688=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F77013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F77013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Crohn's disease of the upper gastrointestinal tract",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Upper gastrointestinal series in a patient with gastroduodenal Crohn's disease shows antral narrowing (small arrow) and two duodenal strictures (large arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of the American Gastroenterological Association&copy;. This slide cannot be downloaded but may be purchased as part of a set from the AGA through Milner-Fenwick, Inc at 1-800-432-8433.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20688=[""].join("\n");
var outline_f20_13_20688=null;
var title_f20_13_20689="ECG changes with exercise";
var content_f20_13_20689=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80752&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80752&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Spectrum of electrocardiographic changes during exercise testing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 422px; height: 350px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFeAaYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiisnWPEmh6JxrOs6bp5xnF1dJEf/AB4igDWorg7n4wfD62JEni3Sjj/nnL5n/oOazZfjz8NIs7vFER/3bWdv5JQB6dRXln/DQHwz/wChl/8AJG5/+N05Pj98M3OB4mQf71ncD/2nQB6jRXm1r8cfhvcuqx+KrVSenmRSxj82UAV0GnfETwZqLBLLxVocrnogvow35E5oA6mimxSJLGrxOrowyGU5BFOoAKKoaTrGn6v9sGm3cVybO4e1uAh5ilQ4ZGHYir9ABRRWJ418RW3hLwrqWu3qNJb2MXmMinBbkAAfUkUAbdFMgljnhjmhcPFIodGU5DAjIIp9ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVjeMfEVl4S8NX+uaoJTZWaB5BCoZyCwXgEjuR3rZrx/8AasvJIPg9fWkP+sv7iK3x6hSZT+kRoA9dglSeGOWJt0cih1PqCMin1keD5PO8JaJIf47GBvzjWtegAooooAKKKZPNFbwSTXEiRQxqXd3ICqoGSSewAoAfVfUL2106ymvNQuYbW0hXdJNM4REHqWPAFeN6p8X9Q8X302h/BvTv7V1CI/6Rqd2vl2dunTcMkFiTnHHbIDVb0j4MrrE0Wq/FLV7rxLrBYSG281o7GE/3EjGMj8ge465AHXvx40G7v5NM8E6Zq3ivVRkJHYwFYs56tI33V/2gCKmL/GHxCBGIfDvhC2b70pY31ynso/1Z/GvTdL0uw0m1W20qxtbK2XpFbRLGg/BQBVygDxY/Ap9TmM3ivx74r1dm5dEuPIjP/APmwPYYrqdD+Dfw/wBGIa38MWNxLjmS9BuST6/vCwz9K9AooAx7XwvoFou200PSoF9IrSNf5Cr8dhaRf6q1t0/3YwKs0UAJsX+6PyqCWxtJgRLawSA9mjBqxRQBkT+GNBuP+PjRNLl/37SNv5isXUvhh4G1KMpdeEtEweS0VmkTf99IAf1rsaKAPHtQ/Z58FSyeZo76zoUnrp18wyf+B7v0xVP/AIVP4m8Nwy3mg/FXXbaK3RpPL1GMXcQAGTkM2Mcf3a9tpk0Uc8LxTRpJFIpV0cZVgeCCD1FAHwF8LNY+IOofE6bxB4RtrjU9VuJ2lvNqbLeYMcsJDwqqc8dMcY5r7402W5n0+2lvrYWt08atLAJBII3I5UMPvYPGe9PtbaC0hWG1hjhhXokahVH0AqWgAryL9qmeVfg9qFpbrukvriCAD6OJD+kdeu15t8ZLdNRv/AmmSjMd1rqlx6qttOT/ADoA3fhJcm8+F3hKdiSzaVbBiTnJESg/yrrK4H4COX+EHhhWzuitjCfqjsh/9BrvqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAAdKKKKACvGP2h2a+v/AAloSruW6Oo3TL/1xspB/wC1K9nrzXxPpsWtfGjQ7ecExWWg30pA9Znji/Vd35UAdR8OHMvw88LyE5LaVatn1zCtdFXK/Cl/M+F/hFu/9kWgP/fla6qgAooooAiupWgtZpUieZo0LCOP7zkDOBnua8JsPBviz4t339pfEw3OjeFgTJZeH7eQxytk8faDgHoO+DycBe/vdFAFHRtJ0/RNOhsNIsreys4htSGBAij8u/vV6iigAooooAKKKKACiijNABRRRQACiiigAooooAKKKKACvPvHi+d8S/htBjIW7vbg/wDALVx/NxXoNcdq8cdz8WPDSvgva6VqFwPYtJaoD+RegBnwlSK38LXVjBgJY6tqNsFH8IF5KVH/AHyVql8fbu7svhH4hl06a+t7rykVZrPPmR5kUEkjkLjO4jkKTVb4eana6P8A8LGl1KdLezsNfuJ5JX+7HG0MUhJ9ssxrTtviv4GuriKCDxNYPNLOtsihj8ztjb2+6cjDfdOetAHz/pGqX6+F2gu7+7PhhPFttHqF5ZXcz2P2Nk+ZYpWPmCLePnyeCV55Ne2fs+3N7deBJ3u5rmeyXUrpdNluGZne0D/uzubkjqAT2ArpP+E88L/21PpX9s2/223Miyj5tkbRoXkVpMbAyqpJGcjBzUVn8RvCN5pmoahBrtp9jsFR7mSTcnlq/wBw4YAkN0UjIPbNAHWUVmeHte03xFYteaPci4t1kMTHYyFXABKlWAIOCDyO9adABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUV5xrvxY02ylvH0XTb/X9P00ltVvrAAwWSj73zEgSMByVTOACTigD0euR0t4rn4p+IXXl7TS7G3J9C0ly5H5bK6PSdRtNX0y11DTZ0uLK6jWaGVOjqRkGuL+HrfafHPxGvAPlOqQWoP8A1ztIsj82P50AWfgpJ5nwr8N9P3dr5X/fDFf6V21cB8CHDfC/TFBJ8qe7iP8AwG6lH5cV39ABXMeKPHfh3wvqWn6frGpRQ319MkMNup3ON7bQ7AfdTPG44FWPF/iqw8MWcbXO+4v7kmOysIBunu5OyIvX0y3RRySBXLaF4Ak1Tw94gk8cx2k+veIgRdtCNy2sYA8qGMntHgMD3bnJ4NAHpFFcL8JtX1S50q/0TxRcJP4j0K4Npdyjjz0I3Qz49HQj6lWruqACiiigAooooAKKKKACiiigAooooAKKKKACiiigArO1zXdK0C0+1a3qVnp9vzh7mZYwSOwyeT7CuM1TTvifqJlht9d8M6PA7YWa2spbiZFz28xgpOP9mr/hz4c6Tpt3FqesPN4h8QIB/wATPVMSyJg5AjX7sYBzjaAeeSaAN7wz4m0XxRYm88P6lbX9up2sYXyUPoy9VPHQgVzEUxn+O1xFkFbXw4nTqDJctnP4RiofGHgbUh4lh8T+ALux0nXnOy/FzGzW+oR4G0SqvdccMOeTz0o8A+F/E1n4113xL4vudIe61C2gtYodN8zZGsZY/wDLQZ53Z/OgDFtND/4SHWvjF4YFwbUX8lvify9+zzrNAW25GcFTxkVZ1D4R/bP7a/4nez+0f7J/5dM+X9h/4Hzv/Db/ALVT63rMPg7xj481gweeV0Sxv2h8wJ5hR7mM/MeBwErsI7nxLJPAf7N0ZbVp8O41CRnEHGGC+SAX6/LkDgfMc8AHn1/8Fo9R8TazqN1rskFlqYuhNa2Fu1uZROpX96fMKPtzkHywSQCxPOYbb4KpDo91b3muW/nqsBt72HTxHJG0Dh0aXdIwkGRyoCryeB27W61rxFZajoVne2mjJNqWoPB+7uZXAhWJpCRmMfPhG4OB059OL+LniLxXHotv4W0g6PJ4q1vzbf7NaTSebFA2QJlyBtCqGyzYGelAFD4fSeNPifpE2pXfii40vwzNNIsD6fZpaXlztwu4HMgjQEEcMzHB5AIA3NA8Xat4O8XWvg/4hX6Xovl3aTrvkiBbkjgwyjOBIOMEdcjuefQ/C2jQeHvDemaRaKiw2VukA2DAO0AE/icn8aZ4o8NaN4q0w6f4h0631Cz3bxHMv3W6blI5U8nkEHmgDXorzHUPhTLbW2PB/jHxPoUka4ghN811bJjoPLkJOPYNU1vqPxP0WxVNR0HQvErphTNp+oG0lkA/iKSJsyfQMBQB6RRXnth428VT6hbW138ONXtUkkVJJvtts6RKTgtkNyB14r0KgAooooAKKDzRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBwfiPw14m8UayYb/W00jwxGSptNMZjc3q/9NZiB5akcbUBPJ+boR1el6JpmlaLHpGn2Fvb6XHGYltUQeXtOcgjvnJznrk5rRooA8m0TTPG/gzUtV0Hw1pFlf+HZpfP0m5ur0RxaarAloXQAyMoblQvY9R20/B/h3xloEGrPLdeHprzU7me/nYRzbFuHAVAoznywqJkHnrzXo1FAHjnwNPiU+D2gtptFFtbXWowyB4pS/wBp+0SkEENjy8svHXGeauN478R3euWmleGF0LxHdxxNFqP2MSpb2k+WwzzlmVVxj92Azkq3TtwPwtsdT8W+LfFPh17+/svC+k6vfyX8Vs/lG8klnOyEuMMF2o5O098d+PoTQtF0zw/pyWGiWFtY2aciG3jCLn1OOp9zyaAOA8PeBfEmnzNreo6no+p+MZLrDaldWsjrFZEcwRIHAQ7skEdQTkHrXXXlt4qd9YFrqekRJIF/s4vZSM0J43eb+8AfvjG38eldFSEgEAnBJwKAPLdf+HPie/8AFl34g0bxr/YV9c2lvbSi105ZEmMYbLOruc8sdvoOOetW9Mt/ippERgubvwv4jjQ5W5nMtjO49CqI6A+hH416R3ooA4R9V+ItqxeXwt4fvUdsLHa6zIjRj1YvAAfw/KiLxD49kIB8B2MQzjL68v58RHj9fau7ooAq6Y95JYQvqcEFvelf3sUExlRT6Byqk/8AfIq1RRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeJ/F6aOHxpqkE95a2MN74SnU3N1D5saGO4U5ZMNuADtxtNesarrel6Dpa3mtalaWVqqjM1xKsanjtn+Qrxj9oexv7z4h+AbLTBCJNYjvdKkeaISpHG4i3OUPDFQWYA9SorvdP8AhL4RilhudV09tc1KMDdeatK107kd9rkqPoqge1AHPa94m1zxzf6UPhjb3KQ2srzHW9QgaKxYNE8fyKQGlI35GBtyBnIrrfAvgS08NSPqV/cyax4nuU23er3QzLIOPkUdEjGBhRxwOtdiiLGioihUUYCgYAHoKWgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArzS+8Zata+MdRtiUGmWmsWunNusnMaxywQOWacNhW3zYAIxyoOM7h6XWDN4R0abVZ9Rlt52nnuI7uVDdzeTJLGqKjtDv8skCOPHy9VB6jNAG9XI+GfEVwYbuHWmluLiLUprKOW0sZWUhduC4QME+91Ygfka6C20u1trO5tYBMkVxJLLJid926RizlWzuXljjaRt7YwKTStKtdIsWttNRo1Z3kLSu8rM7HJZmYlmOfU+1AHN6T4yaXUZrK8tmE4mvVG0jCLb+XxnvnzBzx9KrD4hb1t54dKdrMwafcXErThWjW7fYgVcHcVPJ5HHTJ4q9Y+B7RrVxrczXl5Jdz3bT2rS2gBlwGQBJN2wqFBUsQcZPbGjH4S0SO1a3SyxCYrWEr5r/AHLZt0Izu/hP5980Ac/rfjTVI/DmqaxpGkQSWdvK8FvNPccysk4ictGB8qkh9p3EnAyBmpx4vvRrVzpKaek2qG5WGO3aYRxxj7MszlpcEkDdgYXOSOMZI1pfB2iSrfI9tMYb3zDNALqYRFnbczLHu2oxb5tygHJJzkmiXwfosoYtBciVpVnNwt7Os29YvKDCUPvB2fKcHkZznJoA4Hw3rWleFbbWL7QdJuZYtQz4j1N7m4UPF5sjI6IAp3FTG2Fzjr83PPoviDWZdOudOsrK1W71C/kdIY5JfKQBFLMzNtYgAADgEkkdskRyeEtDe0ltTYKLeWyTTnRZHUG3QsVTg8YLNyOeetXdY0ey1cW/26OQvbyebDJDM8MkbYKnDoQwyCQRnBB5oA890b4mTLo+ji7sZr++awt7y+aFWyPNZgBGqIQzfIxIJQYxgknA25PHhhndp9LdbA3V5YxTCcF3nt0lkYFMcKywyYbOcjBHINakfgrQoo7RLe2uLYWsC2qG2vJoS0SklUco4Migk4DZxub1Oa2leBtNtZr+a8M17NdXF1MN80gSJZ2Ysqx7yqnaxXcoBPPTJoAxrz4lSW0Fuz6BdC4ltBqBtvM3yeQfu7fLVwZGIYBSQPl5YZFWLr4h+ReatCNKdnskdo7cylbqYKUHmeSUz5Xz53qWIAyVHSuhvfC2k3YtN8NxC9rB9miktbua3kEXHyF42VmXgHBJ5561Ri8PaDqGpXreTqf2mBjGXkuLqNYy+1yYCWCrnAy0WO4z1FAGS/xCjjGn3BS3njuLS7k8uynWdJJY7i2hRVlO3GWnwQVGOc4283X8Z3KTw6e2kp/bL6l/ZhgF1+5Vzavch/M25KbEx9zdnPB4zpL4L0AReW1iZB5U8JaWeR3ZZnjeQszMSzFoozuJLDaMEVPZ+GNJtGtWit5Wktrpr2OWa4klkM5iaEuzuxZz5bFfmJAGMdBgAm8MauuvaDZakkLQfaEy0THJRgSGXPfBB571qVU0rT7XSrCKysIvKtos7E3FsZJJ5JJ6k1boAKKKKACiiigArmdZv9QufFVroWm3KWKmze9muTEJHIDqiogPA5JJJBxwMc5HTVl6xoWn6vLbzXscouLcMIp7e4kglQNjcoeNlbadq5GcHAz0FAFzT0uYrOJL6eO4uVGHljj8tXPrtycfnXH6j4ov7fRPFl3GIPN0vUVtYMocFCsB+bnk/vG/SulstH0/TJluYFkR47fyN8lxI48sMW53MQTkkljye5rKi0jw3rt1FqcYeVrvy73yxcTRxz7duyV4NwV8bUwzKfur6CgDPuPHr28krtotzLafabyxgNvIJJp7i3SWQoseOjLDJtO7O4AEDINZt18Rdlnp+qSNax2MU139ujtJxcHy4rN58ZKqyOMD5SAePQ5rWs/Cuh6TfSnVLxpb3Ury6e3WS6kjwZy7MsUe/AcIWG9AGxk8ZNT6loPhbQ7L7VqcLGIzkmW5mmuHlklj8jDFmZnyjbADkY6CgCG58aXNk89pf6P5WqxvZqtvHdB0ZbqRo42L7RjDRuGGDjbxuBBOfP8AEM28twbiwdZbSC4+0WkbBv3sc8UXyyHGQRICMqODzgjFXW8H6Nq+hQppU15BBLdW9w88k1w0zrBICEDu4kQcEDBGMkgc86n/AAhmgGAQtYllEbxEtPIWYPKsrlmLZZi6qxYknjryaAM6LxldS3b6YulR/wBuJfNZG3N1+5G23S4L+bszjZKg+5nccdOaujXr/Vfh8Nc0Cx36hcWf2i2tZCG+YjIHUBj7ZGemRnNN8Q+Eob/fNprQWd/Lei+kuZBMzFxAIcqY5o2QlERThsEKcgkk1d0jw5aaf4RsvDxeaa0t7ZLff5jRyNtA+bcpBU5GcgjHagDz/XdTuJ/Duuayl7Dcaz4ZtJdRgi1XRDDcW7eTIe5X5H2EBk4+Vhkkceg31/J4d8NX2o6zcfbPscTzu0MIjLKoztC5Iz2696rHw3oEdvf6TOGlOs2zwXCXN7LLPcQhSrKHdy+1RIeh+XfngmrHijVdBtLOSx8RXNsltdwuskM3IaLGHLDsmDgscAZ5NAHJS+OtR0rU9Ug1myhFwbq2tbK1hmaRAzwvKxaQR7sbY2JwjYxgZ61Zl+Icv2A3MGh3BMFjNqFzHNL5TJHFI0bhAy5YnaWTIUMMElc1Z/snwcupy6M0zvqU8kch8y+necSohKbZi5ZXEZJADBtue1T3fgHTLvVI5rqW8msUsmszayXc7eaGkLt5jmTMinJBV9wx7cUAU7r4hLDb39yukzm0gvBYQTGUYuJiygYVQWVcNkkrn5TgE4zDF8Rt9zp8M2lGz+0OY3lvZmgiZvM2bYXaMCRjkMA2zII7nA6qfw3pU9jd2ktpmC6uPtcgEjhvOyG8xWByjAqCCpGCOMVVk8HaPMI1nW/nRGDFJtRuZFkIbcPMDSESAHoGz6dOKAOfPxAaaHUcWsdnNa3EMXkyS7rkK1ysOZISF2g5yCCwweueKkvPiKlnpt3qVxpjjThaXt3aSLOC9wLUEuGXHyFgCV5bgc7TxWlqfh3w3p8M15qcc5jkeJGlnup5hH++V1C5Y+WnmBCcYX5RngVYl8FaBKmoJLZO8V9DPbzRm5lKCOc5mCLuxHvPJKBSTzQBY8P63NqV9qlje2Qs7uxeMMqzearI6BlOcDnqCMYBHBI5rbqrbafa21/eXsMW25u9nnPuJ37BheCcDA9KtUAFFFFABRRQKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDK8WX39meFtZv9xX7LZTT7h22oWz+lfF/7PXxS8X6DrMOi2dlqHiLRW+aWxhjeaW3jyA0kWPu4yMg/KfYnNfa+uaXa63o95pmoo0lndxNDMiuVLIwwRkcjI44rxv4yeB7nw42leOPhrp0FnqmhjF1a2iiNbmzAJZSgGGx+eD6qtAHt1tKLi3imCSIJEDhZFKsuRnBB5B9qkrG8H+I9O8W+HLHW9HlMlndpvXdgMh6FWHZgcgitmgAooooAKKKgjvLaS8mtI7iJrqFVeSFXBdFbO0kdQDg4+hoAnooooAKKKKAMXxtazXvg/Wra1iaaaWzlRYk6yZU/IPdhx+Nc34tjbxNaaVNpFi9/pckXnR3tjFbtPET0MUksqeU2O4VvTiu+ooA4PxBp96f+EMks9D1K+l066WaaWaa3aeKMQyIQ7tINzEupO0kHB56Vr+JoH1WzurW+0K/ure3u4Xg+yXiQyTbQriVG8xCu1+MFlJ2kjIIz0tFAHHRafrsnwx1GxuzNJrU1pdpArzKZVDGTyEaQHaXVDGpbOCwJz3rnbrwTdw3F7Lp+nBHQ6ZNaMsqgrMs2bpxluGKKoZurjjLdK9TooA8x0/wRNNqllNq2mrNHLf6s18ZZVcSwSXEj2yuN3zLt2FV52nsDmtRtO10fCXR9Nns1vNZWys4b6CdklZiBGJ8bmCO4w5G5tpI5yOvdUUAeSeG/COpWeraDdahpFzPbWV5eiJJZLfzLWOV4micqjCMKpR8qnTPCmtT4l+HdT1fU5JbK0vZo5dKmskewuY4WEjnkTiRgGiIAxgMR8/GSDXo9FAHnEGgayuurby2I8h9Zh1V7+KRBCqLaJGYwpbfu3oVA242kHP8NaPjzw7c69q9sRa/abKPSNQi2tIAouna2MB2kj5sJKQ38JGcg4rtqa4YgbCByM5GeKAPJr3wdqSpOiWF29vNaabLJFA8EonvENz57TRyuqyghoN2WG7CkElahHhTxHNe6dPqdncKY7W1WAaW0GLGRGJdR5r7kB+XJjL5GVOQq59fbJI2kDB5yOopWYKpY5wBngZoA8xtLJND8K6uPEWiSC/ktZre6v2licapJI2FRcOXYuWAVWUbc7RxXoulRTwaZZxXb+Zcxwokr/3mCgE/nmrVeY6F8SLp/i9rfgnxHZw6ewCy6PNhv9LjxluScFsZIxjGGB5FAHp1FJzuHIx3GKWgAooooAKKRmCqSTwOaWgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKQjIIIyKWigD57vLWb4DeN5tWtgZfh5r9yFuYI0Y/2XMcYkAGRs69O3HVVz79Z3UF9aQ3NlPFPbTKHjliYMrqeQQRwQfWq+uaTZa7o95peqwLcWN3G0M0TEjcp9xyD7jkV4VZ6lqPwD1qHR9VFxqPw5vpibS+wzvpRZuUkIHK5Ocd+SOcigD6DoqCxu7a/s4buxuIrm1mUPHNE4dHU9CCOCKnoAK8T8KahI37Vnjaxz+7/se3Yj3UQkf+jWr2yvnrwHIZv2tPGF22AJtPlgUDnHlNbJn8dtAH0LRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUANkcRozt91QSa5f4ZeNLXx94Rt9esbaW1hmkkj8qVgWUoxXnHHOM/jW3r8og0LUZjwI7aR/yUmvGP2NrozfCi5t3BVrbUpUweDhkjcH/wAeNAHu1eTftF+GbrUPC9r4n0N/K8QeF5f7RtXCbiyLgumO/wB0N/wHHevWaDzQBynwt8Xw+OfAul69EI0luI9txEjZ8qZeHX25GRnnBB711deBeBpV+GHxx1XwW8QTQ/E7f2lpbL92GTDbozn12kDr0T1r32gAoooIyCDnn0NABjnPeiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKO9FFABVXVNPtNV064sNSt4rqzuEMcsMq7ldT1BFWqKAPALzT/E/wQ1W4v9Agn1z4byM80+mo26bSx1Jj3HJXJJ9MZ3YPzH2bwl4n0fxdosWq+Hr2O8snO3cnVGwCVYdVYZHB9a2SAwIIyD2rO0LQ9L0Cya00PT7XT7VpGlMVtEI1Lnq2B34H5CgDRr54+HBc/HR7wg7Lt9ciDEcMI71eh9eB+GK+h68C+GqH/hJPAt2wO67m8RuT65ulP/stAHvtFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBz/AMQ5/s3gDxNPnHlaZcvn0xExrgvgraDRPFHibQtpQ29hpEuw8c/ZBEx+uYhmun+Ndy1t8K/Em3709t9kH1mYRf8As9ZmjRG0+P8A4iXgLeaFaTqB32SyJ/n60Aek0VzXxJ8Sy+DvA+r6/BYm/ksYhILcPs3ZYDJPYDOT7A15rpPxov8AU9Bge00vTrjU7vXY9DtJY7lxbSMy7jKwZRIoUcFSuSencAAsftO6BPJ4WsfGOjt5Wt+F7hbyJwMlo9y7l/AhW57K3rXp/g/XoPE/hbStbtFKQ39sk4QnJQsMlSfUHI/CvLtX+Kmk33wv1Kfxlo+oR20k93ouoDT4/PjikX5D85K4DbhtJ78fXy79nL4taqP+EY+Hthp8c2byTdeysSUtfmkZQg/i+/ySQBjg0AfXVFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRXBfHPxHceFPhlqurWcrxXMTwKjIcH5pkVgD2+UtzQB3tFNikSWJJImDxuoZWHQg9DTqACiiigAoAxRRQAAYzyTRRRQAUUUUAFFFFABRWZ4h17SvDmmvf67qFtYWacGWdwoJ9B6n2HNed6v8AFbVrRX1Sz8Aa7ceFYBvn1ORlhkEf/PSO3b52THOTt45OKAPV68W8E2ht4PhDPjHnRXzHH/TaFpv6Zr1OTWrS48Ly61p1zFPZG1a5inQ7lZQpYGuC0WHyNB+DLNkMgihIz66XP/VaAPU6KyPEfiXRPDVslx4g1Wy06J8hDczKhcjqFB5Y+wzXK3fjXXdZuYLfwJ4cmuraTl9X1VXtLWMHuqMBJL+AA9D6AHU+KPEemeGNMN9q9x5UbMI4o1G6SeQ/djjQcu57AVxtrb+P/F9t9um1QeC7VmZrayhtI7m6Kfwm4aTKqeM7FHGeTWv4X8Bw6ZrM+ua5qNxr2vynK3V2oEdqP7tvHyIl9cEk9zXZ0Acj8L9evNd8NOmsvG2t6ZdTabqBjXapmibG4DphlKPxx81ddXk3iaS/+G3ja88S2dhcX3hPWSsmsiEb3sJkUKJ1QclWXG4AH7ufQHoH+LngBLNbn/hLNKZGwAiTb5D/ANsxl/0oA7miud8K+NfDniuS4j8P6tb3k1v/AK2EZSSP3KMAwHviuioAKKKKACiiigAooooAKK5/xn4u0nwhp0d1q8rl5n8q2tYE8ye6kPRIkHLMcj2GeSK4Ffih4l0i9tLzx14LPh/wvcyeV/aDXyTPbFvuGVFGVBOAT2J5oA3vjixbwRDbDrd6tp0GPXN3EcfpVm/gjtfjPo14zYa+0O7tQPUxTQOP0d/yqv8AFQLf2/gyK3ZZY7jxFYyKyEMGVN02R6jEea5T9pK/1PSB4X1DQvtA1MyXlnb/AGdS0hkltnCBQOSxZVwPWgD07xr4Y0/xh4butE1fzhaXG0loH2OjKwZWU88ggHkEVyY+D+hG1uPNv9Yl1WfUItUOrNOn2pbiMEIwwgTABYY2YOec8V53Pa/EGyuNUlt9U8X3Isp9IuLWOSLctw02PtSkCMbkTHKDAXJyKnv7r4jr8QPEA0lNdvV/0/7E0scltbW+ImEKlXQwyru27WVtxOC2BkUAet6J4C0LSvCFz4ba3e+067aSS7+2Nve5eRtzO5AHJOOgGMDFcL8Lvgfp/gH4i6tr9nciexkh8vT4XBL229j5gJ74AUBupDNnpk8douofEH+wNagtr7xFNemK0kntp7SQXduvmYnaBpQAzFc4C5Xj5SOK9PsfFNh4U8BX2rXb+JJ4EuDHaw61GyXlzIQoSKNXAdgzZA3DP3j0ANAHo1FeLXfw58TeP9Nk1bxp4h1DSdSlgP2HStLmMUFiSMr5h6yPnG48dwOMY6v4NeMIPE/gXSzdXCDWbVfsN9BJJmVbiIbW3Z5JON3/AAKgDvqKKKACiiigAooooAKKKKACiiigAooooAK8p/aUs21X4eW+koSDqOqWttx6F9x/RTXq1cd46SO58Q+B7OUBg+rvOVPcR2lwc/gxSgA+DurLrfwt8LXwzl9PijfP99F2N/48prsa80/Z6gfT/h1/ZEnDaVqV9YkHttuHP9a9LoAKKKKACiiigAooooAKKK47x/8AEfw74GiiGsXTSX052wWFqvm3EzdgEHTPTJwOaAOxrz+b4q+ErnxxD4MtbqXUNVuGaGRbWMvFEQpLB3zjgA5xnHfFcNJ4W+IXxXtrh/GN9J4S8OzL5ltpVmczuCDgXB4JAGCVJHP8KnpueKv7P+Dnw5sLPwla6Ra6xeXEGn281wojjllY/PLMxbdtChjksccDpQB2WifDvwlotytzYaDZ/alO5Z51M8qH/ZeQsy/gRXV1yHwl8XDxx4A0rW38tbuVDHdJH0SZCVcAZOASMjnoRXK/FL4jat4M8d6La29nFdaB9je91TCFpo4VkWMyJg/w7wxGDwD060AXr/4KeDru7nlWLUrWCdmeSztdQlit2LHLfIDgA5OQMD6VV+OiXumeFfDEPhgLb3iavb2VoRn9z5sUsAI5/hEnH0rM8MfGC+vfCGh3LaQNW1q/t76+kjtpFgiS2t53j3AtnJIC4Hc55Fb2lfEy18R6vFaaV4fvL62SyttUe6d4lW3jlRmUsrNu3DGPlDd6AN/wn4A8P+GoE+zWYvL8YMmo337+6lb1aRufwGAOwrq68ST47SyWD3cfg3UDEdK/tqMm9gG60V9kjnngg4wvJOegra8TfGGz0LXLO0/sx7qzm+ymWeK4UyQCfGwvEAdv3h95lJ7ZoA9TorivhPr+oeItE1W51WVZZbfV7y0jKoFxHHKVUcegHWvKfBXxh8VXPw/1jxbrVsk8FrYSTQwR6TNBA0omEa4uS5VwOdyqARzz8poA+i6pxaZYQ3JuYrK1juDn96sKh+ffGa8p8Q+KPGvgzwLLruraloerT3q26Wkcdo0EdtNK6jLMHO+IBuvBJA9a6T4ea/d3viDW9F1HxHbaxfaaEFxEmky2LwOSwPLErIh2/KV+uSCDQBveJ/Bnh7xRsOuaVb3MycJOMxzIPRZEIcD2BrnIvg74RViZ4dVuVPRJ9WumUe2PM/nXodFAHIaX8NfB+lalbahp2g2lteW7b45Y9wYH1PPPXvmuvoooAKKKKACmTRiaGSJiwV1KkqxUjPoRyD7in0UAch4Q+HegeFrtr2ziubvU2BX7dqE7XM4X+6rt90eoXGe9dVd20F5bSW93DFPbyDa8UqhlYehB4IqWigDzzRfhH4d0Txdaa5pU2qW8dq7yw6YLotZRyMjIXWNgSDh2xg4GeBWf+0FGyaP4R1BAT/Z/iawuGI7LvK/zYV6nXCfHG2Nx8LdckVAz2aR3y5H3fJkWUn8kNAFPwhpuoeJ7PTvEk/izVwzxTwm2tSiWsn7yVVfy2jzuAI59VH46w8Ka1HaWEMHjbWVa2hlikkeC3kacsWKu26P7y5AGOMKM9Tnz7wp4g+ImveH7a38D2+iNY20ksb67qpdYr5t7HMESDdsGcbiMHnHQ1tQab8Z5nVLrX/B1rGeGkt7SaR1HqA2AT9aAN74c3V5FL4pg1rW7vVG0y+8hru9tobfYogjcgGPAKjfnJA6n61zmgxRfE/4iweLAZD4Y8OO8Gkk52X1yRiScA/wIcKpHUjOeCKsWXwha9muZfGvirWNfS5uPtEtkrfZLORsKMNEhOR8o43Y9uTn0+ytLewtIrWxt4ba2hUJHDCgREUdAFHAFAE1cdr/wx8Fa/NcTar4a02W5uMmSdIRHKx/vb1w2ffOa7GigDybT/hPrWiyJ/wAI/wDErxPbwxnEcF5su40T+7tcY+nFesICEUM25gOTjGaWigAooooAKKKKACiiigAooooAKKKKACuC8UTLJ8XvA9oCC0drqF0y55HyxID/AOPtXe15kym5/aSUkZjsvC2c+jyXWP5IaANvwBHFZ6343sY2G6PWjcbc8gTW0EmfxZn/ACrsq4Pw65g+MfjK2bpcafp10v4efGf/AEFa7ygAoopGYKpZiAoGST0AoAWgZxzwa81vPjDoMPiGGxtrXUrzSzMLa41uC3JsLaUttCtKcDGcZYZAz1649KoAKKhvbhbSznuHGUhjaQ/QDP8ASvlPQfj34g8baLp/hSza00zxRqEzwz6xM6xQQwcncgJ/1m3j6jjk8AHrfxF+JV+ms/8ACI/DezTWPFj486TGbfT0PV5W6ZHoT9cnCnR+GnwusPCl3JruqzNq3jC8Xde6lMd3ztywiGBtXt0zgdhxWv8ADHwDovw+8PjT9CVpDMRJcXchBkuHx1JHb0A4GT6knryMjHP4UAJzkc8elZGs+GdH1vU9Nv8AVrGO7udO8z7N5rMUQyKFYlM7WJAxkg47YrYooA5TTvh54W02/ivLDSlgnivpNSj2TSBEuJE2O4TdtGV4xjHtWpf+G9I1DWF1S9sknvVtJLHe7MVMEhBdCmdpBwOozXhXibSNc8S/FXxxY6Ha3b3ttqGkyW2pfbhHFpYEMbyN5ZbLFlDDCqevOK2b34eeJ7jwv47mtZLy38R3+r3RsS+pPsksGuI5NihXKRl1UjOA3Y4BoA75vhb4ObQtO0caPtsNOEq2yJdTK8aysWkXzA+8qxJypJB9K2tO8K6Jpt7dXdhYJbzXNrFZSeWzBfJiBEaBc7VABI4Arzz4ceDPEljot9ajU9b8Mq9358cLfY7jAKAMqL+9VEyM4BBzngVh3XgXxd/wtWTVrxNRvrb+1Yrm3vra6hVVtMANBIjuGC43AqqEMTnjrQB6Unw18Jx2YtU0nEA0x9GC/aZf+PRn3tHnfnlhnd973qPUfhf4Q1G/+2Xeks05EAYpdzor+TgRFlVwrMoAAYgnAxnFeaaJ4I8dxp4kRo7uy+26dcRaE0uprKdI3SufJfByWcFcSLvKgbc1naV8PPF8WhT2kVhq9kLi/wBOkmgOowqoWNz5zxNHKSMqRk5Vm44yKAPftA0LTtAtZ7fSLf7PDPcSXUi72fdLI252yxPU9unpXI+BvAPgay0uWfw1psv9nXsEtm8NxcXMkTxl8SL5UzEDLKedoPXnB55rVfA9/ZeN3lGgXuv6EtvbQ6Vt1cxHTGRmMjP5j7mLEht43NgYxXH6t8P/AB1ceDPDFsdPvbrVLJb3zYJryGW33SXLtGZAZVOdhXDozFRxt4xQB7Dpfwu8G6XYX9ja6KjWl9CLeeKeeWdTGDkKBIx2gHkbcYIB7Vo+FPBOgeFJ7ufQ7J4J7pUSaWW5lnd1QYVd0jMQADwBxXkM/gLxn/wsODUryK8njjurOa2u7C9QR20aKokhYSuH8vIfICtvByeTX0DQAUUUUAVNU1Gz0qye81K5itrVGVWlkbCgswVR9SxAHuRSaVqthq1u0+mXkF3EjFGaFw21hg7TjoeRwfWsf4g2V5feHY0061ku7iHUbC68iN0VnSG8hlfBdlXOxGPJGcVSsYtVTXtW8Qf2LPCbmK0sksWniErhJH3zuVYoMLLwAxJEZ7kAAHVTXdvBPbwTTRpNcMUhRjgyEKWIHrwCfwotLu3vEka1mSZY5Gicoc7XU4ZT7ggg1zvjDQ7jWdZ8NPEbhLe0upZbiWCbynjU28iggggnLMBx6+lca3hHVbaEx3Wk3Or2Qm1Mx25uo96ySzq0FwzO4BO0N82d6FuBycAHq13cw2ltJcXMixQRrud2OAo9TUteW3/hDW57DxDNP593rDabBbWU4uiqvKIdsrKpYKpLdyAfemX/AId1W+1fxNdwaJeWE8gMNoyXMSxXEQkVpSxWXcHmAYAlRsXHQlqAPVaiW5ga7ktVmiNzGiyPEHBdUYsFYjqASjgHvtPoa82svCd3dajZrcaObTw82qSTnS5pIysEP2PZhkR2Ta0wLbFJAzuOCTjM07wrr9hby3D6It5qsvhu1sElmmjcRzRG4EiSZcFtySxgEEgkclRzQB6xd31taXFlBcyhJbyYwW6kH944jeQqP+ARuefSsfxfqegJp91pHiC8jihvraSOaPJz5LAozHH3V5I3HA964rwv4W1mz1jTnNjc2+m2+vG9SKdrZDDCdNmhYhITsUGZwNq8/NuOeTW3430zUn1eW+8PWmsxaq9ksKX1jcWwiYqzlI545jyqlycqpOHYDnggF3wzqfhTQLPT/C+k6nbg2iLawwGTdIcHaM+pJ7+tdLqd9baXpt3qF/KIbO0heeaUgkIiqWZuOeACaw7TTtQXxpDqN1HGYhpK20ksZAXzvM3EKpO7HeuZ+LXhzUteh1aKDSW1eK40S4tbJBJEotbtg2JCJGUfMCgDDJG09AaAPS6O/tXmsXhvVx8QptSu47+RTfCa3u7drfy1t/LC+S5ZhKFHzZRVKk4bqSRynhLw/q2seA9HudOsLyyS60bTUuXN0iSX8nmwu04ZJCRiMSfMxVyHxjgCgD3WivLZvB+oW/jcTxQag2nx3VrJYz2skBFrAgQSRO0rCQKzCQsEDblkx1FZVl4Q1iPSLyyk0i9+yiS2kQuto9zdOnmbvtI87yrhOUJZijk8kHAoA9iS5he5lt0kUzxKrOgPKhs4J+uD+VS15LD4c8Rt9kk1PSVnsY0sftWl28yeXOqR3KvGqvJtAV5IHKs207MAtii78G6xe6QYbqzeXy9J1JbSGS4Vvs88k++1jzuxvjjwofJAK8N0oA9aoqGzEotIBPnzhGu/Jz82Of1qagAooooAKKKKACiiigAorl9c8feGNFvmsbzWLd9TB2/YLXNxclvTyowXz+Fc/Fp3inxvfLe6pdap4S0KNCsGnWs6LeXDE8SzSKD5YxwIwSfU9qAPSK4Pw1D5vxe8a3jc+VZ6faqcdOJXI/8AH1rP0rxFrfgh5NL8cRajqmmxbnt/EVtamYNHnhLiOIFlcdN+Cp4JIOa2PhzcJqt34o1yG3uorXUdRRrV7iB4WlhS2hjDhXAO0usmMigAa38j4yxXOB/pugPHn18m4U/+3FdpXDeL7k2XxM8BS79qXRvrFvQ7oVlA/wC+oBXWa1qthoel3Gpavdw2djbrulnmbaqjOBz7kge5NAF2vMtZN18RvEt1odlctB4R0qXyNXZQc6lKVybZGHRF4EhyCSdvqakutR1z4glbPQob/RPDDOrT6vLmGe9h/uWyffQN/wA9GwcfdBzXdaFpFhoOk2ul6RbJa2FsmyKFM4UZz1PJOSSSeSTk0AZ/irw1baz4G1Pw3bpFbW9zYvZwqq4SHKFUwB2U449qj+HWsrr/AII0bUA26Z7ZEnU9UmUbZFPuGDCujrzi+0PWvBniDUtZ8F6bDqWlak3n3+jLMIJPtOcG4hZvlywxuU4ztyDnigDt/ENlLqWganY28ixT3VtLDHI3RGZCAT9Ca8P+Hv7MnhvQ2W58VXD69dj7sO0xW6/8BB3Mfqce1ep+FPHmleIL9tLkju9K15EMkmlajF5U4UfxKOQ6+6k/hXW0AV9PsbXTbKGz0+2htbSFQkUMKBERR2AHAFWK5jUviB4P0y5e21DxRolvcRkh4pL6MOp9CM5FP0Lx34U1+9js9F8RaVfXkillgguUaRgOThc54HNAHSUUUUAFFFFAHjX7Ut/c6T4O8O6haTzQNba/ayM0TlCVCyHBI7ZxXsoIIyDkV4/+1fYtefBXVZEXcbWeCf6DzApP5PXpnhW9Go+GNIvlbctzZwzA+u5Af60Aan1ooooAKKKKACiiigAooooAKKKKAMTxReXUI0uz0+XyLjUbxbYT7Q3lKEeVyAcgkpEyjIIBYEggVnah4ql0/wAR/wBm/ZY9SV5ETZpzmS5tw2PmmjxhU77yw46LWxr+lvqcFsba4FreWlwtzbzFN4VhlWBXIyGRnU8jhjjnFRT+HLCa/e7aTUkldxIyxalcxxkjH/LNZAvbpjmgCtDquof8J/PpEy2w04aeLqEpuMpbftO4ngD0A/PtVfxf4sk0C5eGDTTeNFYT6lKTOIwsMJXeBwcsdwwOAe5HWtT/AIR7T/8AhI/7d23X9peX5W77ZN5ezGNvlb9mO/3evPXmn6noWnanLLLfW/mvLaS2Lney5hkxvTgjrtHPUY4NAHNv45njmktZNIIvjNaxwxC5BVluA/lszbflI8ttwAbHYtU3h/xlNqepWVtc6X9ljupLu2SQXAkPn20hjlXG0fJlX2tnJ28quRWzJ4a0mS9W7e0zcK0DB/MfrDu8vjOON7fXPOeKfa+HtLtJraWC22SW81xcRHzGO2S4dnlPJ53M7HB4GeMUAcnrfinVbDxvfW4hMmnWkdnFDBHIi/aJ7l3jXeWUkKCB90jAVjhsgC7F42nl1K10yLRZZdUeaeC4ijuE8uAxCJmbe2NylZkIwM84IHON6/8ADul373z3VsXe9WFZmEjqT5TFoipBG1lYlgy4IODngU3T/DelafPaz2tu4nthL5crzSSOfNKmQszMS5OxeWyeKAOa+I/iPVtHvYLfR1kYCxubyT7Pa/aZA0ZQRhkyMRsWYEjLZAxgAmq8XizVJ9QN5HPanToNTstMeCJN6zefBDIZVkzng3C47YQ8ZOR12t+HNM1qaOa/hm85I2hEkFzLAxjbG5GMbKWU4HynI4qIeFNFXVIL9LLZPDsKKkrrECilEYxA7CyqcAlcgAegwAQ+J/EM+kXtnZWWni9urmCe4UPP5SKsOwtk7WOTvGMDr6DkYLfEVxZvOdGlAktrW9t/325fInZlV5iqkx7dhLYD4BHJ5x2d5pdneXsF3cw77iCKWGNtxG1JNu8YBxzsX6Y4rOPhLR/LhSOCeHyraGzjeC7midYoiSihlcHjc3OcnPOaAObuPiXAklultYfbj9miurg2crTqEkdlAiKIRIfkY4OzjHfIGrbazrHiHSry40S1SzhZZDYXckyuZXjfaBJGV+VHIPIYnb/dOKtL4L0KMQeRbXFu0Mfkhre8mhaRNxfEjI4MnzMx+fPLMf4jlJ/CdtDa366HPPptxeLIpcTSyRxCR90jRxF9iOTkhgOGOSDyCAbGi6hHq2j2GowKViu4I7hA3UK6hgD+dXKitLeKztYba2QRwQoscaDoqgYA/IVLQAUUUUAFFFFABRRRQAUUUUAUbXSNNtNQub+10+zhvbnma4jgVZJf95gMt0HWr1FFABRRRQB5Z8eLoaSvgbWnkSGKx8SWvnyucBIXWRHJPpg1a8NWEnxBv4fFPiBUk0GOQyaFprIQm0H5LyUH70jDlQRhVIP3iTXW+M/C2leMtBl0fX4DPYyOrlVcqQynIIIrYt4YraCOC3jSKGJQiIgwqqBgADsAKAJKKKKACiiigDmPG3g2y8UwwTedLp2tWbb7HVbUAT2zegJ6oejIeCCfrXMv4b+IWu239leKPEWkW2kbgJrjRoJYru7jH8LMzbYt38W0E8YBANem0UAcjYfDPwPYQLFbeEtD2ryDJZRyN+LMCT+dauneFvD+mX5vtN0LSrS9II+0W9nHHJg9fmAzWzRQAUUUUAFFFFAGR4u0WLxH4W1bRrgDy761kt8kZ2llIDfgcH8K4v8AZy1abVvhBoX2o/6TZK9hIPTynKKP++Qtel14r8GLr/hGviZ4+8BzYCLdnWbH3im2ll+i7ox9d1AHtVFFFABRRRQAUUUUAFFFFABRRRQAUUVgeP8AXJfDPgjXNbt4o5Z7C0kuI0kztZlUkA45xmgDforC8C643iXwZomtvGsUl/ZxXDxochGZQWAz2BzW7QAUUUUAFFFFABRRRQB4b+1FqOpNbeDPDmiX1zZX2tauiB7eZo2IXA6g9A0iH6qD2r2+GPyoY4wzsEULuc5Y47k9zXg3jYHxX+1F4Q0u1HnW/h20a+vCvIhdssoP4iD/AL6r3ygAooooAKKKKACiiigAooooAKZNKkELyzMEjjUszMcAAckmn1FdQRXVtLb3CB4ZUMbqf4lIwR+VAGJomvXmrfY7iPRLmLTLxd8Vy8sYZUKllZ485UMMYAyw3DIXnF/xHq0WhaFfapcRvJDaRNK6R43EDsM1zWm+CZ7fVtAurrUbS5XRcpby/YNl3JH5MkSxyzb8MoEpbAQZZQeK27/RJtW8Hz6LrN7589zam3nu4YhFuYrguqZIXnnGTQBa/taL/hIv7H8uTz/sv2vfxt279uPXOahm8S6NAzLPqVtGymYEO+CDCMy/98jk+3NVtH0S+h1ybV9Y1C3u7xrZbSMW1qbeNEDFiSDI5LEkc5AAA46k4HiH4a2utX2tXL3zxNqMkbqPK3CAeWIrgLz/AMtYhtPp15oA6WXxRpMN4LWa4kjkZdys9vIsb/u/M2rIV2ltgLbQc4B44NLc+J9Gto0eW/jIkgS4jVAztIjnahVVBLFjwAASewrAn8CST+MINbl1CCVYb/7bGJbQvcIPJMfkrMXwsfzFsBB75PNUU+F9tHpk9sL/AMyVbyO4s2mtw0dvBFuEVsUDAvGqySDqp+bORigDsm12ybw/c6zbSCazgillY/cI8vO5TuxtYFSCGxggg4xVePxXoz6kmn/bB9sZ1iKBGKrI0YlVGcDaGKEEAnJ7ZqrD4XCeCtQ0DzLOA3kNxEZLS1MUaGUMCwjLsSfmyctyc9M8VYvBeyeaT7fnzNWt9Ux5PTyraGDy/vd/J3Z7bsYOMkA1pPFOiR2lrdNqMHkXVt9rgYZPmRZRQygDJy0kagdSWAAJqFvGOgIlq0upRxNdSPFFFKjJIzoQGTYQGDDcMggEA56Vzs3wytpbfWI2v2YXVxHNZq8IKWaJMZxFtz86GV3J5U7SqjG0GtPQfB39mapYXxmsUe2Fzujs7MwJIZhEMkGRzkCIcknOe2KAL0Pi/Sbq3Sawma4ieeCFX2NGr+a+1HRnADqTnBUkHHGaVPGOgPFdSjUolit0815HVlUpu271YjDru43LkZ4zXPaZ8PJbTKtqsSQC6s7hLW1tnit08iUyHbG0rhWfIBKbVwB8pxSD4dSvpdvp8+ro8FhYf2ZYFbUq0UHmQufMO8+Y2LeJcjb0JxzQB2ej6vZaxBLLp8rOsUhhkV42jeNwAdrKwDA4ZTyOQQehFX6ytG0j+zdR1268/wA3+1L1bzbsx5WLeGHbnPP+p3Z4+9jHGTq0AFFFFABRRRQAUUUUAFeJfFm2PhD4u+DfH6AtZXDjQ9QRTjaJN2yQ+uMnP+4vrXttcf8AFzwovjT4e6xowLLcSRebbMvVZkO5PzIAPsTQB2FFed/ATxnL44+Gun6je/8AIRt2ayuzzzLHj5ue7KVY+7GvRKACiikQsV+YAH0BzQAtFFFABRRRQAUUUUAFcF8eX2fB/wAVer2ZjH1Yhf613tcV8YYEvfBDae7bRfahYWuR1w95Cpx+BNAFb4Ewz2nws0Wxu8fabA3FjIB2aGeSM/8AoFd9XC/CmcsPGFoc/wCieI7xBn0crN/OU13VABRRRQAUUUUAFZ/iDV7TQNDv9W1JylnZQvPKwGTtUZOB3PoK0K8I+K2qS/EzxlD8L/D0s6WkEi3HiG8j4EcK4IiUnqSSM++OuGwAaX7OVldanbeJPHmpQrDceKL4zQRk7mjtoyyoM/XcPcKDXstVNI0610jS7TTtPhWGztYlhhjXoqqMAfpVugAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACgnAyaKy/FN6dN8MavfA7Ta2c0+cZxtQn+lAFXwN4q07xp4Ztdd0YzfYrguFEy7XUqxUggE9we9b1eR/sxWUulfDqbS5yS9nfMOfSSKKYfpKK9coA8LE8Hwv+PcqTJ9l8M+M418or/q479WAOR/Du3c+7jsDj3SvC/2s7zw+PBEdnrRv4NTVvtWmXEFu7RidQRtZ/ujIyMZyODjisP9nL4p+J/iL48uIdflgFrYaQwEdumxZJTLEPMcZ5bAPTAGTgDJoA+kKKKKACiiigAooooAKKKKACuD+K8h3eDLcdLjxJZqfogeX/2mK7yuA+JGZfF/w5t/72syTY/3LSc/1oAT4eDyPHnxItOgGp29wB/10tIufzU/lXoFcVokUVn8W/FKKcSXumafdkE9Sr3EZI/BUrtaACiiigArN1XXNM0m70611K8it59Rm+z2qOcebJtLbR+A798DqQK0q+OP2sPEerah8VNO0zRluGOgRxyxmCMsyXD4k3cDrgRY+hoA9v8Ai18Rbyyu4/CPgCJdT8aXpCFIxvWwjPWWUjhSMjAPTqeMA9H8KvANl4C8PLbR4udXucS6jfsS0l1MepLHnaCTgfj1JJ4r9mCy0yLwtc3a6TrFr4juCr6rd6pDIGuZCWOUduGXqcDkZGeTmvaqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooIyMGigAooooAKKKKACiiigAooooAKO9FFABRRRQAUUUUAFcL8c7wWPwf8XTH+LT5Ief+mg2f+zV3VeY/tIAzfCTUrJSQ97c2lsv/ArmP+gNAE/wxBs/FvjHTSMCMadOB/vWaR/zhr0evM9HuDa/tDeIbEcLeaBaXX/fuWRP/Z69MoAralYWup2E9lqNvFc2dwhjlhlXcrqeoIrgfh18I9E+H3irVNV8Oyzx2t9brD9jlO8RENklXJyQeODnp17D0eigAooooAKKKKACiiigAorM1DxDo2mlxqOr6daFPvCe5SPb9cnivONR8Sax8StQfSvh5fz6ZoVrIv27xEsXE46GG13D5j6vwBgYzkZAPWq4Pxipl+KPw9jAyI21C4J9Atvs/wDatc3a+I9Z+F2q/wBm+PL+61fwxdMf7P1wwl5LU55iuio9CMP3we33eiTV7DWfi1og028tryGHQrycSQSrIhEk9sAQRn+4aAIb64Fp8ftKRjgX/h+eIe7Rzo4/Rmr0SvKviKTafGz4WXYB2StqNq5HfdApUfmK9VoAKKKKACigkAZPSvN9b+KkK65Jo/hDQdT8VXsWBNLp+0WsLH+B5ydobpkdvrxQB6RRXl2pfEfxToSxzeIfhrrAtH436RdR6g6n/aRQpUe/SmaT8atIm1KG28Q6H4h8LwXBxBea3Z/Z7d2/ul84U/Xj3oA9UoHNZdn4h0W9jElnq+nXEZGQ0Vyjgj6g1GfFGgCYxHXNKEo6obuPP5ZoA2KKrWN/Z6hGz2F3b3KKdrNDIHAPocGrNABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABiiiigAooFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcH8XIBd2nha1YArN4hscqehCOZCPyQ13lcj40KS+JvA1sxBJ1WSfb6hLO45/BmWgDB1WH7L+0ToF3/AM/vh+6tOn/POaOT/wBmr0yuH+J+laq8WleIfC9lHe+INEnMkVu0gj+0wSDZNDuPAyMMCe6Csqy8QfEjxFcMlh4WsfDViePter3PnygdysMZHPoGYDigD0LU9SstKspLzVLy3s7WPl5riQRov1J4rjD8VdCuQJNDstd160DFZLvStNlnhjI6/PgBsei7jTbT4X6beSLc+Nry58W36tuR9SA8iL2jgXEa54zwSfWu7treG1t44LWKOGCMbUjjUKqj0AHAFAGd4Y8RaV4o0pdS0K8S7tGZkLKCpVx1VlYBlYehANa1eZ29pb+DvjL+5kaHTfF0Ekhgz+7GoRbWLAdAXjLE+pSvTKACiiigAooooA5eX4e+DptUm1Gbwvost9NIZZJpLON2ZycljkdSec106KqKqooVVGAAMAClooAR1V0ZXUMrDBBGQR6Vz/h7wV4a8N6jc32g6JY6fd3K7JZLeIIWXOcYHAGQDgeldDRQB558XIQuoeAr8L89t4jt0LeiypJGR+JZa7h9SsUvhZPeWy3hAIgMqiQg9DtzmuH+PlzJpvwyvtXtollutJubTUIVboWiuY259sAj8ax/Cfwd8L3nhexuvFGmLqHiG9jF3e37yuJjO/zsVcMCu0nAxjoPegD1uivN0+H/AIj0yXd4e+IuuRR5yIdVhi1BcemWCtj/AIFn3pLnwP4y1Zfs+t/EW7Fi3+sj0rTY7KVh6CXc7D8KAKPiPVb34k6q/hnwtJcQeHIZtmsa3EcJKF+/aQnglmyAzg4Az16H0jQtG03QNLh07RbKCxsYQdkMCBVGeSfck8k9TTfD+i6d4d0e20vRbSO0sLddscUY4HOST6kkkknkk1o0AFRXdtBeW0lvdwxzwSDa8cqhlYehB4NS0UAcRd/CbwDdymSXwlo4Y8ny7cRj8lwKd/wqnwFsRf8AhENEwvT/AERM/icc/jXa0UAYvhjwroXhaK4i8O6Va6dHcOJJVt02h2AwCa2qKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACs7xBrmmeHdLk1HXL6CxsYyA00zbRk9B7k+grm9V1/wAaW19cw2HgiC9t1dlguP7ZjjEi54ZlKZXI7DOPfrVLQfCGpax4lg8U+PhaPqNqpTTtMtnMlvYg9ZCWA3yn+9gADp2IAOp8L+KND8V2T3fh3U7bUII22OYW5RvRgeQfqK53xPL5nxc8D2oOQlrqNyw9CFiQH/x9qPF/gu/n8R23ijwffw6br0MZimhmUm11BOyzhcHK5OGGSKh8M6B4sufHEXiPxk+hRG1sJbG3t9LMsmfMkjdnZpAMY8sDAB6mgD0GiiigAooooA4v4s6Dd6z4Ue50VCfEOkyDUdMYYz58fOzngh13IQePmp/gf4gaL4n0y2LXtrZ6ztCXmmTShJ7accPGUbDcMCM45xXY1z2u+CfC+vyyS614e0m9nkG1pprRGkI6ffxu/WgDoaK8x0/wP4n8HTXEPgHWrFtFmfemm62k062h7rDIrhgp/unOMe5q0138VYeG0rwbde8d9cR/o0Z/nQB6JR3rzv8At74ljg+CdFYjqV1zAP5w1peH9U8cXmsQJrfhrSdM0zDedLHqhuJc7TjaojUctjqemaAOyrhvG1xrD+MdB03SJrhYprC+uJo4Z0hLNHJaqrFmRunmuMYH3vau5rO1bQtI1l4W1fS7C/aEMIjdW6SmMNjdt3A4ztXOOuB6UAWLCQeRHBJIGuYo081DIHZSR/ERjrg84Ga86utU1a10/wAQ63Fq9y09jqz20Fg4jMM6h0VYQNu7c27AIOckdRkH0W00+ys5Hks7S3gkdEjdoolQsqDCKSByFBIA7dqqR+HdFi1RtTj0fTU1FmLm6W1QSljwTvxnPvmgDjLrxjq0ltNNFp9jdw3R1GC0s8N5gktfMAEp5BDmIggKNhZR81MtPiTLf3c0djp8ZhEM9/A7Of3lnHGyiTjoWnXb6bSD3rvLfSNNttRn1C306ziv5xiW5jgVZZB/tOBk9B1PaiLR9Mhjjji06zRI7c2iKsCgLCcfugMcJwPl6cCgDhF8Y+IyksEdjZ3F2bawvg1vE7+TDcGcEeWXDTMnkH7pUkNnA2nNa18ZX1xr4NjcwTjUbDS44GdJFt4ZZZb7fIYzhgSIVXaSCSFUnvXf3fh/Rr2Mx3mk6fcIUjjKy2yOCse7y1wR0Xe+B23HHU1im68KyaVcS3tjYQaT5g00y3NvGsEqQltq56CNW8wLuwM5x94EgGFN441h4JVt4NMintLTULm4lm3mKQ2k4iITBG0PycknZ0w2OZbbxdql5rEtjp8cUUl1qotYzeqXFun9mw3J+RdpJyxGC3Uk57C/4n0vwdpkNlr+tW1l/Z2n2zW9tF9mSSBFdlcFECnDfIMEdia6mSy06CZ72W2tI5RIbhrho1DB/LEZct67AFz12gDpQB55a/ELU77SodRt7axhihh057qGQMzSNdSBD5ZBG1VzkEhtxyOMZrsPEeq3ttqulaVphto7q+E0nn3SM8aJEASNoZSWO4Y5GAGPOMHDvtC8Ia7qukSJqOnlICkdpZWv2Xaxhk8zajBDIMMFyqOB8uCOTnd1fUPC19G8esXeiXEdpIjst1JE4hc5CEhj8pPIB+uKAOA8JeN9fn0Tw7b2lg+pSQ6Npt1fSyfNJOZ4wWfeXGzADNuIbcQR8uM1qXXjzVbS1uL6W1spLUvq0MMKbxIrWTzAO7ZwVYQ4IAGCy8nOB0yad4dvdVGmTaHY/aNJhi+zLNaRlY4T9ww8HaoKEYGMFemMEyaP4P0PSlv/ACdPtpZb+W5luZ5oEaSYTyvK6O20bky5ABz8oAOetAHKah4z8TW94LODR7W5votPTU5Ybcl1kR3dViV2ZNpHltlyCBuX5Rmp7rxhrsGo6tZnT4PtirOdPszEwM6RzInmLNu8uT5XDGMbHBIXnk12Wp6FpGqrAuqaVYXqwf6kXFukgj6fd3A46Dp6VGfDWhNJeSNoumGS9BF0xtI8zgnJ3nHzc8855oA4W48f3UJs5QUuZfsl8JU8mS1RZo7m0hXzI3y6bfPJPzEYyecgjS/4SnWzqyaGqaadR/tFrB7zypPJwLQXIYR7s5wQpXf755xXWw6FpEEEcEOl2EcMcUkCRpboFWOQgyIABgKxVSR0JAz0p1loul2EVvFY6bZW0ds7SQpDAiCJmBDMoA4JBIJHXJoAr+ENWfXvC2larLEsMt3bJM8anIViOQD6ZrXqK0toLO2jt7SGKC3jXakUShVQegA4AqWgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKK5xvE5bxRcaLb2EkrW5iEsxnjQASDOQpbc2B1wK29RvItP0+6vbjf5NtE0z7FLNtUEnAHU4HSgCxRXJ2Hiu+vdJOowaDJLbNEJo3gvYJAyYyQSGwGAxwMj3rV8L6y+uaJb6nJYy2MNxEk0SyyIxaNlDBjtJA4PSgDXorlrrxvpQshPp8huybqzt9m1o9yXNwkKyqWHzplyQy5U7SAatjxfoXmzRnUEUxHlnRlRsOsZKMRhwHZVJUkKSAcUAb1FY2oeJdKsHuVnnld7Z/LnWC3kmMTbA/zBFOBtZWyeACKz5fHOkC71O2iaWWSwjhldwAIpElClSkmdp4YdSPbNAHU0VhnxXogubuBr9Fe1WV5WZWCYi/1u1yNrFP4gpJXvirWja5p2teeNNuDKYCu8NGyEBhlWAYAlSOjDg9iaANKiiigAooooAKKKKACiiigAooooAK4bT7PWv8AhCrLSdMV7W+0+QWVw0sht/OjRSvmJIYZAQ/yNkL/ABEZDAiu5ooA4C98KXy/DfUvD+jaZpdlc3nmLsbUJZIxv6yGQxbixPbb+Nb/AIt0q98QeCdS0wrbQX17atEVMjPErEdN20Ej32/hXQUUAcNeeDbiTVdRurf7FGLjV7C/jxkMIoFiVlOF6nY2B056jJqhZ+ALqG106J/7PLW+k6nYuRnmW5liZGHy9AEkDHr83AOTXpFFAHJ6DZXK+ILJZYnVdJ0pbKScowW4lkMbHYSBuCCIfN0zJjqGA6yiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAwrTw3aw+JtS1qZIJ7i68nyy8I3QbFK8Nyec57Vftbe/TSmgub5Jb4hwLpIAgBJO07MnoCB15x2zV6igDjtD8GGw1O/1CebTkuru1Nq403T/skb5Od8i+Y5dwehyMAkd629L0WOz8KWmhzSmaKGySyeRRsLgRhCQMnGcZ6nFctHd21l4Q1XV7y6uIbq41CbzbiCeKKRHSdokTdKRGAioq4b5Tg8EnnN1PXbi6+Fvii61DxJpgeCCX7PdaZep5ifISiySL8vmE8fIB149aAL2m/DgWdhDa/a9PHkS2TpPDp5jmdba5imCyN5hDFvKxlQoBYnB4FP0b4a2VjDc2VwbG506W2ntFP2MrdCKTqrTbyDgcZCKThSenPRDVVbwQ+qadcxXGyxaWOZHEisyoecjg8iuDm8ReIraG8mfVzL9k07TNV2G2jAka5llR4TgZEYEPGPny3LEDFAGvL8OriTSLG1uNYivbhDcPeve2XmxXkkxU+aYhIoDoFCoSWAUkYJwRJF8PpodLuNOi1eP7NcWNnay7rQl99uFUOp3gAELypB5/i7VTg1jXr7WbWJdXa3gvdWv9N2R28R8mODzGR1LA5f8AdYJbK4b7ueat+FdQm1Cfwhq8rJ9v1bTXW9WMbRKEVWEmP9liQPTziPSgCS78AS3Vrc2Mmqp/Z4F81ogtj5kL3QkDF334kC+a4A2rxjJJGa6LR9C/s7Wb6/8AtHmfabW2tvL2Y2+T5nzZzznzOnbHetqigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAKllp1tZXF5NbRmN7uQSzDexUvtC5Ck4UkAZwBk8nJ5q3RRQAUUUUAFVF062XVH1HyybxohBvZ2IVAc4VScLk9cAZwM5wMW6KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     A: Normal resting electrocardiogram (lead V5) before exercise; B: Normal J point depression during exercise; C: Upsloping ST depression of subendocardial ischemia; D: Horizontal ST depression of subendocardial ischemia; E: Downsloping ST depression of subendocardial ischemia; F: ST elevation caused by transmural ischemia; G: U wave inversion.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20689=[""].join("\n");
var outline_f20_13_20689=null;
var title_f20_13_20690="Pathogenesis of angiodysplasias";
var content_f20_13_20690=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F76997&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F76997&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 478px\">",
"   <div class=\"ttl\">",
"    Proposed mechanism for the development of angiodysplasia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 458px; height: 334px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This cartoon depicts one possible explanation for the development of gastointestinal angiodysplasias. Mucosal and submucosal venous drainage is intermittently obstructed by muscular contraction or increased intraluminal pressure (panels A, B, and C). After many years of intermittent obstruction, submucosal veins may become dilated and tortuous (panel D) and involve additional veins and venules draining into the system. Eventually, the capillary ring dilates and the precapillary sphincter becomes incompetent resulting in a small arteriovenous communication lesion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Boley SJ, Sammartano R, Adams R, et al. On the nature and etiology of vascular ectasias of the colon: Degenerative lesions of aging. Gastroenterology 1977; 72:650. Copyright &copy; 1977 Elsevier Science.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20690=[""].join("\n");
var outline_f20_13_20690=null;
var title_f20_13_20691="Rimexolone: Drug information";
var content_f20_13_20691=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Rimexolone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?39/0/39940?source=see_link\">",
"    see \"Rimexolone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F217246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Vexol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F217247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Vexol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F217266\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Corticosteroid, Ophthalmic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F217248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Anti-inflammatory:",
"     </b>",
"     Ophthalmic: Instill 1-2 drops in conjunctival sac of affected eye 4 times/day beginning 24 hours after surgery and continuing through the first 2 weeks of the postoperative period",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Anterior uveitis:",
"     </b>",
"     Ophthalmic: Instill 1-2 drops in conjunctival sac of affected eye every hour during waking hours for the first week, then 1 drop every 2 hours during waking hours of the second week, and then taper until uveitis is resolved",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F217249\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F217235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, ophthalmic [drops]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vexol&reg;: 1% (5 mL, 10 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F217222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F217236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of inflammation after ocular surgery and the treatment of anterior uveitis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F217271\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Vexol&reg; may be confused with VoSoL&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F217264\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 5%: Ocular: Blurred vision, discharge, discomfort, pain, increased intraocular pressure, foreign body sensation, hyperemia, pruritus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;2%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Taste perversion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Pharyngitis, rhinitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Ocular: Browache, conjunctival edema, corneal edema, corneal erosion, corneal staining, corneal ulcer, dry eye, edema, increased fibrin, infiltrate, irritation, keratitis, lid crusting, photophobia, sticky sensation, tearing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Frequency not defined: Cataracts, damage to the optic nerve, defects in visual activity, perforation of globe, secondary ocular infection",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F217239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to rimexolone or any component of the formulation; fungal, mycobacterial, viral (including dendritic keratitis, vaccinia, varicella), or untreated pus-forming bacterial ocular infections",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F217226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Immunosuppression: Prolonged use of corticosteroids may increase the incidence of secondary infection, mask acute infection (including fungal infections), or prolong or exacerbate viral infections. Corticosteroids should not be used to treat ocular herpes simplex. Fungal infection should be suspected in any patient with persistent corneal ulceration who has received corticosteroids.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ocular effects: Prolonged use may result in glaucoma and injury to the optic nerve. Visual defects in acuity and field of vision may occur. Posterior subcapsular cataracts may form after long-term use. Use with caution in presence of glaucoma (steroids increase intraocular pressure). Perforation may occur with topical steroids in diseases which thin the cornea or sclera. Steroid use may delay healing after cataract surgery. Intraocular pressure should be monitored if this product is used &gt;10 days.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300003\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6222783\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aldesleukin: Corticosteroids may diminish the antineoplastic effect of Aldesleukin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticorelin: Corticosteroids may diminish the therapeutic effect of Corticorelin. Specifically, the plasma ACTH response to corticorelin may be blunted by recent or current corticosteroid therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Corticosteroids may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Corticosteroids may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving corticosteroids (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: Corticosteroids may decrease the serum concentration of Telaprevir. Telaprevir may increase the serum concentration of Corticosteroids.  Management: Concurrent use of telaprevir and systemic corticosteroids is not recommended.  When possible, consider alternatives.  If used together, employ extra caution and monitor closely for excessive corticosteroid effects and diminished telaprevir effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F217231\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13386461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Rimexolone was shown to be teratogenic in animal reproduction studies when administered subcutaneously. The amount of rimexolone absorbed systemically following ophthalmic administration is not known.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F11569324\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F217240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Vexol Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (5 mL): $55.62",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F217233\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Intraocular pressure and periodic examination of lens (with prolonged use)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F217241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Baxol (KP);",
"     </li>",
"     <li>",
"      Rimexel (LU);",
"     </li>",
"     <li>",
"      Vexol (AR, AT, BR, CH, DE, DK, ES, FI, FR, GB, GR, HK, IE, IT, KP, MX, NL, NO, NZ, PT, SE, SG, TR);",
"     </li>",
"     <li>",
"      Vexolon (BE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F217225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Decreases inflammation by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F217238\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Through aqueous humor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic for any amount of drug absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine and feces",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9867 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-4D580CFE0A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20691=[""].join("\n");
var outline_f20_13_20691=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217246\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217247\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217266\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217248\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217249\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217235\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217222\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217236\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217271\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217264\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217239\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217226\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300003\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6222783\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217231\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13386461\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11569324\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217240\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217233\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217241\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217225\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F217238\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9867\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9867|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?39/0/39940?source=related_link\">",
"      Rimexolone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_13_20692="Doppler echo cardiac tamponade";
var content_f20_13_20692=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51257&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51257&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Doppler echocardiogram in cardiac tamponade",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 329px; height: 495px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In cardiac tamponade, the Doppler echocardiogram shows respiratory variation of left sided Doppler flow signals. Drift in ECG baseline identifies respiration. Panel A is recorded from the left ventricular outflow tract; the arrows denote the peak forward velocity of each beat, demonstrating that respiration causes a change in velocity that exceeds 25 percent. Panel B is obtained from the mitral inflow; the large and small arrows are the E and A waves, respectively. The E and A waves change in amplitude with respect to each other within each beat (ie E&gt;A or A&gt;E) and to their analogues in neighboring beats. The pattern of mitral inflow and E/A ratio are similar to those seen with the major types of diastolic dysfunction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20692=[""].join("\n");
var outline_f20_13_20692=null;
var title_f20_13_20693="Telbivudine: Patient drug information";
var content_f20_13_20693=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Telbivudine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/15/3317?source=see_link\">",
"     see \"Telbivudine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F3424967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tyzeka&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F4414326\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Sebivo&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10028503\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700716",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause liver problems and a change in acid levels in the blood. Closely read the part in this leaflet which lists when to call your doctor. Pregnancy, obesity, and/or longer therapy may raise this chance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10028505\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691881",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hepatitis B infection.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10028504\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to telbivudine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10028509\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697039",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are being treated for both hepatitis B and AIDS, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To protect from diseases caused by having sex, use a latex condom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2770240",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10028510\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697883",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Back pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698249",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698195",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698350",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sore throat.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10028512\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698656",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling cold.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10028507\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10028508\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10028513\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10028514\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11877 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.80.101-E34D2EC933-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20693=[""].join("\n");
var outline_f20_13_20693=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3424967\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4414326\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028503\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028505\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028504\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028509\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028510\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028512\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028507\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028508\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028513\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028514\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?3/15/3317?source=related_link\">",
"      Telbivudine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_13_20694="Ethanol intoxication in adults";
var content_f20_13_20694=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ethanol intoxication in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/13/20694/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20694/contributors\">",
"     Ethan Cowan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20694/contributors\">",
"     Mark Su, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/13/20694/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20694/contributors\">",
"     Stephen J Traub, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/13/20694/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20694/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/13/20694/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two-thirds of American adults consume beverages containing ethanol (ethyl alcohol), and moderate ethanol intake appears to reduce the risk of myocardial infarction and other heart diseases. However, up to 10 percent of adults in the United States abuse ethanol, and acute ethanol intoxication is associated with a number of complications including traffic accidents, domestic violence, homicide, and suicide. Uncomplicated ethanol intoxication is estimated to be responsible for over 600,000 emergency department visits each year in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/33/31258?source=see_link\">",
"     \"Cardiovascular benefits and risks of moderate alcohol consumption\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/22/2409?source=see_link&amp;anchor=H7#H7\">",
"     \"Alcohol abuse and dependence: Epidemiology, clinical manifestations, and diagnosis\", section on 'Adverse consequences'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An overview of the pathophysiology, clinical features and management of acute ethanol intoxication in adults will be presented here. The health effects of chronic alcohol abuse, the recognition and management of alcohol withdrawal, and ethanol intoxication in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/61/20441?source=see_link\">",
"     \"Management of moderate and severe alcohol withdrawal syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link\">",
"     \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;According to the Department of Health and Human Services and the United States Department of Agriculture, one standard drink contains approximately 0.5 ounces of ethanol&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/2\">",
"     2",
"    </a>",
"    ]. This corresponds to 12 fluid ounces of regular beer, 5 fluid ounces of wine, or 1.5 fluid ounces of 80-proof distilled spirit. Ethanol is also found in a variety of common household products, including mouthwash, perfume, cologne, cooking extracts, and over-the-counter medications.",
"   </p>",
"   <p>",
"    Ethanol (CH",
"    <sub>",
"     3",
"    </sub>",
"    CH",
"    <sub>",
"     2",
"    </sub>",
"    OH) is a water-soluble alcohol that rapidly crosses cell membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/3\">",
"     3",
"    </a>",
"    ]. Absorption of ethanol occurs via the gastrointestinal system, primarily in the stomach (70 percent) and duodenum (25 percent), with a small amount absorbed by the remaining intestine [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/4\">",
"     4",
"    </a>",
"    ]. When the stomach is empty, peak blood ethanol levels are reached between 30 and 90 minutes after ingestion.",
"   </p>",
"   <p>",
"    The primary pathway of ethanol metabolism occurs in the liver via alcohol dehydrogenase [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/5\">",
"     5",
"    </a>",
"    ]. Although the majority of ethanol metabolism takes place in the liver, other tissues do contribute to alcohol metabolism. Alcohol dehydrogenase is also located in the gastric mucosa, but this gastric metabolism of alcohol is decreased in women. Decreased \"first-pass metabolism\", combined with a smaller volume of distribution, may explain the enhanced vulnerability of women to acute complications of alcohol intoxication [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/5/30807?source=see_link&amp;anchor=H2#H2\">",
"     \"Pathogenesis of alcoholic liver disease\", section on 'Alcohol metabolism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ethanol intoxication is common among patients requiring emergency care, although it is rarely the primary reason for acute presentation. In one study, ethanol was detected in 15 to 40 percent of unselected emergency department patients, depending on geographical location [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/7\">",
"     7",
"    </a>",
"    ]. Binge drinking, which is generally defined as consuming &ge;5 alcoholic drinks on a single occasion, generally results in acute intoxication [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Signs and symptoms of acute ethanol intoxication vary with severity and can include slurred speech, nystagmus, disinhibited behavior, incoordination, unsteady gait, memory impairment, stupor, or coma. Hypotension and tachycardia may occur as a result of ethanol-induced peripheral vasodilation, or secondary to volume loss [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Signs associated with particular serum ethanol concentrations in nonalcoholics are described below. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Serum alcohol concentration and associated signs'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Acute alcohol intoxication can also induce multiple metabolic derangements including hypoglycemia, lactic acidosis, hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6613?source=see_link\">",
"     \"Alcoholic and fasting ketoacidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/2/9258?source=see_link\">",
"     \"Clinical manifestations and treatment of hypokalemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     IMPORTANCE OF THE DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alcohol intoxication as a cause of altered mental status is a diagnosis of exclusion and should be considered only after ruling out more serious conditions such as head trauma, hypoxia, hypoglycemia, hypothermia, hepatic encephalopathy, and other metabolic and physiologic derangements.",
"   </p>",
"   <p>",
"    In addition, intoxication with other alcohols (methanol or ethylene glycol) should be suspected in patients with severe metabolic acidosis and an increased anion gap. Similarly, isopropyl alcohol ingestion should be suspected in a patient with unexpectedly increased levels of serum ketones or acetone without metabolic acidosis in the setting of clinical alcohol intoxication. All alcohol poisonings are associated with an increased osmolal gap, if the patient presents soon after the ingestion (",
"    <a class=\"graphic graphic_table graphicRef52568 \" href=\"UTD.htm?4/63/5115\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/3/4154?source=see_link\">",
"     \"Methanol and ethylene glycol poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/60/20423?source=see_link\">",
"     \"Isopropyl alcohol poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/29/41430?source=see_link\">",
"     \"Serum osmolal gap\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20503888\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Serum alcohol concentration and associated signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurements from serum provide the most accurate determination of a patient&rsquo;s alcohol level. Alternative methods, such as breath analysis, provide more rapid results, but often give slightly lower ethanol concentrations than those obtained from venous blood [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. In most of the United States, the legal blood alcohol concentration (BAC) limit is 80",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (17",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p>",
"    The signs and symptoms of alcohol intoxication vary widely depending upon: the patient&rsquo;s genetics; the type, amount, and rate of alcohol intake; and the frequency and pattern of alcohol use [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/13\">",
"     13",
"    </a>",
"    ]. In individuals who do not abuse alcohol, the clinical effects of ethanol intoxication are relatively more predictable. Conversely, the effects of inebriation on individuals with a history of chronic alcohol abuse are unpredictable and such patients may demonstrate little clinical evidence of intoxication even with blood alcohol concentrations over 400",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (88",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p>",
"    Among patients who do not abuse alcohol, clinical signs often associated with particular ranges of the blood alcohol concentration (BAC) are as follow (",
"    <a class=\"graphic graphic_table graphicRef64642 \" href=\"UTD.htm?11/53/12123\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With a BAC between 0.01 and 0.10 percent (&lt;100",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      or 22",
"      <span class=\"nowrap\">",
"       mmol/L),",
"      </span>",
"      euphoria and mild deficits in coordination, attention, and cognition may be observed.",
"     </li>",
"     <li>",
"      With a BAC between 0.10 and 0.20 percent, an individual experiences greater deficits in coordination and psychomotor skills, decreased attention, ataxia, impaired judgment, slurred speech, and mood variability.",
"     </li>",
"     <li>",
"      With a BAC between 0.20 to 0.30 percent, severe alcohol intoxication results in a lack of coordination, incoherent thoughts, confusion, and nausea and vomiting.",
"     </li>",
"     <li>",
"      When the BAC exceeds 0.30 percent, stupor and loss of consciousness can occur. Some patients experience coma and respiratory depression, and death is possible.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It should be noted that the clinical signs and symptoms of alcohol intoxication may",
"    <strong>",
"     not",
"    </strong>",
"    correlate with the BAC depending upon the factors described above and whether the concentration is increasing or decreasing; effects may be more prominent when levels are rising (so-called Mellanby effect).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20503981\">",
"    <span class=\"h2\">",
"     Additional studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory studies are usually unnecessary in patients with an isolated mild ethanol intoxication. For patients with moderate to severe but uncomplicated ethanol intoxication (ie, not requiring intubation, not initially hypoglycemic, no history or clinical signs of trauma), we initially obtain a serum ethanol concentration and basic chemistry studies (serum glucose, basic electrolytes). Thereafter, assuming no initial laboratory abnormalities, a serum glucose concentration can be monitored every eight hours, while serum electrolytes do not need to be remeasured. This approach assumes that the patient is purely \"intoxicated\" and does not develop any acute changes in clinical status (eg, seizures).&nbsp;Patients with significant concomitant problems require more intensive monitoring based upon their injuries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general approach to any poisoned patient must include the following elements:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation: including recognition that poisoning has occurred, identification of the agent (or agents) involved, assessment of the severity, and prediction of toxicity. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link\">",
"       \"General approach to drug poisoning in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Management: consisting of supportive care, prevention of drug absorption, and when appropriate, the administration of antidotes and enhancement of drug elimination. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=see_link\">",
"       \"Gastrointestinal decontamination of poisoned adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26695?source=see_link\">",
"       \"Enhanced elimination of poisons\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The treatment for acute ethanol intoxication is primarily supportive. As a general rule, all intoxicated patients should receive a rapid bedside glucose determination, followed by dextrose infusion if hypoglycemia is present. In addition, all patients presenting with acute ethanol intoxication should be carefully assessed for occult traumatic injuries. Patients presenting with coma secondary to ethanol intoxication should receive at least 100 mg of parenteral thiamine to prevent or treat Wernicke's encephalopathy, along with dextrose. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/62/10217?source=see_link&amp;anchor=H14#H14\">",
"     \"Wernicke's encephalopathy\", section on 'Treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/62/10217?source=see_link&amp;anchor=H16#H16\">",
"     \"Wernicke's encephalopathy\", section on 'Prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some patients with acute ethanol intoxication and altered sensorium can be agitated, violent, and uncooperative. In such cases, the use of chemical sedation may be needed to prevent the patient from harming themselves or others. Benzodiazepines and typical antipsychotics are frequently used in these patients, but caution must be taken as these drugs can worsen the respiratory depression caused by alcohol [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/22/25962?source=see_link&amp;anchor=H10#H10\">",
"     \"Assessment and management of the acutely agitated or violent adult\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Mild ethanol intoxication and ethanol clearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with mild ethanol intoxication will require only observation and serial examination until clinical sobriety has been achieved. In patients with a clear history of alcohol intake and mild ethanol intoxication, and without signs of volume depletion, intravenous (IV) catheter insertion and fluid hydration are not usually necessary.",
"   </p>",
"   <p>",
"    There is wide variation in the metabolism of ethanol. The unhabituated drinker clears ethanol from the blood stream at an approximate rate of 15 to 20",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (3 to 4.5",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    per hour. Patients with chronic ethanol abuse can clear ethanol at a rate of 25 to 35",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (5.5 to 8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    per hour, or even faster in some cases [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. However, the disposition of these patients should not be based solely on the measured (or calculated) serum alcohol concentration. Patients with mild intoxication can be safely discharged when no longer clinically intoxicated and deemed by the clinician to be no danger to themselves or others. Ideally, the patient should be discharged into the care of a competent, sober individual.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Moderate ethanol intoxication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with moderate ethanol intoxication with signs of volume depletion, hypotension or malnutrition may require IV catheter insertion and fluid hydration. At a moderate to severe level of intoxication any alteration in the level of consciousness must be further investigated.",
"   </p>",
"   <p>",
"    If there is a clear history of alcohol consumption and serial examinations demonstrate improvement in the patient's mental status, further work-up may not be necessary. However, if there is any question of possible occult trauma or if the patient's mental status does not improve after serial examinations, a computed tomographic scan of the head should be obtained, along with other diagnostic tests as indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Severe ethanol intoxication (ethanol poisoning)",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with severe ethanol intoxication must be provided aggressive supportive care. At high blood alcohol concentrations, special attention must be paid to the patient&rsquo;s respiratory status, including frequent reassessment of the airway and breathing. If the patient is unable to protect their airway or has inadequate respiration, tracheal intubation and mechanical ventilation are required.",
"   </p>",
"   <p>",
"    In patients with evidence of volume depletion or hypotension, IV hydration with isotonic crystalloid is given. All patients presenting with coma secondary to ethanol intoxication should receive parenteral thiamine to prevent or treat Wernicke's encephalopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/62/10217?source=see_link&amp;anchor=H14#H14\">",
"     \"Wernicke's encephalopathy\", section on 'Treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/62/10217?source=see_link&amp;anchor=H16#H16\">",
"     \"Wernicke's encephalopathy\", section on 'Prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with severe intoxication,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"     activated charcoal",
"    </a>",
"    and gastric lavage are generally",
"    <strong>",
"     NOT",
"    </strong>",
"    helpful because of the rapid rate of absorption of ethanol from the gastrointestinal tract. Patients with severe intoxication requiring aggressive supportive care may be kept in the Emergency Department in an observation unit or admitted to the hospital. Most patients presenting with coma or other significant complications of ethanol intoxication require admission for close monitoring until sobriety is achieved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     FUTURE DIRECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The acute and chronic effects of alcohol abuse result in significant morbidity and mortality worldwide. Efforts have been made to create novel therapies that accelerate the clearance of alcohol. As an example, metadoxine, a pyrrolidone carboxylate of pyridoxine, appears to be safe and effective in lowering blood alcohol levels and improving symptoms following acute intoxication [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. In a double-blind, randomized controlled trial in humans with acute alcohol intoxication, metadoxine decreased the half-life of ethanol in the blood, resulting in more rapid ethanol clearance and faster recovery times compared to placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20694/abstract/18\">",
"     18",
"    </a>",
"    ]. Metadoxine is not yet approved by the United States Food and Drug Administration for the treatment of acute ethanol intoxication, and its use should be considered experimental.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3683710\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/17/37137?source=see_link\">",
"       \"Patient information: Alcohol poisoning (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute alcohol intoxication is common among patients presenting for emergency care, although it is rarely the chief reason for medical evaluation.",
"     </li>",
"     <li>",
"      Management of acute intoxication requires recognition and exclusion of other potential causes of changes in mental status, such as head trauma, hypoglycemia, hypoxia, and poisoning. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Importance of the differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serum ethanol concentrations may be helpful in confirming the diagnosis, and for legal and forensic investigations. Ethanol concentrations often do",
"      <strong>",
"       NOT",
"      </strong>",
"      correlate closely with the symptoms of acute intoxication, especially among patients who use alcohol on a chronic basis. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Serum alcohol concentration and associated signs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once the diagnosis is established, treatment is largely supportive, and consists of identification and correction of hypovolemia and hypoglycemia, close monitoring of respiratory status, and intravenous thiamine in patients at risk of Wernicke's encephalopathy. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/1\">",
"      Pletcher MJ, Maselli J, Gonzales R. Uncomplicated alcohol intoxication in the emergency department: an analysis of the National Hospital Ambulatory Medical Care Survey. Am J Med 2004; 117:863.",
"     </a>",
"    </li>",
"    <li>",
"     Nutrition and your health dietary guidelines for America. Home and garden bulletin, 4th ed, no. 232, US Department of Health and Human Services and the US Department of Agriculture (USDA), Washington, DC 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/3\">",
"      Vonghia L, Leggio L, Ferrulli A, et al. Acute alcohol intoxication. Eur J Intern Med 2008; 19:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/4\">",
"      Marco CA, Kelen GD. Acute intoxication. Emerg Med Clin North Am 1990; 8:731.",
"     </a>",
"    </li>",
"    <li>",
"     Lieber CS. Metabolism of ethanol. In: Medical disorder of alcoholism, Lieber CS.  (Ed), WB Saunders, Philadelphia 1982.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/6\">",
"      Frezza M, di Padova C, Pozzato G, et al. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990; 322:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/7\">",
"      Cherpitel CJ. Breath analysis and self-reports as measures of alcohol-related emergency room admissions. J Stud Alcohol 1989; 50:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/8\">",
"      Naimi TS, Brewer RD, Mokdad A, et al. Binge drinking among US adults. JAMA 2003; 289:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/9\">",
"      Yost DA. Acute care for alcohol intoxication. Be prepared to consider clinical dilemmas. Postgrad Med 2002; 112:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/10\">",
"      Boba A. Management of acute alcoholic intoxication. Am J Emerg Med 1999; 17:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/11\">",
"      Jones AW, Andersson L. Comparison of ethanol concentrations in venous blood and end-expired breath during a controlled drinking study. Forensic Sci Int 2003; 132:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/12\">",
"      Currier GW, Trenton AJ, Walsh PG. Innovations: Emergency psychiatry: Relative accuracy of breath and serum alcohol readings in the psychiatric emergency service. Psychiatr Serv 2006; 57:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/13\">",
"      Sullivan JB Jr, Hauptman M, Bronstein AC. Lack of observable intoxication in humans with high plasma alcohol concentrations. J Forensic Sci 1987; 32:1660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/14\">",
"      Chase PB, Biros MH. A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population. Acad Emerg Med 2002; 9:1402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/15\">",
"      Nobay F, Simon BC, Levitt MA, Dresden GM. A prospective, double-blind, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients. Acad Emerg Med 2004; 11:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/16\">",
"      Bogusz M, Pach J, Sta��ko W. Comparative studies on the rate of ethanol elimination in acute poisoning and in controlled conditions. J Forensic Sci 1977; 22:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/17\">",
"      Jones AW. Disappearance rate of ethanol from the blood of human subjects: implications in forensic toxicology. J Forensic Sci 1993; 38:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/18\">",
"      Shpilenya LS, Muzychenko AP, Gasbarrini G, Addolorato G. Metadoxine in acute alcohol intoxication: a double-blind, randomized, placebo-controlled study. Alcohol Clin Exp Res 2002; 26:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20694/abstract/19\">",
"      D&iacute;az Mart&iacute;nez MC, D&iacute;az Mart&iacute;nez A, Villamil Salcedo V, Cruz Fuentes C. Efficacy of metadoxine in the management of acute alcohol intoxication. J Int Med Res 2002; 30:44.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 333 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-115.124.72.62-5A3D10F1CE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20694=[""].join("\n");
var outline_f20_13_20694=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      IMPORTANCE OF THE DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20503888\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Serum alcohol concentration and associated signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20503981\">",
"      Additional studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Mild ethanol intoxication and ethanol clearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Moderate ethanol intoxication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Severe ethanol intoxication (ethanol poisoning)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      FUTURE DIRECTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3683710\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/333\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/333|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/63/5115\" title=\"table 1\">",
"      Concentrations from osmolal gap",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/53/12123\" title=\"table 2\">",
"      Clinical effects of blood alcohol concentration",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/22/2409?source=related_link\">",
"      Alcohol abuse and dependence: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6613?source=related_link\">",
"      Alcoholic and fasting ketoacidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/22/25962?source=related_link\">",
"      Assessment and management of the acutely agitated or violent adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/33/31258?source=related_link\">",
"      Cardiovascular benefits and risks of moderate alcohol consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/2/9258?source=related_link\">",
"      Clinical manifestations and treatment of hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26695?source=related_link\">",
"      Enhanced elimination of poisons",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=related_link\">",
"      Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=related_link\">",
"      Gastrointestinal decontamination of poisoned adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=related_link\">",
"      General approach to drug poisoning in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/60/20423?source=related_link\">",
"      Isopropyl alcohol poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/61/20441?source=related_link\">",
"      Management of moderate and severe alcohol withdrawal syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/3/4154?source=related_link\">",
"      Methanol and ethylene glycol poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/5/30807?source=related_link\">",
"      Pathogenesis of alcoholic liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/17/37137?source=related_link\">",
"      Patient information: Alcohol poisoning (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/29/41430?source=related_link\">",
"      Serum osmolal gap",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/62/10217?source=related_link\">",
"      Wernicke's encephalopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_13_20695="Treatment and prevention of malaria in pregnancy";
var content_f20_13_20695=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment and prevention of malaria in pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/13/20695/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20695/contributors\">",
"     Peter A Chedraui, MD, MSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20695/contributors\">",
"     Johanna Daily, MD, MSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20695/contributors\">",
"     Blair J Wylie, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/13/20695/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20695/contributors\">",
"     Peter F Weller, MD, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20695/contributors\">",
"     Susan M Ramin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/13/20695/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20695/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20695/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/13/20695/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malaria in pregnancy is a major cause of maternal morbidity worldwide and leads to poor birth outcomes. Pregnant women are more prone to complications of malaria infection than nongravid women. Treatment involves antimalarial drugs and supportive measures. Prevention involves chemoprophylaxis and mosquito avoidance.",
"   </p>",
"   <p>",
"    Issues related to treatment and prevention of malaria in pregnant women will be reviewed here. Issues related to the prevalence, epidemiology, pathogenesis, clinical manifestations, diagnosis, and outcome of malaria in pregnancy are discussed separately, as are general details on treatment of uncomplicated and severe malaria.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/33/16921?source=see_link\">",
"       \"Overview of malaria in pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13338?source=see_link\">",
"       \"Treatment of severe falciparum malaria\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25241?source=see_link\">",
"       \"Treatment of uncomplicated falciparum malaria\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/18/4394?source=see_link\">",
"       \"Overview of non-falciparum malaria\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/20/20809?source=see_link\">",
"       \"Antimalarial drugs: An overview\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malaria in pregnancy is dangerous for both the mother and the fetus. Therefore, pregnant women with malaria must be treated promptly with an effective antimalarial agent to clear parasites rapidly. Safety and efficacy data to guide management are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/1\">",
"     1",
"    </a>",
"    ]. In general, the newer the drug, the more likely it is to be effective (in part because there has been insufficient time for resistance to emerge), but fewer data will be available on safety in pregnancy. Clinicians therefore have to make treatment decisions based on the clinical severity of infection, epidemiologic resistance patterns, and available data regarding safety of the drug or class of drug in pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     P. falciparum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women with severe P. falciparum malaria should receive parenteral therapy; the intravenous route is preferred over the intramuscular route. Options for therapy include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/54/4965?source=see_link\">",
"     artesunate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/46/15080?source=see_link\">",
"     quinine",
"    </a>",
"    (plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    ) (",
"    <a class=\"graphic graphic_table graphicRef52961 \" href=\"UTD.htm?15/10/15533\">",
"     table 1",
"    </a>",
"    ). In nonpregnant adults and children with severe malaria, a mortality benefit has been demonstrated with artesunate over quinine [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. No trials have compared the efficacy of these agents in pregnant women. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13338?source=see_link\">",
"     \"Treatment of severe falciparum malaria\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H8\">",
"     'Drug safety'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Administration of antimalarials and attention to multiorgan system complications are discussed in further detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13338?source=see_link\">",
"     \"Treatment of severe falciparum malaria\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pregnant women with uncomplicated P. falciparum malaria may be treated as outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef52058 \" href=\"UTD.htm?40/29/41437\">",
"     table 2",
"    </a>",
"    ). Historically,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/46/15080?source=see_link\">",
"     quinine",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    has been recommended during pregnancy given adequate safety data and low cost. Nonetheless, quinine is associated with hypoglycemia even in uncomplicated infections, which may increase risks for both mother and fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/4\">",
"     4",
"    </a>",
"    ]. Management of uncomplicated P. falciparum malaria outside of pregnancy is discussed further separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25241?source=see_link\">",
"     \"Treatment of uncomplicated falciparum malaria\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many countries are using artemisinin combination therapies (ACTs) as first-line treatment of malaria outside of pregnancy. Data from the use of artemisinins in over 1500 pregnancies during the second and third trimester appear reassuring, and ACTs were included among the treatment options for uncomplicated malaria in pregnancy in the World Health Organization (WHO) 2010 treatment guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/5\">",
"     5",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Non-falciparum malaria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Non-falciparum malaria (eg, malaria infection due to Plasmodium species other than P. falciparum: P. vivax, P. ovale, P. malariae, and P. knowlesi) seldom kills, but can be a cause of significant morbidity in pregnancy. Pregnant women with non-falciparum malaria may be treated as outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef67642 \" href=\"UTD.htm?15/47/16126\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Following treatment of infection due to P. vivax or P. ovale, non-pregnant patients are treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/59/38837?source=see_link\">",
"     primaquine",
"    </a>",
"    to prevent P. vivax and P. ovale relapse by eradicating hypnozoite forms that may remain dormant in the liver. Primaquine is contraindicated in pregnancy since it can cause hemolytic anemia in individuals with G6PD deficiency and the fetal G6PD status is uncertain. Therefore, pregnant women should receive a treatment course of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/54/25447?source=see_link\">",
"     chloroquine",
"    </a>",
"    and then continue once weekly chloroquine until after delivery, when primaquine can be administered.",
"   </p>",
"   <p>",
"    Further discussion of non-falciparum malaria is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/18/4394?source=see_link\">",
"     \"Overview of non-falciparum malaria\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major tools for prevention of malaria in pregnant women include chemoprophylaxis and mosquito avoidance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Chemoprophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant travelers should be advised to defer travel to areas where risk of malaria is high until after delivery, if feasible. For pregnant, non-immune women who cannot defer travel, chemoprophylaxis is recommended. The agents of choice are",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/54/25447?source=see_link\">",
"     chloroquine",
"    </a>",
"    (for travel to areas with chloroquine-sensitive malaria) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/21/17751?source=see_link\">",
"     mefloquine",
"    </a>",
"    (for travel to areas with chloroquine resistant malaria) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/3/13370?source=see_link&amp;anchor=H17#H17\">",
"     \"Prevention of malaria infection in travelers\", section on 'Pregnant travelers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pregnant women living in endemic areas who have developed natural immunity (due to prolonged exposure to malaria) benefit from chemoprophylaxis against malaria [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/7-13\">",
"     7-13",
"    </a>",
"    ]. Implementation of continuous prophylaxis is not practical on a widespread scale. An effective alternative approach to reduce the risk of malaria infection for women with prior immunity in endemic areas is Intermittent Preventive Treatment during pregnancy (IPTp) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. The optimal antimalarial agent, dose, and frequency for IPTp depend on regional transmission intensity, drug resistance patterns, and HIV prevalence.",
"   </p>",
"   <p>",
"    For pregnant women who live in areas with medium and high malaria transmission, we are in agreement with the 2012 World Health Organization (WHO) recommendation to provide IPTp with sulfadoxine",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/51/23350?source=see_link\">",
"     pyrimethamine",
"    </a>",
"    (SP) at each scheduled antenatal care visit in the second and third trimesters (WHO recommends four focused antenatal care visits as standard care: a first visit in the first trimester, a second visit at 24 to 26 weeks of gestation, a third visit at 32 weeks, and a fourth visit at 36 to 38 weeks) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/16\">",
"     16",
"    </a>",
"    ]. Each dose suppresses or clears any existing asymptomatic infections from the placenta and provides up to six weeks of posttreatment prophylaxis. The previous recommendation for only two doses of SP one month apart resulted in a large number of missed opportunities for delivering IPTp during antenatal care and providing it close to the time of delivery, resulting in poorer pregnancy outcomes. In a systematic review and meta-analysis of trials of IPTp with SP during pregnancy that compared &ge;3 dose regimens with the standard 2 dose regimen, the &ge;3 dose regimens resulted in fewer low birth weight infants (RR 0.80, 95% CI 0.69-0.94;",
"    <span class=\"nowrap\">",
"     134/1000",
"    </span>",
"    versus",
"    <span class=\"nowrap\">",
"     167/1000),",
"    </span>",
"    less placental malaria (RR 0.51, 95% CI 0.38-0.68;",
"    <span class=\"nowrap\">",
"     32/1000",
"    </span>",
"    versus",
"    <span class=\"nowrap\">",
"     63/1000),",
"    </span>",
"    and less moderate to severe maternal anemia (RR 0.60, 95% CI 0.36-0.99;",
"    <span class=\"nowrap\">",
"     22/1000",
"    </span>",
"    versus",
"    <span class=\"nowrap\">",
"     36/1000)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The benefit of IPTp diminishes as local drug resistance increases. In a study among 880 pregnant women in Muheza, Tanzania, where SP resistance has reached 68 percent, IPTp with SP did not decrease the odds of placental malaria or increase mean maternal hemoglobin or neonatal birth weight [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/18\">",
"     18",
"    </a>",
"    ]. This underscores the need for additional research to identify effective alternative regimens for IPTp.",
"   </p>",
"   <p>",
"    Dosing and adverse effects of SP are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/20/20809?source=see_link&amp;anchor=H13#H13\">",
"     \"Antimalarial drugs: An overview\", section on 'Sulfadoxine-pyrimethamine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20211931\">",
"    <span class=\"h3\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women with HIV infection require more intensive IPTp dosing to reduce the risk of placental malaria if they are not using cotrimoxazole prophylaxis for opportunistic infections [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Among HIV-positive women in their first or second pregnancy, monthly IPTp with SP resulted in less placental malaria and higher neonatal birth weights than two dose IPTp over the range of resistance tested (up to 39 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Mosquito avoidance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Avoidance of mosquitoes is important for reducing the likelihood of malaria infection. Mosquitoes capable of transmitting malaria infection (Anopheles species) usually feed at night; thus, it is advisable to diminish exposure between dusk and dawn by remaining in screened areas whenever possible, using mosquito netting (ideally treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/22/28004?source=see_link\">",
"     permethrin",
"    </a>",
"    ), covering exposed skin with clothing, and applying insect repellent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43031?source=see_link\">",
"     \"Prevention of arthropod and insect bites: Repellents and other measures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Use of insecticide treated bed nets (ITNs) is an important tool for reducing the likelihood of malaria among pregnant women in endemic areas [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. A Cochrane review of the impact of ITNs during pregnancy included five randomized trials (four trials from sub-Saharan Africa compared use of ITNs to no nets and one trial from Thailand compared use of ITNs with use of untreated nets). In the African trials, use of ITNs significantly reduced the risk of placental malaria in all pregnancies (RR 0.79, 95% CI 0.63-0.98). In first through fourth pregnancies, use of ITNs significantly reduced the risk of low birth weight (RR of 0.77, 95% CI 0.61-0.98) and",
"    <span class=\"nowrap\">",
"     stillbirth/abortion",
"    </span>",
"    (RR 0.67, 95% CI 0.47-0.97). The trial from Thailand demonstrated significant reductions in anemia and stillbirth in all pregnancies, but no significant change in rates of LBW or clinical malaria [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional issues related to ITNs are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/5/16473?source=see_link&amp;anchor=H7#H7\">",
"     \"Epidemiology, prevention, and control of malaria in endemic areas\", section on 'Insecticide treated nets'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DRUG SAFETY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pharmacokinetics of most antimalarials in pregnancy remains largely undefined.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/54/25447?source=see_link\">",
"     Chloroquine",
"    </a>",
"    is well-tolerated and has not been shown to be harmful in pregnant women.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/46/15080?source=see_link\">",
"     Quinine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"     quinidine",
"    </a>",
"    can be used in pregnant women with P. falciparum infections at recommended therapeutic doses, and do not lead to more adverse pregnancy outcomes compared with the malaria infection itself. At high doses, quinine is reported to have a weak abortifacient effect, but such levels are not achieved with recommended therapeutic doses. Quinine has also been associated with maternal and fetal hypoglycemia [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/4\">",
"     4",
"    </a>",
"    ]. Unfounded fears of toxicity and unjustified withholding of quinine has led to many fatal maternal outcomes. Quinine is not contraindicated in pregnancy-associated malaria and should be used when needed. Glucose levels should be monitored.",
"   </p>",
"   <p>",
"    Published data on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/21/17751?source=see_link\">",
"     mefloquine",
"    </a>",
"    use during pregnancy have demonstrated that pregnant women who took mefloquine for treatment of malaria did not have an increased risk of adverse pregnancy outcomes compared with the background rate in the general population. Based on these studies, the US Food and Drug Administration (FDA) categorized mefloquine as category B [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Amodiaquine is used in Africa, where multidrug resistant P. falciparum is common. A randomized trial reported that amodiaquine alone or in combination with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/37/34389?source=see_link\">",
"     sulfadoxine-pyrimethamine",
"    </a>",
"    (SP) was significantly more effective than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/54/25447?source=see_link\">",
"     chloroquine",
"    </a>",
"    or SP [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/24\">",
"     24",
"    </a>",
"    ]. Treatment with amodiaquine was not associated with an increased risk of preterm birth, stillbirth, or congenital anomalies, but the trial was too small to conclude that its use was safe for the fetus. In general, amodiaquine is not used by clinicians in the United States or United Kingdom due to risk of agranulocytosis.",
"   </p>",
"   <p>",
"    Data on the safety of artemisinin drugs in pregnancy, especially during the first trimester, are limited. The World Health Organization (WHO) has advised that artemisinin drugs be avoided in the first trimester unless the treatment is believed to be life saving for the mother and other antimalarial drugs are contraindicated, are likely to be ineffective (eg, for treatment of malaria acquired in regions with partial",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/46/15080?source=see_link\">",
"     quinine",
"    </a>",
"    resistance, such as Southeast Asia), or have previously failed [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/25\">",
"     25",
"    </a>",
"    ]. Among 773 women with first-trimester pregnancies treated for malaria in Thailand, the risk of miscarriage was similar for women treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/54/25447?source=see_link\">",
"     chloroquine",
"    </a>",
"    , quinine, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/54/4965?source=see_link\">",
"     artesunate",
"    </a>",
"    (26, 27, and 31 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/26\">",
"     26",
"    </a>",
"    ]. In the same study, the risk of congenital abnormalities in neonates was not statistically increased in treated pregnancies or different among the three drugs",
"    <span class=\"nowrap\">",
"     (0/262,",
"    </span>",
"    <span class=\"nowrap\">",
"     2/258,",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     2/44,",
"    </span>",
"    respectively versus 1 percent in women with no",
"    <span class=\"nowrap\">",
"     malaria/no",
"    </span>",
"    treatment). In experimental animal studies using artemisinin compounds, fetal resorption early in gestation has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/27-30\">",
"     27-30",
"    </a>",
"    ]. These animal studies suggest depletion of embryonic erythroblasts may underlie artesunate-associated embryo toxicity. However, erythrocytes develop over a longer period of time in primates and therefore similar effects may not be observed in humans.",
"   </p>",
"   <p>",
"    More data in humans are available for second and third trimester exposure: artemisinin derivatives have not been found to be harmful to the fetus during this period of pregnancy and are acceptable for use during these trimesters [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/31-36\">",
"     31-36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'P. falciparum'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/20/20809?source=see_link\">",
"     \"Antimalarial drugs: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     Tetracycline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/59/38837?source=see_link\">",
"     primaquine",
"    </a>",
"    , and halofantrine are contraindicated in pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/37\">",
"     37",
"    </a>",
"    ]. Doxycycline is avoided during pregnancy because other tetracyclines have been associated with transient suppression of bone growth and with staining of developing teeth, but available data do not show teratogenic effects from doxycycline. Pregnancy is a contraindication for primaquine therapy since it is not possible to assess G6PD status of a fetus in utero [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/38\">",
"     38",
"    </a>",
"    ]. Primaquine and the tetracyclines should also be avoided while breastfeeding [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/39\">",
"     39",
"    </a>",
"    ]. There are no human data on halofantrine exposure in pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;General principles of management of patients with malaria are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25241?source=see_link\">",
"     \"Treatment of uncomplicated falciparum malaria\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13338?source=see_link\">",
"     \"Treatment of severe falciparum malaria\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In severe malaria infection, fetal assessment is recommended, as nonreassuring fetal heart rate tracings and fetal growth restriction are common. It has been one author's (PC) experience that amniotic fluid volume decreases during febrile periods and tends to normalize with defervescence. Assuming available resources, a reasonable program of surveillance consists of serial ultrasound examinations for assessment of fetal growth and amniotic fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20695/abstract/40,41\">",
"     40,41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Malaria in pregnancy is a major cause of maternal morbidity and mortality worldwide and leads to poor birth outcomes. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/33/16921?source=see_link\">",
"       \"Overview of malaria in pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Treatment consists of antimalarial therapy and supportive care. The choice of drug for treatment of malaria infection depends on the clinical severity, epidemiologic resistance patterns, and available data about the safety of the drug in pregnancy. In",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/54/25447?source=see_link\">",
"       chloroquine",
"      </a>",
"      -sensitive areas, we suggest chloroquine for first-line therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For treatment of uncomplicated",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/54/25447?source=see_link\">",
"       chloroquine",
"      </a>",
"      -resistant malaria during the first trimester, we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/46/15080?source=see_link\">",
"       quinine",
"      </a>",
"      combined with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      (",
"      <a class=\"graphic graphic_table graphicRef52058 \" href=\"UTD.htm?40/29/41437\">",
"       table 2",
"      </a>",
"      )&nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In the second or third trimesters, artemisinin combination therapy or quinine plus clindamycin may be used. For treatment of severe chloroquine-resistant malaria, we suggest intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/54/4965?source=see_link\">",
"       artesunate",
"      </a>",
"      (",
"      <a class=\"graphic graphic_table graphicRef52961 \" href=\"UTD.htm?15/10/15533\">",
"       table 1",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Treatment'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Prevention involves chemoprophylaxis and mosquito avoidance. Pregnant travelers should be advised to defer travel to areas where risk of malaria is high until after delivery, if feasible. For pregnant women who cannot defer travel or reside in malarious regions, we recommend chemoprophylaxis and mosquito avoidance (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/3/13370?source=see_link&amp;anchor=H17#H17\">",
"       \"Prevention of malaria infection in travelers\", section on 'Pregnant travelers'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For pregnant women who reside in areas of medium and high malaria transmission, we recommend three doses of IPTp with sulfadoxine",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/51/23350?source=see_link\">",
"       pyrimethamine",
"      </a>",
"      rather than two doses (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Sulfadoxine pyrimethamine is given at each scheduled antenatal care visit in the second and third trimesters (at 24 to 26 weeks, at 32 weeks, and at 36 to 38 weeks). Pregnant women with human immunodeficiency virus (HIV) who are not using cotrimoxazole prophylaxis should receive monthly doses. The optimal antimalarial agent, dose, and frequency for IPTp depend on regional transmission intensity, drug resistance patterns, and HIV prevalence. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Chemoprophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mosquito avoidance is important for reducing the likelihood of malaria infection. It is advisable to diminish exposure between dusk and dawn by remaining in screened areas whenever possible, covering exposed skin with clothing, and applying insect repellent. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Mosquito avoidance'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43031?source=see_link\">",
"       \"Prevention of arthropod and insect bites: Repellents and other measures\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/5/16473?source=see_link\">",
"       \"Epidemiology, prevention, and control of malaria in endemic areas\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/1\">",
"      Orton LC, Omari AA. Drugs for treating uncomplicated malaria in pregnant women. Cochrane Database Syst Rev 2008; :CD004912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/2\">",
"      Dondorp A, Nosten F, Stepniewska K, et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005; 366:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/3\">",
"      Dondorp AM, Fanello CI, Hendriksen IC, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010; 376:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/4\">",
"      Taylor WR, White NJ. Antimalarial drug toxicity: a review. Drug Saf 2004; 27:25.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Guidelines for the treatment of malaria. Geneva: World Health Organization, 2010.",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Yellow Book for Traveler's Health: 2012. file://wwwnc.cdc.gov/travel/page/yellowbook-2012-home.htm.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/7\">",
"      Greenwood BM, Greenwood AM, Snow RW, et al. The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. Trans R Soc Trop Med Hyg 1989; 83:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/8\">",
"      Greenwood AM, Menendez C, Todd J, Greenwood BM. The distribution of birth weights in Gambian women who received malaria chemoprophylaxis during their first pregnancy and in control women. Trans R Soc Trop Med Hyg 1994; 88:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/9\">",
"      Greenwood AM, Menendez C, Alonso PL, et al. Can malaria chemoprophylaxis be restricted to first pregnancies? Trans R Soc Trop Med Hyg 1994; 88:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/10\">",
"      Menendez C, Todd J, Alonso PL, et al. Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae. J Trop Med Hyg 1994; 97:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/11\">",
"      Mola GL, Wanganapi A. Failure of chloroquine malaria prophylaxis in pregnancy. Aust N Z J Obstet Gynaecol 1987; 27:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/12\">",
"      Nosten F, ter Kuile F, Maelankiri L, et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. J Infect Dis 1994; 169:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/13\">",
"      Garner P, G&uuml;lmezoglu AM. Drugs for preventing malaria-related illness in pregnant women and death in the newborn. Cochrane Database Syst Rev 2003; :CD000169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/14\">",
"      Men&eacute;ndez C, Bardaj&iacute; A, Sigauque B, et al. Malaria prevention with IPTp during pregnancy reduces neonatal mortality. PLoS One 2010; 5:e9438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/15\">",
"      Taylor SM, Antonia AL, Chaluluka E, et al. Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infect Dis 2012; 55:42.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization; Global Malaria Program. Updated WHO Policy Recommendation (October 2012): Intermittent Preventive Treatment of Malaria in Pregnancy Using Sulfadoxine-Pyrimethamine (IPTp-SP). Geneva, Switzerland: World Health Organization; 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/17\">",
"      Kayentao K, Garner P, van Eijk AM, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA 2013; 309:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/18\">",
"      Harrington WE, Mutabingwa TK, Kabyemela E, et al. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis 2011; 53:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/19\">",
"      Filler SJ, Kazembe P, Thigpen M, et al. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis 2006; 194:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/20\">",
"      ter Kuile FO, van Eijk AM, Filler SJ. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA 2007; 297:2603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/21\">",
"      ter Kuile FO, Terlouw DJ, Phillips-Howard PA, et al. Reduction of malaria during pregnancy by permethrin-treated bed nets in an area of intense perennial malaria transmission in western Kenya. Am J Trop Med Hyg 2003; 68:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/22\">",
"      Gamble C, Ekwaru JP, ter Kuile FO. Insecticide-treated nets for preventing malaria in pregnancy. Cochrane Database Syst Rev 2006; :CD003755.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cdc.gov/malaria/new_info/2011/mefloquine_pregnancy.html (Accessed on August 22, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/24\">",
"      Tagbor H, Bruce J, Browne E, et al. Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial. Lancet 2006; 368:1349.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Guidelines for the treatment of malaria, second edition, 2010. Geneva: World Health Organization, 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/26\">",
"      McGready R, Lee SJ, Wiladphaingern J, et al. Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. Lancet Infect Dis 2012; 12:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/27\">",
"      Clark RL, White TE, A Clode S, et al. Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Res B Dev Reprod Toxicol 2004; 71:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/28\">",
"      White TE, Bushdid PB, Ritter S, et al. Artesunate-induced depletion of embryonic erythroblasts precedes embryolethality and teratogenicity in vivo. Birth Defects Res B Dev Reprod Toxicol 2006; 77:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/29\">",
"      Clark RL, Lerman SA, Cox EM, et al. Developmental toxicity of artesunate in the rat: comparison to other artemisinins, comparison of embryotoxicity and kinetics by oral and intravenous routes, and relationship to maternal reticulocyte count. Birth Defects Res B Dev Reprod Toxicol 2008; 83:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/30\">",
"      Boareto AC, Muller JC, Bufalo AC, et al. Toxicity of artemisinin [Artemisia annua L.] in two different periods of pregnancy in Wistar rats. Reprod Toxicol 2008; 25:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/31\">",
"      McGready R, Brockman A, Cho T, et al. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 2000; 94:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/32\">",
"      McGready R, Ashley EA, Moo E, et al. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. J Infect Dis 2005; 192:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/33\">",
"      McGready R, Cho T, Keo NK, et al. Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. Clin Infect Dis 2001; 33:2009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/34\">",
"      McGready R, Cho T, Villegas L, et al. Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 2001; 95:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/35\">",
"      McGready R, Cho T, Cho JJ, et al. Artemisinin derivatives in the treatment of falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 1998; 92:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/36\">",
"      McGready R, Keo NK, Villegas L, et al. Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. Trans R Soc Trop Med Hyg 2003; 97:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/37\">",
"      Nosten F, McGready R, d'Alessandro U, et al. Antimalarial drugs in pregnancy: a review. Curr Drug Saf 2006; 1:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/38\">",
"      Baird JK, Hoffman SL. Primaquine therapy for malaria. Clin Infect Dis 2004; 39:1336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/39\">",
"      White NJ. The treatment of malaria. N Engl J Med 1996; 335:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/40\">",
"      Griffin JB, Lokomba V, Landis SH, et al. Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study. Malar J 2012; 11:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20695/abstract/41\">",
"      Schmiegelow C, Minja D, Oesterholt M, et al. Malaria and fetal growth alterations in the 3(rd) trimester of pregnancy: a longitudinal ultrasound study. PLoS One 2013; 8:e53794.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4812 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-0C172D990F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20695=[""].join("\n");
var outline_f20_13_20695=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      P. falciparum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Non-falciparum malaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Chemoprophylaxis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20211931\">",
"      - HIV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Mosquito avoidance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DRUG SAFETY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MANAGEMENT OF PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/4812\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/4812|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/10/15533\" title=\"table 1\">",
"      Parenteral treatment of severe malaria in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/29/41437\" title=\"table 2\">",
"      Rx uncomp malaria preg",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/47/16126\" title=\"table 3\">",
"      Rx nonfalcip malaria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/20/20809?source=related_link\">",
"      Antimalarial drugs: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/5/16473?source=related_link\">",
"      Epidemiology, prevention, and control of malaria in endemic areas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/33/16921?source=related_link\">",
"      Overview of malaria in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/18/4394?source=related_link\">",
"      Overview of non-falciparum malaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43031?source=related_link\">",
"      Prevention of arthropod and insect bites: Repellents and other measures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/3/13370?source=related_link\">",
"      Prevention of malaria infection in travelers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13338?source=related_link\">",
"      Treatment of severe falciparum malaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25241?source=related_link\">",
"      Treatment of uncomplicated falciparum malaria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_13_20696="Mycosis fungoides patches";
var content_f20_13_20696=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F60650%7EHEME%2F63888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F60650%7EHEME%2F63888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mycosis fungoides - patch stage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erythematous patches are present on the trunk and proximal extremities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mycosis fungoides - poikiloderma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A poikilodermatous patch exhibiting red-brown mottled pigmentation, telangiectasias, and subtle atrophy is present on the chest of this patient with mycosis fungoides.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20696=[""].join("\n");
var outline_f20_13_20696=null;
var title_f20_13_20697="Clinical manifestations and diagnosis of rheumatoid vasculitis";
var content_f20_13_20697=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of rheumatoid vasculitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/13/20697/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20697/contributors\">",
"     Patrick Whelan, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20697/contributors\">",
"     John H Stone, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/13/20697/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20697/contributors\">",
"     Gene G Hunder, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/13/20697/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/13/20697/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/13/20697/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood vessel inflammation is a central feature of rheumatoid arthritis (RA). Synovial membrane inflammation is characterized histologically by mononuclear cell cuffing of postcapillary venules. In addition, vascular inflammation is considered the primary event in the formation of rheumatoid nodules [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/1\">",
"     1",
"    </a>",
"    ]. In nodule formation, small-vessel vasculitis leads to fibrinoid necrosis that forms the core of the lesion, surrounded by fibroblastic proliferation.",
"   </p>",
"   <p>",
"    In contrast to this type of blood vessel inflammation, however, the term &ldquo;rheumatoid vasculitis&rdquo; (RV) refers specifically to a protean, destructive inflammatory process that is centered on the blood vessel wall itself and that is associated with substantial morbidity. RV may affect a wide range of blood vessel types, from medium-sized muscular arteries to somewhat smaller arterioles to post-capillary venules. Within a given patient, clinical features of both medium- and small-vessel disease may be found. RV leads to necrosis, to blood vessel occlusion, and to tissue ischemia in a manner that resembles other forms of systemic vasculitis, particularly polyarteritis nodosa. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/26/9641?source=see_link\">",
"     \"Clinical manifestations and diagnosis of polyarteritis nodosa\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic will review the clinical features of RV and the ways in which the diagnosis is established. The epidemiology, pathophysiology, and treatment of RV are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/26/42407?source=see_link\">",
"     \"Epidemiology and pathogenesis of rheumatoid vasculitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/19/22841?source=see_link\">",
"     \"Treatment of rheumatoid vasculitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;RV typically occurs in patients with longstanding, joint-destructive RA. In one study, the mean duration between the diagnosis of RA and the onset of vasculitic symptoms was 13.6 years [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/2\">",
"     2",
"    </a>",
"    ]. Presentations of RV within five years of the RA diagnosis are very unusual. Patients with RV nearly always have rheumatoid nodules (",
"    <a class=\"graphic graphic_picture graphicRef56514 \" href=\"UTD.htm?28/18/28963\">",
"     picture 1",
"    </a>",
"    ) and are typically strongly positive for rheumatoid factor [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/3\">",
"     3",
"    </a>",
"    ]. RV usually develops at a time when the inflammatory arthritis is &ldquo;burned out&rdquo; (ie, when the erosive process that led to joint destruction has become less active). At such times, unfortunately, patients who have already incurred considerable morbidity from RA and its therapies require intensive, potentially toxic treatments more than ever.",
"   </p>",
"   <p>",
"    The areas of the body involved most commonly by RV are the skin, digits, peripheral nerves, eyes, and heart. The most devastating form of RV is characterized by a medium-sized vasculitis reminiscent of (and histologically identical to) polyarteritis nodosa. Many of the clinical manifestations of RV reflect this predilection for medium-sized vessels, even though purpura, petechiae, and papules (manifestations of small-vessel involvement) may also occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Constitutional symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who develop RV typically have significant constitutional symptoms. Because RV patients are often significantly debilitated from their previous RA, the onset of constitutional symptoms such as increased fatigue may be insidious. Myalgias may be mistaken for a flare of synovitis, but (as noted), by the time RV develops, patients&rsquo; joint disease is usually less active than in the past. Weight loss occurs in a significant percentage of patients, and fevers occur in a smaller subset [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/2,4,5\">",
"     2,4,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Cutaneous vasculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin vasculitis, which occurs in as much as 90 percent of patients with RV, is the most common manifestation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/2,6\">",
"     2,6",
"    </a>",
"    ]. Isolated cutaneous lesions characterized by one or more nailfold lesions, however, are not necessarily associated with necrotizing vasculitis and do not require a modification of therapy if they occur alone (",
"    <a class=\"graphic graphic_picture graphicRef61231 \" href=\"UTD.htm?19/48/20224\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Similarly, the appearance of rheumatoid nodules on the finger pads or palmar surfaces of the hands do not mandate intensification of therapy if no manifestations of more severe disease are present [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The classic skin lesions of RV are deep cutaneous ulcers on the lower extremities [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/6\">",
"     6",
"    </a>",
"    ]. These lesions, found typically in the area of the medial or lateral malleoli (",
"    <a class=\"graphic graphic_picture graphicRef64706 \" href=\"UTD.htm?25/3/25648\">",
"     picture 3",
"    </a>",
"    ), are the result of necrotizing vasculitis of medium-sized arteries (",
"    <a class=\"graphic graphic_picture graphicRef57320 \" href=\"UTD.htm?15/7/15480\">",
"     picture 4",
"    </a>",
"    ). Such lesions must be distinguished from pyoderma gangrenosum, much less common in RA. Medium-vessel vasculitis can also lead to digital ischemia, necrosis, and gangrene (",
"    <a class=\"graphic graphic_picture graphicRef74320 \" href=\"UTD.htm?0/0/7\">",
"     picture 5",
"    </a>",
"    ). Clinical manifestations of small-vessel vasculitis (eg, palpable purpura) may also be present in RV, but the clinical picture and most challenging problems are dominated by disease in medium-sized arteries and arterioles. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4345?source=see_link&amp;anchor=H16171977#H16171977\">",
"     \"Evaluation of adults with cutaneous lesions of vasculitis\", section on 'Cutaneous findings'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Neurologic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vasculitic neuropathy, a frequent component of RV, results from infarction of individual peripheral nerves by vasculitis in the vasa nervorum [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/57/22423?source=see_link\">",
"     \"Clinical manifestations of vasculitic neuropathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/55/11129?source=see_link\">",
"     \"Neurologic manifestations of rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately 40 percent of patients with RA have a sensory neuropathy, and up to 20 percent develop manifestations of a mixed motor or sensory neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/2,10\">",
"     2,10",
"    </a>",
"    ]. Both mononeuritis multiplex and a distal symmetric sensory or sensorimotor neuropathy can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mononeuritis multiplex has three clinical hallmarks: asymmetry, asynchrony, and a predilection for distal nerves. Early in the process, nerve involvement is likely to affect one side (eg, the left peroneal nerve leading to foot drop) more than the other. Within days to weeks, however, the process may develop a more symmetrical appearance, as distal peripheral nerves are affected in an additive fashion. Motor mononeuritis multiplex may cause a devastating loss of function of the hands and feet, requiring assistive devices for feeding and leg braces (ankle-foot orthoses) for ambulation. Recovery from severe vasculitic neuropathy is extremely slow, typically 12 to 18 months. Many patients have permanent sequelae of their nerve infarctions (",
"    <a class=\"graphic graphic_picture graphicRef57387 \" href=\"UTD.htm?1/34/1570\">",
"     picture 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In contrast to the myriad other causes of peripheral neuropathy, the onset of vasculitic neuropathy in RV is rapid. Patients often experience their first symptoms (numbness, tingling, or other sensory symptoms) after a period of sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/12\">",
"     12",
"    </a>",
"    ]. As a rule, pain is not striking at the onset of vasculitic neuropathy; rather, the predominant symptom is anesthesia. Within days or weeks of the start of sensory symptoms, muscle weakness caused by motor nerve infarction may ensue [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/55/11129?source=see_link\">",
"     \"Neurologic manifestations of rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The full development of motor dysfunction within a given nerve may often take place within the day of onset. There is maximal damage at the time the condition is recognized, followed by deficits that persist for weeks or months. Assuming that the inflammatory process is arrested by therapy, most patients then have a slow, gradual return of nerve function, typically to something less than their full neuromuscular function before the nerve injury. Persistent muscle wasting in at least some sites of nerve involvement (eg, the web space between the thumb and first finger secondary to median nerve infarction) is the rule, although many patients make significant recoveries in muscle bulk and strength. During the recuperative period, painful neuropathy from damaged sensory nerves may constitute a major problem.",
"   </p>",
"   <p>",
"    Central nervous system involvement occurs rarely in RV. The development of central nervous system dysfunction (eg, a stroke) in a patient with RA is seldom due to RV, particularly in the absence of flagrant vasculitis in other organ systems. Most central nervous system events in RA are caused by intercurrent processes or problems related only indirectly to the underlying disease (for example, the sequelae of treatment). Nevertheless, well-documented cases of central nervous system vasculitis associated with RV exist, particularly from the period of the 1940s to 1960s when less effective therapy was available and when autopsies were performed more frequently than in subsequent decades.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Ocular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two principal ocular manifestations of RV are",
"    <span class=\"nowrap\">",
"     episcleritis/scleritis",
"    </span>",
"    and peripheral ulcerative keratitis (PUK) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Necrotizing scleritis and PUK must be distinguished from the other common but less serious ocular abnormalities that may result in red eyes. In RA, these conditions include keratoconjunctivitis sicca, episcleritis, choroiditis, and other inflammatory conditions of the uveal tract. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/23/22903?source=see_link\">",
"     \"Ocular manifestations of rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Scleritis may occur in either anterior or posterior locations [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/13,15\">",
"     13,15",
"    </a>",
"    ]. Anterior forms of scleritis are evident not only from the appearance of the eye (",
"    <a class=\"graphic graphic_picture graphicRef63762 \" href=\"UTD.htm?20/52/21319\">",
"     picture 7",
"    </a>",
"    ) but also from the substantial pain associated with this condition. One series of nine patients with RA and necrotizing scleritis who underwent scleral biopsies found vasculitis in all [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/16\">",
"     16",
"    </a>",
"    ]. Bilateral scleritis is not unusual.",
"   </p>",
"   <p>",
"    Anterior scleritis is subdivided further into three clinical variants:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Diffuse (least severe)",
"     </li>",
"     <li>",
"      Nodular (intermediate in severity)",
"     </li>",
"     <li>",
"      Necrotizing (most severe)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These three variants are largely non-overlapping; progression from one variant to another is unusual. The necrotizing form of scleritis may lead to scleromalacia perforans.",
"   </p>",
"   <p>",
"    In contrast to anterior scleritis, which is typically obvious on clinical examination, posterior scleritis must be diagnosed by inference from the patient&rsquo;s symptoms, primarily a deep-seated pain and ocular tenderness, but also visual blurring as well as thickening of the posterior coat of the eye on B-scan ultrasonography or magnetic resonance imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    PUK, a process in which inflammatory cells infiltrate the peripheral area of the cornea, often coexists with necrotizing scleritis (",
"    <a class=\"graphic graphic_picture graphicRef63438 \" href=\"UTD.htm?18/37/19025\">",
"     picture 8",
"    </a>",
"    ). In PUK, a crescent-shaped ulceration develops near the corneoscleral junction. A major concern in patients with PUK is the complication of the &ldquo;corneal melt&rdquo; syndrome, in which corneal keratolysis, perforation of the globe, and visual failure may result in a short timeframe [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/14\">",
"     14",
"    </a>",
"    ]. Following the occurrence of a corneal melt, patients often lose all useful vision in the eye. Both necrotizing scleritis and PUK require urgent therapy with high doses of immunosuppressive medications, generally both high-dose glucocorticoids and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/19/22841?source=see_link\">",
"     \"Treatment of rheumatoid vasculitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Cardiac disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Much of the early RV literature, drawing on the experience with rheumatic fever, focused on the cardiac valves and vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/18\">",
"     18",
"    </a>",
"    ]. An autopsy series of 72 RA patients described cardiac pathology arteritis within the hearts of 11 patients (15 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/19\">",
"     19",
"    </a>",
"    ]. The arteritis, which affected small arteries, was often found in subacute and healing forms, typically in different stages, often associated with necrosis. Thrombosis was not observed, and aneurysm formation was not seen. However, all layers of the blood vessel wall, particularly the adventitia, were involved.",
"   </p>",
"   <p>",
"    Pericarditis is the cardiac manifestation most likely to present early in the setting of RV; its appearance should heighten concern about vasculitis. One series of 50 patients documented cardiac manifestations, including pericarditis, arrhythmia, aortic incompetence, and myocardial infarction, in approximately one-third of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/2\">",
"     2",
"    </a>",
"    ]. Arrhythmias, found in 9 of 44 patients, included atrial fibrillation, ventricular arrhythmias, and complete heart block. The direct attribution of such rhythm disturbances to RV, however, is often problematic given the significant number of comorbidities suffered by many RV patients.",
"   </p>",
"   <p>",
"    Although cases of coronary vasculitis are well-documented in the medical literature, myocardial infarctions that are the direct result of coronary arteritis in RV are unusual [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. Clinically manifested coronary vasculitis is likely to occur only in RA patients with clear-cut evidence of vasculitis in other organ systems. One case report incorporated detailed autopsy information on a 74-year-old man with RA who developed systemic vasculitis and who died of myocardial infarction. The post-mortem examination revealed granulomatous vasculitis of the left anterior descending and circumflex arteries, with memory T cell and multinucleated giant cell infiltration of the media [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the rarity of true coronary vasculitis in RV, one of the most important determinants of the increased mortality in RA patients is an elevated risk of cardiovascular disease. This appears to represent a significant acceleration of common atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. However, there is no evidence that clinical complications of atherosclerosis are more common in patients with RV than they are in patients with RA who do not have RV. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10631?source=see_link\">",
"     \"Coronary artery disease in rheumatoid arthritis: Epidemiology, pathogenesis, and risk factors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Pulmonary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary disease is a common extraarticular manifestation of RA, but primary vasculitic involvement of the lung is uncommon. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/31/17912?source=see_link\">",
"     \"Interstitial lung disease in rheumatoid arthritis\"",
"    </a>",
"    .) Pulmonary vasculitis as a complication of RV must be distinguished from interstitial lung disease that is not vasculitic in nature. Although rheumatoid nodules occur in the lungs and although pathologic evidence of vasculitis is an inherent feature of rheumatoid nodules whenever they are found, most patients with rheumatoid nodules in the lungs do not have evidence of systemic vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/18,26\">",
"     18,26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26969?source=see_link\">",
"     \"Overview of lung disease associated with rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Renal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compared with the skin, peripheral nerves, and eyes, the kidneys are much less likely to be involved in extraarticular RA. Nevertheless, several forms of renal disease are known to occur. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37812?source=see_link\">",
"     \"Renal disease in patients with rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The major forms of renal disease in RA patients are acute tubular necrosis related to nonsteroidal antiinflammatory drug (NSAID) use, secondary amyloidosis due to the chronic inflammation, nephrotic syndrome secondary to membranous nephropathy, and, in a small number of cases, true vasculitis, consisting either of necrotizing glomerulonephritis or of destructive inflammation within the walls of renal arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/27\">",
"     27",
"    </a>",
"    ]. Secondary amyloidosis is now relatively rare in RA, because of more effective means of controlling inflammation. In addition, because gold and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/6/4200?source=see_link\">",
"     penicillamine",
"    </a>",
"    are rarely used in RA since the increasingly widespread use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    and biologic agents, membranous nephropathy is observed less often than in the past.",
"   </p>",
"   <p>",
"    Both renal artery involvement similar to that which occurs in polyarteritis nodosa (without aneurysm formation) and glomerulonephritis reminiscent of the type associated with microscopic polyangiitis or with granulomatosis with polyangiitis (Wegener&rsquo;s) are well-described in the medical literature [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. The glomerular pathology caused by vasculitis in RA is a pauci-immune glomerulonephritis (similar to that seen in granulomatosis with polyangiitis [Wegener&rsquo;s]), sometimes associated with crescent formation and the presence of antineutrophil cytoplasmic antibodies (ANCA) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. This type of glomerular disease contrasts with common beliefs about the pathophysiology of RV in other organs, generally considered to result from an immune complex-mediated process characterized by the organ deposition of rheumatoid factor, complement components, and other immunoreactants.",
"   </p>",
"   <p>",
"    Some reported cases of glomerulonephritis in RA may represent the co-occurrence of two diseases (eg, an ANCA-associated vasculitis and RA). However, a number of glomerulonephritis cases accompanied by typical RV manifestations in other organs have occurred in settings that are classic for the development of RV. Thus, it seems safe to conclude that, in a minority of patients with RV, clinically significant renal disease does occur.",
"   </p>",
"   <p>",
"    In contrast to other diseases associated with pauci-immune glomerulonephritis, however, antineutrophil cytoplasmic antibodies (ANCA) do not appear to play a role in necrotizing glomerulonephritis in RV. One report indicated that RA patients with renal disease are more likely to have circulating ANCA [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/28\">",
"     28",
"    </a>",
"    ], but this finding has not been duplicated by other investigators. Moreover, the antigens against which these ANCA are directed are neither proteinase-3 nor myeloperoxidase, the two antigens most strongly associated with the ANCA response in systemic vasculitis. In short, there is no compelling evidence that ANCA have any role in RV, even in the rare cases of glomerulonephritis. When ANCA directed against proteinase-3 or myeloperoxidase do occur in RA accompanied by clinical findings compatible with vasculitis, the simultaneous occurrence of two diseases must be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Gastrointestinal, pancreatic, and hepatic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The older RV literature provides a number of cases in which mesenteric vasculitis complicated RA. The clinical presentations of patients with this extraarticular manifestation of RA are similar to those of polyarteritis nodosa with gastrointestinal tract involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/9,21,30\">",
"     9,21,30",
"    </a>",
"    ]. Although microaneurysms in RV appear to be less common than in polyarteritis nodosa, cases associated with microaneurysms are described [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/31\">",
"     31",
"    </a>",
"    ]. The manifestations of mesenteric vasculitis associated with RV include abdominal aneurysmal rupture with syncope and hemorrhage, sigmoid and ileal infarction, intestinal perforation, and intrahepatic hemorrhage due to pseudoaneurysm formation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/30-33\">",
"     30-33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     LABORATORY FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory testing in patients with RV typically reveals nonspecific signs of the underlying inflammatory process. These include elevations in erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), thrombocytosis, hypoalbuminemia, and the anemia of chronic disease. RV is also associated with a number of serological abnormalities, including autoantibodies and (in many cases) hypocomplementemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Autoantibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among the autoantibodies that have been noted in patients with RV are the following:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Rheumatoid factor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The serum titers of rheumatoid factors, including IgM, IgG, and IgA, are elevated in most patients with RV. They also tend to be higher in RV patients than in those with RA alone, but there is significant overlap in rheumatoid factor levels across these two populations [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/2\">",
"     2",
"    </a>",
"    ]. High titers of rheumatoid factor are reported consistently to be the strongest predictor of the development of RV [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Vasculitis in seronegative RA is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/3,5,34\">",
"     3,5,34",
"    </a>",
"    ]. One study suggested that titers of IgG rheumatoid factor correlate well with disease activity. However, this has not been confirmed by others, and the test is not readily available in most laboratories [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/2\">",
"     2",
"    </a>",
"    ]. Levels of IgM rheumatoid factor (the serotype usually measured) are not good markers of disease activity [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Anti-CCP antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticyclic citrullinated peptide (CCP) antibodies may be helpful in distinguishing RV from other forms of small vessel vasculitis, although the relationship between anti-CCP antibodies and RV has not been investigated thoroughly. Anti-CCP antibodies have a higher specificity for RA than does rheumatoid factor, which may occur in many rheumatological and non-rheumatological conditions, and the presence of anti-CCP antibodies in a population of patients with undifferentiated arthritis is associated with a high odds ratio for the development of RA [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/35\">",
"     35",
"    </a>",
"    ]. However, anti-CCP antibodies are not superior to rheumatoid factor titers in predicting RA-associated mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Several studies have indicated that anti-CCP antibodies are a valuable adjunct to the diagnosis of RV [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. One study found that 93 percent of patients with RV tested positive for anti-CCP (85 percent with values &gt;15 international",
"    <span class=\"nowrap\">",
"     units/mL),",
"    </span>",
"    compared with 7 percent of patients with other forms of systemic small-vessel vasculitis (2 percent with values &gt;15 international",
"    <span class=\"nowrap\">",
"     units/mL).",
"    </span>",
"    The anti-CCP titers were higher in patients with systemic RV compared with RA patients without vasculitis and with those with ANCA-associated vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Antinuclear antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antinuclear antibodies (ANA) are present in the majority of patients with RV [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/2\">",
"     2",
"    </a>",
"    ]. The ANA are nonspecific, however, and do not contribute either to making the diagnosis of RV or to following the degree of disease activity in RV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Antineutrophil cytoplasmic antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there was considerable interest in ANCA testing in RA and RV throughout the 1990s, ANCA assays do not have an important role in the evaluation of either RA or RV patients (aside from their utility in the exclusion of other conditions). With immunofluorescence testing for ANCA, which provides information about the pattern of immunofluorescence observed, significant percentages of both RA and RV patients are ANCA positive. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/28/9674?source=see_link\">",
"     \"Clinical spectrum of antineutrophil cytoplasmic antibodies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The usual immunofluorescence patterns observed in RA are perinuclear (P-ANCA) and atypical (A-ANCA). Cytoplasmic (C-ANCA) patterns are very rare. In nearly all cases, however, ANCA positivity in RA is caused by one of the &ldquo;minor&rdquo; ANCA antigens (eg, lactoferrin, elastase, cathepsin G, or others), not by proteinase-3 or myeloperoxidase, the two antigens strongly associated with systemic vasculitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Anti-endothelial cell antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anti-endothelial cell antibodies have been proposed to have roles in the pathophysiology or monitoring of multiple forms of systemic vasculitis, including RV. Many studies of anti-endothelial antibodies, however, suffer from inconsistent assay qualities (leading to results that are difficult to reproduce), from the absence of appropriate control groups, and from the fact that most antigens to which anti-endothelial cell antibodies are directed remain unidentified. Thus, anti-endothelial cell antibody assays have no defined role in making the diagnosis, in assessing the prognosis, or in gauging disease activity of RV [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Antibodies to glucose-6-phosphate isomerase",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a mouse model, antibodies to the glycolytic enzyme glucose-6-phosphate isomerase (GPI) cause an erosive joint disease that is strikingly similar to RA [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/40\">",
"     40",
"    </a>",
"    ]. Among 131 human patients with RA, antibodies to GPI appeared to have promise as a marker for extraarticular manifestations of RA. Whereas only 5 percent of all RA patients and 4 percent of healthy controls had antibodies to GPI, 45 percent of RA patients with RV and 92 percent of patients with Felty&rsquo;s syndrome had these antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/41\">",
"     41",
"    </a>",
"    ]. The numbers of patients in these subgroups, however, were small (only 11 in the RV subgroup, for example, and 13 in the Felty&rsquo;s syndrome subgroup). The results of this study require confirmation in larger numbers of patients and controls. Anti-GPI antibodies do not have a defined clinical role in RA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Hypocomplementemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum complement levels are generally normal in RA or are even elevated in active disease as a reflection of the acute phase response. However, hypocomplementemia may be more common in patients with RV [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/2,42-44\">",
"     2,42-44",
"    </a>",
"    ]. Despite the finding of hypocomplementemia in some patients with RV, there are no data to suggest that following serum complement levels is useful in monitoring disease activity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of RV should be suspected in any patient with a long history of RA or juvenile idiopathic arthritis (JIA) who develops new or significantly worse constitutional symptoms. Weight loss, fever, and fatigue may be subtle indicators of the development of RV. Extraarticular manifestations of RA that strongly suggest RV include cutaneous ulcers on the lower extremities, digital infarctions, palpable purpura, new sensory or motor deficits, eye redness (particularly if associated with ocular pain), pericarditis, and the development of an active urine sediment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Confirming the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The level of immunosuppression required to treat RV effectively is associated with substantial toxicity. On the other hand, RV patients who are not treated aggressively have poor prognoses. These two facts dictate that, whenever possible, the diagnosis of RV should be confirmed by tissue biopsy. For certain RV manifestations (eg, scleritis or PUK), the diagnosis is sufficiently clear on physical examination as to preclude the need for biopsy. In many patients, skin involvement offers the opportunity to confirm the diagnosis (",
"    <a class=\"graphic graphic_picture graphicRef52548 graphicRef66296 \" href=\"UTD.htm?7/58/8106\">",
"     picture 9A-B",
"    </a>",
"    ) and to distinguish RV from other forms of vasculitis. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In delineating the specific cause of vasculitis, defining the distribution of the size of blood vessels involved is helpful. In patients with palpable purpura, deep punch biopsies are useful in sampling both the small blood vessels of the superficial dermis and the medium-sized muscular arteries of the deeper dermis and subcutaneous fat. Immunofluorescence studies for IgG, IgM, IgA, and complement components help narrow the differential diagnosis. Immunofluorescence studies must be performed on fresh tissue and require sampling from a second biopsy site. In the biopsy of cutaneous ulcers, the greatest yield is from the border of the lesion. The finding of cutaneous vasculitis consistent with RV in the setting of clinically apparent systemic involvement is sufficient to confirm the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4345?source=see_link&amp;anchor=H16171991#H16171991\">",
"     \"Evaluation of adults with cutaneous lesions of vasculitis\", section on 'Biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the absence of a site amenable to skin biopsy, ancillary testing may identify other potential biopsy sites. For example, electromyographic testing and determination of nerve conduction velocities",
"    <span class=\"nowrap\">",
"     (EMG/NCV)",
"    </span>",
"    may reveal findings compatible with a mononeuritis multiplex, in which case combined nerve-muscle biopsies may be indicated. Sural nerve biopsy may show either active arteritis, particularly in patients who have not received previous treatment with glucocorticoids, or a proliferative endarteritis of the epineurium, which reflects the healed stage of a previous acute arteritis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/45\">",
"     45",
"    </a>",
"    ]. Even among patients who have vasculitic nerve involvement, however, sural nerve biopsy is negative approximately half the time. For this reason, simultaneous biopsy of an adjacent muscle (eg, the gastrocnemius in the case of the sural nerve) is important. Muscle tissue, in contrast to nerve, is highly vascular. Muscle biopsy may yield the diagnosis even in the absence of clinical muscle abnormalities.",
"   </p>",
"   <p>",
"    In the absence of other explanations for a decline in renal function or for an active urine sediment in RA, kidney biopsy may yield useful diagnostic information. A pauci-immune glomerulonephritis confirms the presence of a small-vessel vasculitis (",
"    <a class=\"graphic graphic_picture graphicRef53506 \" href=\"UTD.htm?6/12/6345\">",
"     picture 10",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/28\">",
"     28",
"    </a>",
"    ]. Labial salivary gland biopsy may be an even less invasive approach to the diagnosis of RV. In one report, labial salivary gland biopsies were positive for vasculitis in 11 of 12 patients with proven RV, compared with 20 percent of 35 patients with RA alone [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/21\">",
"     21",
"    </a>",
"    ]. Because these findings have not been confirmed in additional studies, the generalizability of this study is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiography is rarely useful in RV for two reasons. First, the vessels involved in RV, though technically &ldquo;medium-sized,&rdquo; are often below the resolution of angiography. Second, the findings on angiography in RV are nonspecific, generally revealing segmental narrowing or perhaps narrowing alternating with dilatation of blood vessels. These angiographic features are found in a broad array of disorders, particularly vasospasm (resulting from myriad causes) and atherosclerosis. Microaneurysms, a hallmark of polyarteritis nodosa (PAN) that may be diagnostic of that disease in the proper setting, are unusual in RV [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disorders that must be considered in the differential diagnosis of RV include mimics of vasculitis and, when vasculitis has been confirmed by biopsy, a vasculitis other than RV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Mimics of vasculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection, thromboembolic diseases, and malignancies may mimic the clinical features of RV [",
"    <a class=\"abstract\" href=\"UTD.htm?20/13/20697/abstract/46\">",
"     46",
"    </a>",
"    ]. As an example, infective endocarditis can be associated with fever, skin lesions, and renal disease with an active urine sediment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/23/37241?source=see_link&amp;anchor=H42#H42\">",
"     \"Classification of and approach to the vasculitides in adults\", section on 'Differential diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4345?source=see_link&amp;anchor=H606119#H606119\">",
"     \"Evaluation of adults with cutaneous lesions of vasculitis\", section on 'Differential diagnosis'",
"    </a>",
"    .) Cholesterol emboli may also lead to digital ischemia, leg ulcers, livedo reticularis, and other findings easily confused with vasculitis. Among the cancers, patients with RA are known to be at increased risk for lymphoma compared with age- and sex-matched population-based controls. This risk may be heightened by both conventional and biologic disease-modifying agents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Other vasculitides",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other possible causes of biopsy-proven vasculitis in a patient with RA include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Polyarteritis nodosa &mdash; In terms of the size of blood vessels involved and the types of organs affected, polyarteritis nodosa and RV overlap nearly completely. The two diseases are histopathologically indistinguishable, with the exception (noted above) that RV rarely leads to microaneurysm formation. The key to distinguishing these two disorders is the clinical setting. Arthritis and other musculoskeletal complaints associated with PAN do not lead to a destructive arthritis. In the patient with a history of many years of seropositive, erosive RA, the correct diagnosis is likely RV.",
"     </li>",
"     <li>",
"      ANCA-associated vasculitides &mdash; ANCA-associated diseases (granulomatosis with polyangiitis [Wegener&rsquo;s], the Churg-Strauss syndrome, and microscopic polyangiitis) have several features in common with RA. First, a migratory oligoarthritis is often among the initial disease manifestations of these conditions. Second, a significant proportion of patients with ANCA-associated vasculitides are rheumatoid factor positive. Third, cutaneous nodules known as &ldquo;Churg-Strauss granulomas,&rdquo; which tend to occur over extensor surfaces (particularly in the olecranon regions), may mimic rheumatoid nodules. Because of these disease similarities, many patients with ANCA-associated vasculitis are misdiagnosed initially as having RA.",
"     </li>",
"     <li>",
"      Hypersensitivity vasculitis &mdash; The potential for small-vessel involvement (cutaneous venules) in RV may lead to confusion with other small-vessel vasculitis syndromes such as hypersensitivity vasculitis, usually caused by a reaction to a medication. Antibiotics, for example, are prime offenders. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30614?source=see_link\">",
"       \"Hypersensitivity vasculitis in adults\"",
"      </a>",
"      .) Although involvement of medium-sized arteries and arterioles is responsible for many RV manifestations, inflammation in cutaneous venules may often be observed.",
"     </li>",
"     <li>",
"      Cryoglobulinemic vasculitis &mdash; Palpable purpura, cutaneous ulcers, arthralgias (and even frank arthritis), and myalgia typically accompany cryoglobulinemic vasculitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/63/22522?source=see_link&amp;anchor=H3#H3\">",
"       \"Overview of cryoglobulins and cryoglobulinemia\", section on 'Cryoglobulinemia'",
"      </a>",
"      .) In addition, because the IgM component in mixed cryoglobulinemia has rheumatoid factor activity, patients with type II and type III cryoglobulinemia are almost always rheumatoid factor positive. Cryoglobulinemia also shares with RV the tendency to produce hypocomplementemia, although the degree of hypocomplementemia (particularly C4 levels) in cryoglobulinemia is usually more profound in mixed cryoglobulinemia than in RV. Cutaneous features of small-vessel vasculitis (purpura, pustules), nearly universal in cryoglobulinemia, are less common in RV.",
"     </li>",
"     <li>",
"      Vasculitis associated with an overlapping connective tissue disease &mdash; Arthritis, rheumatoid factor positivity, and joint syndromes such as Jaccoud&rsquo;s arthropathy frequently occur in connective tissue diseases such as systemic lupus erythematosus, mixed connective tissue disease, and the inflammatory myopathies (polymyositis and dermatomyositis). Cutaneous vasculitis is also a common manifestation of such disorders, potentially leading to confusion with RV. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42968?source=see_link\">",
"       \"Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes\"",
"      </a>",
"      .) Some connective tissue disorders are also associated with antiphospholipid antibodies, known to cause digital gangrene and cutaneous ulcers.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The typical patient with rheumatoid vasculitis (RV) has longstanding rheumatoid arthritis (RA), a high level of anticyclic citrullinated peptide (CCP) antibodies",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      rheumatoid factor, erosive joint disease, and rheumatoid nodules. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical presentation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Laboratory findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Skin lesions, noted in 90 percent of patients with RV, range in severity from nailfold infarcts to large ulcers and digital necrosis. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Cutaneous vasculitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Peripheral neuropathy, either a mononeuritis multiplex or a symmetrical polyneuropathy, occurs in approximately 40 percent of patients with RV. Central nervous system involvement is uncommon. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Neurologic disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The two principal ocular manifestations of RV are necrotizing scleritis and peripheral ulcerative keratitis. Patients with these extraarticular manifestations of RA do not require a tissue biopsy in order to make the diagnosis of RV. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Ocular disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Coronary vasculitis is rare, and myocardial infarction in patients with RV may be the result of atherosclerosis, which is more prevalent in patients with longstanding, active RA. Pulmonary vasculitis, also uncommon in RV, can cause pulmonary arterial hypertension or diffuse alveolar hemorrhage. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Cardiac disease'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Pulmonary disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      necrotizing glomerulonephritis, similar to that seen with granulomatosis with polyangiitis [Wegener&rsquo;s] or with microscopic polyangiitis, may occur. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Renal disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      RV is suspected on the basis of the presence of compatible clinical features. There is no diagnostic laboratory test for RV. Nonspecific signs of the underlying inflammatory process include elevations in erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), thrombocytosis, hypoalbuminemia, and the anemia of chronic disease. A variety of autoantibodies and hypocomplementemia also may be present. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Laboratory findings'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of RV includes mimics of vasculitis such as infection, malignancy, embolic diseases, and thrombotic disorders. Patients with biopsy proven vasculitis and rheumatoid arthritis may have another type of vasculitis. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend confirmation of RV by biopsy of a clinically involved organ whenever it is feasible to do so. Angiography is an alternative to biopsy but is only likely to provide diagnostically useful information if the clinical setting suggests medium- or large-artery involvement. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Confirming the diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/1\">",
"      SOKOLOFF L, MCCLUSKEY RT, BUNIM JJ. Vascularity of the early subcutaneous nodule of rheumatoid arthritis. AMA Arch Pathol 1953; 55:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/2\">",
"      Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981; 60:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/3\">",
"      Voskuyl AE, Zwinderman AH, Westedt ML, et al. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis 1996; 55:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/4\">",
"      Vollertsen RS, Conn DL, Ballard DJ, et al. Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore) 1986; 65:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/5\">",
"      Geirsson AJ, Sturfelt G, Truedsson L. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis 1987; 46:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/6\">",
"      Sayah A, English JC 3rd. Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol 2005; 53:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/7\">",
"      Bywaters EG. A Variant of Rheumatoid Arthritis resembling Palindromic Rheumatism. Ann Rheum Dis 1949; 8:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/8\">",
"      Watts RA, Carruthers DM, Scott DG. Isolated nail fold vasculitis in rheumatoid arthritis. Ann Rheum Dis 1995; 54:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/9\">",
"      BYWATERS EG. Peripheral vascular obstruction in rheumatoid arthritis and its relationship to other vascular lesions. Ann Rheum Dis 1957; 16:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/10\">",
"      Pu&eacute;chal X, Said G, Hilliquin P, et al. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 1995; 38:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/11\">",
"      Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol 2005; 252:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/12\">",
"      SCHMID FR, COOPER NS, ZIFF M, McEWEN C. Arteritis in rheumatoid arthritis. Am J Med 1961; 30:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/13\">",
"      Okhravi N, Odufuwa B, McCluskey P, Lightman S. Scleritis. Surv Ophthalmol 2005; 50:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/14\">",
"      Squirrell DM, Winfield J, Amos RS. Peripheral ulcerative keratitis 'corneal melt' and rheumatoid arthritis: a case series. Rheumatology (Oxford) 1999; 38:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/15\">",
"      Horo S, Sudharshan S, Biswas J. Recurrent posterior scleritis--report of a case. Ocul Immunol Inflamm 2006; 14:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/16\">",
"      Fong LP, Sainz de la Maza M, Rice BA, et al. Immunopathology of scleritis. Ophthalmology 1991; 98:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/17\">",
"      McCluskey PJ, Watson PG, Lightman S, et al. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology 1999; 106:2380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/18\">",
"      SOKOLOFF L. The heart in rheumatoid arthritis. Am Heart J 1953; 45:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/19\">",
"      CRUICKSHANK B. The arteritis of rheumatoid arthritis. Ann Rheum Dis 1954; 13:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/20\">",
"      van Albada-Kuipers GA, Bruijn JA, Westedt ML, et al. Coronary arteritis complicating rheumatoid arthritis. Ann Rheum Dis 1986; 45:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/21\">",
"      JOHNSON RL, SMYTH CJ, HOLT GW, et al. Steroid therapy and vascular lesions in rheumatoid arthritis. Arthritis Rheum 1959; 2:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/22\">",
"      Takayanagi M, Haraoka H, Kikuchi H, Hirohata S. Myocardial infarction caused by rheumatoid vasculitis: histological evidence of the involvement of T lymphocytes. Rheumatol Int 2003; 23:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/23\">",
"      W&aring;llberg-Jonsson S, Cvetkovic JT, Sundqvist KG, et al. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J Rheumatol 2002; 29:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/24\">",
"      Park YB, Ahn CW, Choi HK, et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002; 46:1714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/25\">",
"      Kumeda Y, Inaba M, Goto H, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002; 46:1489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/26\">",
"      Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 1985; 131:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/27\">",
"      Boers M, Croonen AM, Dijkmans BA, et al. Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies. Ann Rheum Dis 1987; 46:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/28\">",
"      Harper L, Cockwell P, Howie AJ, et al. Focal segmental necrotizing glomerulonephritis in rheumatoid arthritis. QJM 1997; 90:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/29\">",
"      Qarni MU, Kohan DE. Pauci-immune necrotizing glomerulonephritis complicating rheumatoid arthritis. Clin Nephrol 2000; 54:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/30\">",
"      Pagnoux C, Mahr A, Cohen P, Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 2005; 84:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/31\">",
"      Achkar AA, Stanson AW, Johnson CM, et al. Rheumatoid vasculitis manifesting as intra-abdominal hemorrhage. Mayo Clin Proc 1995; 70:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/32\">",
"      Babian M, Nasef S, Soloway G. Gastrointestinal infarction as a manifestation of rheumatoid vasculitis. Am J Gastroenterol 1998; 93:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/33\">",
"      Mizuno K, Ikeda K, Saida Y, et al. Hepatic hemorrhage in malignant rheumatoid arthritis. Am J Gastroenterol 1996; 91:2624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/34\">",
"      Mongan ES, Cass RM, Jacox RF, Vaughen JH. A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis. Am J Med 1969; 47:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/35\">",
"      van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 2004; 50:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/36\">",
"      Sihvonen S, Korpela M, Mustila A, Mustonen J. The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis. J Rheumatol 2005; 32:2089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/37\">",
"      Laskari K, Laskaria K, Ahmadi-Simab K, et al. Are anti-cyclic citrullinated peptide autoantibodies seromarkers for rheumatoid vasculitis in a cohort of patients with systemic vasculitis? Ann Rheum Dis 2010; 69:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/38\">",
"      Tervaert JW, Damoiseaux J, Boomsma MM, Stegeman CA. Absence of anti-cyclic citrullinated peptide antibodies in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2002; 46:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/39\">",
"      Belizna C, Duijvestijn A, Hamidou M, Tervaert JW. Antiendothelial cell antibodies in vasculitis and connective tissue disease. Ann Rheum Dis 2006; 65:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/40\">",
"      Matsumoto I, Staub A, Benoist C, Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 1999; 286:1732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/41\">",
"      van Gaalen FA, Toes RE, Ditzel HJ, et al. Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis. Arthritis Rheum 2004; 50:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/42\">",
"      Franco AE, Schur PH. Hypocomplementemia in rheumatoid arthritis. Arthritis Rheum 1971; 14:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/43\">",
"      Glass D, Soter NA, Schur PH. Rheumatoid vasculitis. Arthritis Rheum 1976; 19:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/44\">",
"      Schneider HA, Yonker RA, Katz P, et al. Rheumatoid vasculitis: experience with 13 patients and review of the literature. Semin Arthritis Rheum 1985; 14:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/45\">",
"      Conn DL, McDuffie FC, Dyck PJ. Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum 1972; 15:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/13/20697/abstract/46\">",
"      EPSTEIN WV, ENGLEMAN EP. The relation of the rheumatoid factor content of serum to clinical neurovascular manifestations of rheumatoid arthritis. Arthritis Rheum 1959; 2:250.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8237 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-194.187.108.93-9EF4B3CCD6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20697=[""].join("\n");
var outline_f20_13_20697=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Constitutional symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Cutaneous vasculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Neurologic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Ocular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Cardiac disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Renal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Gastrointestinal, pancreatic, and hepatic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LABORATORY FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Autoantibodies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Rheumatoid factor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Anti-CCP antibodies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Antinuclear antibodies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Antineutrophil cytoplasmic antibodies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Anti-endothelial cell antibodies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Antibodies to glucose-6-phosphate isomerase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Hypocomplementemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Confirming the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Angiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Mimics of vasculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Other vasculitides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/8237\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/8237|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/18/28963\" title=\"picture 1\">",
"      Rheumatoid nodule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/48/20224\" title=\"picture 2\">",
"      Nailfold infarction in RV 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/3/25648\" title=\"picture 3\">",
"      Cutaneous ulceration in RV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/7/15480\" title=\"picture 4\">",
"      Skin biopsy findings in RV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/0/7\" title=\"picture 5\">",
"      Gangrene due to RV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/34/1570\" title=\"picture 6\">",
"      Vasculitic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/52/21319\" title=\"picture 7\">",
"      Scleritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/37/19025\" title=\"picture 8\">",
"      Peripheral ulcerative keratitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/20/43333\" title=\"picture 9A\">",
"      Leukocytoclastic vasculitis I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/37/23126\" title=\"picture 9B\">",
"      Leukocytoclastic vasculitis II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/12/6345\" title=\"picture 10\">",
"      Necrotizing GN",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/23/37241?source=related_link\">",
"      Classification of and approach to the vasculitides in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/26/9641?source=related_link\">",
"      Clinical manifestations and diagnosis of polyarteritis nodosa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/57/22423?source=related_link\">",
"      Clinical manifestations of vasculitic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/28/9674?source=related_link\">",
"      Clinical spectrum of antineutrophil cytoplasmic antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10631?source=related_link\">",
"      Coronary artery disease in rheumatoid arthritis: Epidemiology, pathogenesis, and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/26/42407?source=related_link\">",
"      Epidemiology and pathogenesis of rheumatoid vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4345?source=related_link\">",
"      Evaluation of adults with cutaneous lesions of vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30614?source=related_link\">",
"      Hypersensitivity vasculitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/31/17912?source=related_link\">",
"      Interstitial lung disease in rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/55/11129?source=related_link\">",
"      Neurologic manifestations of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/23/22903?source=related_link\">",
"      Ocular manifestations of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/63/22522?source=related_link\">",
"      Overview of cryoglobulins and cryoglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26969?source=related_link\">",
"      Overview of lung disease associated with rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37812?source=related_link\">",
"      Renal disease in patients with rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/19/22841?source=related_link\">",
"      Treatment of rheumatoid vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42968?source=related_link\">",
"      Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_13_20698="Blood smear too thick";
var content_f20_13_20698=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F61577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F61577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Blood smear too thick",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 410px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Suboptimally prepared peripheral blood smear which is too thick. All that is seen on this low power view are dense collections of darkened red cells. No morphologic characteristics of the red cells can be discerned.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jackie Mitus, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20698=[""].join("\n");
var outline_f20_13_20698=null;
var title_f20_13_20699="Rating of perceived exertion";
var content_f20_13_20699=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F70470&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F70470&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Rating of perceived exertion",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Original scale",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        very, very light",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        9",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        very light",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        11",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        fairly light",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        13",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        somewhat hard",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        15",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        hard",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        16",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        17",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        very hard",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        18",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        19",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        very, very hard",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        20",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20699=[""].join("\n");
var outline_f20_13_20699=null;
var title_f20_13_20700="BMI waist circumference risk";
var content_f20_13_20700=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F70466&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F70466&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification of overweight and obesity by BMI, waist circumference, and associated disease risk",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"3\">",
"        BMI kg/m",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"3\">",
"        Obesity class",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Disease risk* relative to normal weight and waist circumference",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Men &le;102 cm",
"        <br/>",
"        (&le;40 in)",
"       </td>",
"       <td class=\"subtitle2\">",
"        &gt;102 cm",
"        <br/>",
"        (&gt;40 in)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Women &le;88 cm",
"        <br/>",
"        (&le;35 in)",
"       </td>",
"       <td class=\"subtitle2\">",
"        &gt;88 cm",
"        <br/>",
"        (&gt;35 in)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Underweight",
"       </td>",
"       <td>",
"        &lt;18.5",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        18.5 to 24.9",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Overweight",
"       </td>",
"       <td>",
"        25.0 to 29.9",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Increased",
"       </td>",
"       <td>",
"        High",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Obesity",
"       </td>",
"       <td>",
"        30.0 to 34.9",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        High",
"       </td>",
"       <td>",
"        Very high",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        35.0 to 39.9",
"       </td>",
"       <td>",
"        II",
"       </td>",
"       <td>",
"        Very high",
"       </td>",
"       <td>",
"        Very high",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Extreme obesity",
"       </td>",
"       <td>",
"        &ge;40",
"       </td>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        Extremely high",
"       </td>",
"       <td>",
"        Extremely high",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Disease risk for type 2 diabetes, hypertension, and CVD.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Increased waist circumference can also be a marker for increased risk even in persons of normal weight.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res 1998; 6:515.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20700=[""].join("\n");
var outline_f20_13_20700=null;
var title_f20_13_20701="ANP BNP LV dysfunction";
var content_f20_13_20701=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55557&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55557&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 564px\">",
"   <div class=\"ttl\">",
"    Serum ANP and BNP correlate with LV dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 544px; height: 237px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Among 1252 subjects from the general population, median serum concentrations of N-terminal atrial natriuretic peptide (NT-ANP) and brain natriuretic peptide were significantly higher in those with left ventricular systolic dysfunction (LVD) as assessed with echocardiography. Among the patients with LVD, 77 percent were asymptomatic. Boxes are median concentrations and vertical lines are the ranges.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from McDonagh TA, Robb SD, Murdoch DR, et al. Lancet 1998; 351:9.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20701=[""].join("\n");
var outline_f20_13_20701=null;
var title_f20_13_20702="Minor RBC antibodies pregnancy1";
var content_f20_13_20702=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55421%7EOBGYN%2F67208&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55421%7EOBGYN%2F67208&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Minor red blood cell antibodies associated with hemolytic disease of the newborn",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Blood system",
"       </td>",
"       <td class=\"subtitle1\">",
"        Specific antigens",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severity of hemolytic disease of the newborn (HDN)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"7\">",
"        Kell",
"       </td>",
"       <td>",
"        K",
"       </td>",
"       <td>",
"        Mild to severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        k",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ko",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kp(a)",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kp(b)",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Js(a)",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Js(b)",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Duffy",
"       </td>",
"       <td>",
"        Fy(a)",
"       </td>",
"       <td>",
"        Mild to severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fy(b)",
"       </td>",
"       <td>",
"        Not a cause of HDN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fy(3)",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Kidd",
"       </td>",
"       <td>",
"        Jk(a)",
"       </td>",
"       <td>",
"        Mild to severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Jk(b)",
"       </td>",
"       <td>",
"        Mild to severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Jk(3)",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Lewis",
"       </td>",
"       <td>",
"        Le(a)",
"       </td>",
"       <td>",
"        Not a cause of HDN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Le(b)",
"       </td>",
"       <td>",
"        Not a cause of HDN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        I",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        Not a cause of HDN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        i",
"       </td>",
"       <td>",
"        Not a cause of HDN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"11\">",
"        MNSs&nbsp;",
"       </td>",
"       <td>",
"        M",
"       </td>",
"       <td>",
"        Mild to severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        N",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        S",
"       </td>",
"       <td>",
"        Mild to severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        s",
"       </td>",
"       <td>",
"        Mild to severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        U",
"       </td>",
"       <td>",
"        Mild to severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mi(a)",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mt(a)",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vw",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mur",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hil",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hut",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Lutheran",
"       </td>",
"       <td>",
"        Lu(a)",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lu(b)",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Diego",
"       </td>",
"       <td>",
"        Di(a)",
"       </td>",
"       <td>",
"        Mild to severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Di(b)",
"       </td>",
"       <td>",
"        Mild to severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Xg",
"       </td>",
"       <td>",
"        Xg(a)",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        P",
"       </td>",
"       <td>",
"        PP1P(k)",
"       </td>",
"       <td>",
"        Mild to severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        P1",
"       </td>",
"       <td>",
"        Not a cause of HDN",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from data in Weinstein L. Clin Obstet Gynecol 1982; 25:327 and Reid ME, Toy PTCY. In: Hematology of Infancy and Childhood, 5th ed, Nathan DG, Orkin SH (Eds), WB Saunders, Philadelphia, 1998, p. 1768.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Minor red blood cell antibodies associated with hemolytic disease of the newborn",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Blood system",
"       </td>",
"       <td class=\"subtitle1\">",
"        Specific antigens",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severity of hemolytic disease of the newborn (HDN)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"8\">",
"        Public antigens",
"       </td>",
"       <td>",
"        Yt(a)",
"       </td>",
"       <td>",
"        Moderate to severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yt(b)",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lan",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        En(a)",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ge",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Jr(a)",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Co(a)",
"       </td>",
"       <td>",
"        Severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Co(a-b-)",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"26\">",
"        Private antigens",
"       </td>",
"       <td>",
"        Batty",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Becker",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Berrens",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Biles",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ch/RG",
"       </td>",
"       <td>",
"        Not a cause of HDN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cromer",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dombrock",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Evans",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gerbich",
"       </td>",
"       <td>",
"        Not a cause of HDN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gonzales",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Good",
"       </td>",
"       <td>",
"        Severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        H",
"       </td>",
"       <td>",
"        Not a cause of HDN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heibel",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hunt",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Indian",
"       </td>",
"       <td>",
"        Not a cause of HDN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Jobbins",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Knops",
"       </td>",
"       <td>",
"        Not a cause of HDN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LW",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Radin",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rm",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Scianna",
"       </td>",
"       <td>",
"        Not a cause of HDN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ven",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wright(a)",
"       </td>",
"       <td>",
"        Severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wright(b)",
"       </td>",
"       <td>",
"        Mild",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        XK",
"       </td>",
"       <td>",
"        Not a cause of HDN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zd",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from data in Weinstein L. Clin Obstet Gynecol 1982; 25:327 and Reid ME, Toy PTCY. In: Hematology of Infancy and Childhood, 5th ed, Nathan DG, Orkin SH (Eds), WB Saunders, Philadelphia, 1998, p. 1768.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20702=[""].join("\n");
var outline_f20_13_20702=null;
var title_f20_13_20703="Langerhans sternum CT";
var content_f20_13_20703=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F56235&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F56235&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Langerhans cell histiocytosis of bone",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 433px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGxAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwCiYITNITFHku38I9TQ9rBj/Vxf98Cr89o8blivDZI/E1UbAOCpoASK3hz/AKmL/vgVMLaDP+pi/wC+BUfTkVLGSetADhbwj/lhF/3wKRreDqIYv++BT6acY4oAVYIDn9zFn/cFI9vBj/Uxf98CpI6eaAKxt4c/6mL/AL4FHkQj/ljFj/cFStTCO9ACfZ4GGRDF/wB8Cmm2hAz5MX/fAqZcY6U5yMUAV1ghI/1MX/fApWtoB/yxi/74FPAOfapMe1AFCaCH/njF/wB8CqPkR+Zjyo+f9kVsSx5B6VTaPDdKAFW2hCj9zEf+ACnrDDyPIi/74FSRpxTj8tACLFB08iLP+4Kk8iHH+oi/74FRI2GqfcCPegBphg2/6iH/AL4FVzbwEn9zF/3wKnPJFBGKAKslvCAf3MX/AHwKi8iHP+pj/wC+BVqXmoGHFAEb20OOIov++RUkdtDtz5UX/fAo6+1PLBVx3oAge2hP/LKL/vkUz7LEBkRRj/gAqRTk1KUJWgCsIIiP9VH/AN8CnxwQjrDGT/uCp44xjHepVhwaAIBBDkfuYv8AvgVMlvD/AM8Yv++BUoi5qQKMUARNbQbf9TF/3wKatrD/AM8Yv++BVkLxQ3ymgCuLeBTzBF/3wKQxQE48iL/vgVL160bBQBELaAj/AFEX/fApGtYf+eMX/fAqbODgdaQHJoAalvCP+WEX/fAo8iAn/URf98Cnq3zU4gYzQBAbaHPEER/4AKX7PB/zwi/74FOzg09fm60ARfZYc58mL/vgUC1g/wCeMX/fAqxjApdtAFcWsJ/5YRf98CirIG0e9FAHTw26z2se4DG2sbUdLwrSRDgdq6K2KpYw5/u1Ru7tFBUGgDjGykhDDFTRugHWpNUjWVGdOCPSsYsyAZNAGsZFzw1AIJrMSQkdamikOcZoA0A2DigsSeKrBs85p5mwuDQBMz0m4YqAPk0vJFAEoYVIDxUCDFPJ44oAlDDFOPbFVuRUsbZoAkbBHNQvjB45pX60nbnNABGeOarTOc8VZZgFqpMMnNACq3rUqP61VGR2p6Mc8igC4CM0haog2R1pQ2OtAEjYI6VA4A7VKWz0qN1JINAEJPtTHY5p8inpTBGxoAdFgdetWkORVcIeDUy0ASxjk1KD61EGAFPBPWgB9PA4zTFalJ44oAXdjvSbtxpg65NLnHNADiAOBTCcGm7vWkJ96AJBgtycU4KM1Ackipl6CgBCBnrTdwxikkByMGo+cmgCTIqRCMVWOc04HAoAsbgTQXx0qsc+tIGIPWgCyW5oqszntRQB2ETl7SMei4rIvWwSMVeimC2q+uKxrqdnk+WgBNgePbWTeQhZMAZFaIlbptpGiD8kc0AYLZU8Cno2ME1cuLcqTxVCVWU8DpQBb34XjvQrbqrLJ8vTpUsJyKALaADmphjFQp0pyHmgCTApwXHNJTyQV96AGUoO2nqOKHAx70AMZuKVRu69Keq5XkUm3HTGBQAbR/FjFQSJmriAHrTXXr0oAoFcdqRxxmrDKM01kGBmgCCI+pp5Jx8uD9aRlC8inx8jnvQA6Ibvb2qVkAxjmmxrg1Mo3FQQc55oAgaLOaRV2jmrciccVFs9aAIsZBpNlTMMDimKMtQAmzgZp46VIEpNvNAEfOTS7sdakK4pki8e9ADAdxqQHsaiTjFSgEmgBpFJyO1ObinKCaAEUZFKqY61IFwKSgAMeRUQjOTVpRRtAyaAKhTmmSJgcVNMwHSq0khx3oAcozxTXBB5qNHOasBN496AKzvzxRVyO03sOODRQA46rGoaPjIYjr700TiQ5AryqfxVs12+gY/6u5kXB9mNdho+s+eq8igDqVB9OtTRqSaoQXZYDkVfhckckUAOkhDDBFULmzznArVjp7KCMCgDlpLZlJApyRMqVuyWwZs44qKS2GOlAGVGTjmnZO6rT2hByKY0JA6c0ANBIApy5JppU4x3pQ4Q4oAnjPan4xUcbZ5p++gB69KTpSpzTzigCIHBpznIpSBTX4oAhNRuGPSpiAe1LkA4oArbTnmpVTPAqUANU0FsC2aAEigOMnpU6RjOO9WliCphqdFGhY+tAFN0B61C0OBxwK0ZLdc5z1pGtBt4JoAx2jYt96nLG26r32Q56mrMVlmgCikZC0CM81pvabBUDKA3SgCmycVC44xVyXHSoWQleKAKe00+PIFSFMUBM/SgBoXPNPAwKXouKjeTsBmgAd+O1JGw71XZ8nihGJwOOKALxYbagkkbtSqhI4JNKsJPHNAFNyxoWF2YAitBLXnkVbjgUYJFAGdFbY6irUcGCOKvpGg6ij5RkigBqRCipl5HtRQB8n+I5GTxNqzIcEXcv/oZrR0LxBNAyozEdqzPE3/Iyat/19y/+hms5SVOQcGgD27QtV84KWfn3NdlYzBl+9nNeB+H9WkSVUZuOg5r17wzerLCu4gnFAHYo2OlTIx+tQ28iMoNXEA29KAI0UnrTmiBFSRrzip2jyvFAFExZHFRtbggVZbk04AbaAM5rYc8VBLa59q1ygI5phVWGKAMcoUXBHSmA46cVqzQrt96pyQ88UAMVuKUct1xTChz0prqwHAxQBYC470MARVfc2Oadv8AloAk2ZOBirMNru7ZNU4nzIB710ljCHRTg9KAKsNgpwCBV2OxVei1oxQqMZq2kaEUAZEtqNg7/wBKiitV344roGij2VWSBDLxQBRexTinCzXGMiteaBAgIPIquyLigDNayA7irMFqoWrKoDwTxU/lqEwDQBh3q4yAaymGGNbl/HgHHU1klD1IoAqtHuY5FKIvlNTsuO1NYhVOaAKTgLn1qJnwaS6lG47TUCNk/WgB7nqagY7mwMg1aVc09YVzk0AVYbcZ5FWYrMZBq1HEvarCAD8KAIUtsKO1SLEBTy4qJ5QGoAkKDGadgYpUOUyKgmYg+lAE2QeKaRyKrCQ4o805A60AaEYzRSQHKgmigD5J8S/8jJq3/X3L/wChms6tHxN/yMmrZ/5+5f8A0M1nUAOicxuGU4xzXpXgrV1ZVUtj2rzKrmn381lKGjJx3FAH0rpd2GQc/nWyl0NvFePeEfEpuAiuxBI5BNehWV6siAhuPrQB00MuetWmfcuefwrEhuMDg8Vchm3GgCweKUD5feovMy3tUu4YoAYwPSkVTnmlPJpx4FAELrkjmo2hOOuakLAGnb/loAqGPHWkaLI4GanJDH3pVHagDPeLBppTFXJF56VDKOOKAKnCSqc112iXMbQhTjNcbOTnpWho915cwGaAO1bHBFPjYd6r28gkUY54qUnb2oAuB1ZeBTYiqtkioUcBKY0wH1oAuyurLxVWo2mwtIsu7rQBOgz0pWJ6URPigklhxQBVuIiR7VQliwOBW0RnjFVriIYPFAGLMhUZI4FY1/OegNa2qXIjBUVgupmYnmgCsqsxyTU9uhDc1NHbEAcGpFi2t70AAGOaeDTXQj6U6NOlAEi5A604OcU0jApyJuOaAHRxs55PWobqB0Oc1qW6hcZ6U28dGGOKAI7Agx/N1qG9GTxSxSBBgUx2DNQBCiHvT8BakHBBHUUyV8daAJA5H0oqnJc4HXmigD5e8Tf8jJq3/X3L/wChms09a0vE3/Iyat/19y/+hms0dOaADNGaQikoAs2l1LayB4mIOeea9O8Ka75kKb5OcDIzXlOTWho92ba6X5jtPbNAH0HZXwkxg1s20/TmvOfDWoiVF57V2lrMNqn2oA30l4GasIwIzWPDOCRg1oQuCKALAbBNKWzUPXoaeBg80ALtGQSacQpHFQSn0NCP2NACsuDTUfBqQEHgUgjznigBG+YAmopFFWEiwOaGj60AZcyYzxVMEpJkcd61pI/XrVCeHmgDf0e+LAAmukixIgPWuE09zGRnrXT2F8AuPagDY8sd6jaICovt6beRUcl/GRxQBKyr3NCBR1IrOlvMk44qq942aAOkhZM8nipw0Q6kVyAv5AetO/tCQjkn8aAOqaWIMMEVm6ndpGDhhWDJqDn1rNvLmWVvvDrQA+/lM0px0pYEAWq0SktzV+FSoFADwQBTP4jmpCMZxUX8VAA3JpTwFxSkcUqDIFAC4yuaWJsECg9KagOaAJ3kZRxVRpmY81M545qsRg8UAPVuuaTJzUcjAVC02OlAFoycdarTT8dagkuOKpzzcUAJcz8Hmisu+mCo1FAHhnib/kZNW/6+5f8A0M1m1o+Jv+Rl1b/r7l/9DNZlAC5oH3s0mKBQArdaF+lIaXmgDufB1/8AKFPBFem2UrPCMHtXhOj3z2c4IPyk16z4e1LzrZW3gnFAHVQSbMZNaUF2B3rnkmLmrsROBkUAdJDcZGeKsq4f2rCtpjkDtWpBJkUATyL7VFjFSsxIprAnGKAHRdasJwKrohHOKlBbacdKAJM0E/Sq/wA3pSgNnkUAJIhY9qilg+U5qenFcigChGnzYArRhiYYNTWVisjc/Wt23sI9vOOlAGDscjjNI1rKecmt6S0VDxj86aiLnGKAMJ7OUjqeacmnyHk5NdEipjFK21RjtQBiR6WSeQc1OdFbbWmk4Q8DNTC5JoA5O+0t4QW5+lZTRYfGK7y5jE8ZzjNclqcPkzcCgCGOLjNWI14qvFIScVcU4TNADCvU1GEAp0kmBjFCvlc0ABHFORcYqIyfN7UokwaAJCQrYxTdwBpjPk0xnAoAc8gqtJKKjuJcKSKzWuGyRQBbllyQQeKru5PQ01BvHNP2DAoAi5NQyKathO9RygBaAOZ8QTeTC2fTrRWP4zvGWNwDxRQB5p4mA/4STVv+vuX/ANDNZuBWl4m58Sat/wBfcv8A6GazM4oADSgUhOTRnjFAAetA460lKTmgBTg11ng+8bf5ZY4HArkxjFbXhaQJqK570Ae06QgeNSec1riLArK0Rwbde2BW2rZHSgBbZBkE1dRgtQRnA6CkmfC8UAW1mBPWrkLpjk1zqysHFWBdFR1oA6JHjPGacWjHANc8l0SetXIp8jGaANTK+1RuwFVo5CBTw28kHmgBQcnircCbnANRwQnrirluu1hQBdRVRMr1qZJ8KfWqZ3ZPJo5oAmmnYtxyKb5h9ajY5AoHSgCwjnI2805ix60y2xn1NWHHPSgBirlhTm4xinRjnFOKjPSgBiM/pWbrFrvTcOtapAxxUbqHUhuRQByMcLK54wKnBxwx6VvHTw+So96w9QiaFiDQAxip7imO4FVw/FBbPagB5YU0uKidwB0qEk9aAJpZgAMGqc1yc8Gm3TnAwao87qAJ3mZu9MCEnNCrkVagUdMUAJCu3rT3IA4605hgfKOagfPOaAGGUjvVG/nKxNz2zU78GszVn227Z9KAPN/GN2zFl3GisjxRNvuiATkE0UAUPEv/ACMmrf8AX3L/AOhms01peJf+Rk1b/r7l/wDQzWbQA2ndqbTu2KAG0opO+KcARQAduK0vDxI1FM1nVt+F7cyXqtigD2TQButk9cdK341wKxdAXECVtscCgCZc44pkgJXmliPapmT5eaAM0rzS+XmnycMadHyOetAEKqQ1WUl2nrSbOahnUjOKANGOfd3q5aOGlANYEMrDA5q7bTFZFPvQB2kcO2IGmBcNU+jOs9uFJycVakgCnkUAVkiLDJ5NQv8AIcGtGAL0zVe7hJkyBxQBUzkgAVII88ClERUggZNaFvBkZNAFW2iIfpV0pxnFWo7cAjGKL2PYmV9KAKEI/ee1WZUAxVSzJMhzVycZxigCAjioiCGxUhJBpyLvYcUAXLKPMRyO1cl4mG2c49a7i2jKWxOO1cH4jffdMPSgDDJwetKHzTJAc8U9fu9KAEI9aY/SpFGaaRzzQBTnTPNVtnNaDrxUBjGSaAI0GBUiHb061XZiDgU7fwKALycjmoJhjNEUmQaZcvjk0AVJTWJrb/6Mwz2rSvZwiEjrXKa3dMI26mgDzfXT/pzUUaupaUt70UAR+JuPEerf9fcv/oZrMPUVp+J/+Rj1b/r7l/8AQzWZg0AGaCeKSgUAFKvWl4oBFACrksABzXb+ErPhTj865bR7Zri5GBx616d4esvKjXgZoA7DSE2xKK02wFxVHT+EGe1WZTx1oAsQEAjFWZGG2qVryc5qxJ0oAqy8tkU+H3pjdakXpQBKcDvUUwBFMyd1I0gI4IPagCIgBuKkQncDUbMAalhAYigDpvDtyyOATxXRzzjZnPJrjrBxEQa1XutyYzigDQhm/ejBrVWPzCK5ywPmSgZ712NpDiME9KAIBa8jj9KsLb8DAqwpDuFWrogKxgmgCqsRVMmqN5hgQauXd1tXZWfKwZSRQBFbRKDmiUHfjFOgYDirsdvuUyNwoGST0FAGVIAoLNwB1JrmbXxW134mgsdNtjc22Ssjr1P+0O2B79fyrO8TazceItS/sbw+DJCTh5F4D+pz2Uevf+fdeDfC0Oi2wRBvnfBllI5Y+g9BXL7SVWVqey3Z9B9So5dh/aYxXqTXuw7J/al+i/pdQbbbpjPj+GvLNcbddSA9c17bc2pGiMAOi14broKX8oznmuo+fMv+I08dMVESc9KV8gdaAF5BNKeRTEJNOoAUADk9aqzDGamZsnjpUUpG2gCi/wB6mlsGiU/NwajzlqALds3PNLdkEZpkHWm3Q+WgDLuxuVselctq8LOjeldbIuRis6+hBjIKigDy/U7Y7Worf1m0+VsCigDjvE3/ACMuqj/p7l/9DNZgOa0/E4I8Sarkf8vcv/oZrN69KAGkYFA6HrSgH0NTw20kh+6aAK46d81YtLR7hwApxW3ZaNuQEjJ9xW/p+j7WGAMUAHhvSdoUkcj2rvLK32KAo6d6p6RZ+Wg45xW5FER0HI9aALFqABjvVuSPK1XhUg1cJyoFADYFCL0qRzkfWkBAHWmsxoAjZeakCcUzJ3VKp4oAhuLczQSxrI8TOpUOnVfcV51YX174S1VrLU90tlI24OOf+BL/AFH+T6SScVmazptvq1m1tdrkHlWHVD6igCRXiniSaBg8bjKsp4IqaEkYrz3T7278JakbHUQ0lg5yrDoB/eX+o/yfQ7R454klhdXjcZVlOQRQBoxPtUVKZsnGaqjATjrSA5Yc4oA39HYhwa66G8/dhQc1w9hLsIINdDYzh5FBNAHR2IPmq/vXQuwa3x/FgVk2MY8sEVpRDtQBj3Vvvk6Z5qN7T930Nbstv83SsnxLeR6Lot1fTYxEhKg/xN0UficUm0ldl06cqs1CCu3ojkn1/TodZk06WcRTx4GX4QnGcZ9frWB4h8Q33iW7XQPDwZoXO2SRTjzB3yeyD9f5+e3E0lxPJNM26SRi7N6knJr1z4CPaXDX9kbcLdjEvngZ3p02k9sHt3z7V5scRLES9m9E/wCrH3tbJaOTUXjornnFLR7J/wA3/A/pdr4E8E2mi6aEjAkuXAM05HLH0HoPQV2cGlpFg8Vdt4VhjCrUtejGKiuWJ8JXr1MRUdWq7yZDPGGtZI8cFSK+fvGERh1SQe9fQ55BFeEfEFFXVpB71RkcepyaWSmtgHigMGODQAJ1xTycU0kAcGmF8UAOYYqrK2DipN2aicAmgCq4yTTDwafJ96kxmgCWJsc96ZcPke9KFPaonBoAhIqrcrlTV9FJpJIge1AHK39j5oYgUV0clqG60UAeUeJLENr+pEDJNzIc4/2jVK30sE424NdLraY1q/J7zv8A+hGpLG3LncQKAMeHRwRnZWtZ6GD/AA1uW9t0GBW3aW4AHAoAxrPSguMr09a1YbAKAcc1qpbjjiphEOmKAKttBgelXUjwOxpNm008N7UAPUDFSDpTEGeoqQjigBoGTRsyaVeoqRelADPLwKQjFSs2OoqMkE9KAGnGOaqSyAMKsSthSKz5slsDmgCLVNOt9Wsmgul4PKsOqH1FcfpeoXnhHUjY6iGksHOVYdAP7y/1H+T3URO0e9Q6npltq1m1tdLkHlXHVD6igDRt5o5oUmhdXjcZVlOQRUhPPFeMtqd9pkV1plpfFrbzCN0ffH909QD7V2nw31T7Tp8lhK2Zbc7kz1KH/A/zFA7HbwSFSOa2tMnbzV5rBHFXrKbY4NAj0jT7wLEoY1vaa3nSDBrzyzu+mTXceHbgcNQB1ItsjpXlXxcj1LXNSt9C0W1kmjt8TXTgYRXI+VWY8DCnOP8AaFewW0okQVT1of6Owx2rOrT9pHluduAxn1Ksq6ipNbX2v38zxvwt8MrRZFk1y4Nw4OfIhJVPxbqfwxXs+hWdlp1qltp9vDbwjokShR9eK5Oxk2Sndmup0p/MIPpRTowpr3UPG5licdK9ebfl0+42qKQsAOSKoXl+IwQv51ocJfz1rw34kRkak7Dua9XtL9mkYZzXmfxHQtcs1AHmzucHNMWQnPNE45IqFODigCwr8YpCT07UmKco7UAKMheTUZBJzT5OBSJzQBCU5oVeatbQBUbDk+9AAoGar3AwakL4bFNnO5QQBQBHCeOadIRTF4pWXcaAEwTRUijatFAHmetODrN8M9J3/wDQjT7WYoeDWTrdwBr+ognpcyD/AMeNW7GTJGaAOr0594Umt+2AwMdK53TecYrp7BeAKALiKRjipMZPSrAiJUcU9IeM0AUmU5HFNK4YVfaPFMeLIzQBWBPapN3HNKIyOtNdT2oAaWGetSq3y1WKsDUkZPfpQA6VzjikUkrTHbmpYiCvWgCpOTnFVTndWhMoPSoFTnpQAxQcVIYRNbyRMzKrqVJU4IyMcGnKvNWY0wBQB5trHgS5g3SaZILhP+eb4Vx+PQ/pWFo11PoOuQyzxyRFG2yoykEoevH6/hXtTLgcVVvdLtNTj8q+t0mTtuHI+h6igdyVWDIrqdysMgjoRU8ZGajs7FLCxitomdo4htUuckDsM+3T8KjJKtQI2I7gxqCK6rw3qgwASc5rhNz7Kt6ddSQuOcc0Ae76LdrIoy1XNQkVl25rgPD2oMYgd3NbZ1Dc3zNQBZW2QSHJ71taeBF0PFYJukI+U81Pp9zI8gFAHQXMoEZ55rldSu3EhGDjNbN68iYGKwtQXdzjmgBthdnzKyvFcK3URY4LVKrNHniqzl5s7vu0AeYajbskp4OM1RCEP0ruNchiG7CjNc4YQT0oApBc80rKRjFWjCc0NEcCgCg+SaapIq40JzwKabZhjigCuHJPemNuHPNXUtj1xUn2b1FAGUFLHpzTzGT1FaS2wB44pwgGe1AGSIznpUiRHuK0HhAbgcU4xigCgY/air3liigD5y16Ux+J9V3f8/cv/oRrS0+8HFYvil8+JNVxxi7l/wDQjVewvGjcA80Aeq6FcBiBjrXZ2Dg4NeYaHfYZelehaRLvjUk0AdRE2RUy4xjFVLc9Mmra4xQAeXkU0oMEYqTd70u2gCsYuc0CIVO1LGMnmgCs8Ix0qu8GD8oOK1CmT0pvlZPSgDFeIgniiNSevFaskGT0qNLYCgCk0ftxTAmcjFaTxjGKiEIBoArQwHuKsGMnAAqXGFqzYxebIAaAKIgOec1OE29a3LrTdkO5Rz6Vz87sjkN1oAmcfKDiqEuNxqRrk7cZqk8pLdaALKPjinhs9KrxkN3qZcDigDptAnYDknAroY2O8cn8643SrgJIOfau306MzqDjNAFyKJjg81s6LERKDzUltZgwjI7VYtcQHigC3qTEhTisK6BYHitOWYzuB2q4umq8OeM0Acp5W9SMc1TuP9GjYsOa6O8tRbozZ6Vw+uagS7Jk9aAMLU7hZJST61nkqx4FSTMsjn605YQvQ0ARsm4cCoivtVzAppx2oAq7QCM0o25GFp033qYDj60AOIU0jCgHNDdaAEzS8d6aadtyKAImxu4pGGcYp7jBpF60ARNRTnXPQ0UAfMPib/kZNW/6+5f/AEM1nLwQRWj4mGfEmrf9fcv/AKGazMUAdLo1w4ZfSvT/AA3cbo1ya8s0N1LD8q9G0JwoXHpQB30Eg29TV1JOBWFaykgGtS3bKgmgC8OelOG6mROMVbTbt470AMCggUoUD0zUmOwpCDzQA0detPwKYBmnhSOnSgBHAxTAual20oHrQBD5Weo4pfJFTk9qSgCm8Rz04qeyHlygngVYABFQyA9jigDvdPggu7AkkbgtcF4msWhuW2rxmtnQNUNt8sj5BrR1WJNQiLRgdOtAHmcwYe1VxXQalYGJzkGseWE5wBQAkRwKnDKV681CsD1Zt7Yk855FAFrT0LToccA16v4bhU26lvSvPtIs2Eilgcda9A0aZYYwCcUAdCxWNAorOuJwjHBqSeRmXKnNZF07bjQBet7sCbJNdNYXscmFJ/OvO5boowGeau2OoOsmQ2KAOl8XfJas0Zzx2rx3UpXM7bgetej6hfGeEq5zmuB1qLbKcdzQBnqAQT3pjSMGwKeoO2mupoAkVsrk9aaeBmmRAqeelTEZHagCEYJ5qJs78CpmQgUkUZLAkUAIE46UpTNTOuDShRxQBBspcBV5xmpGIGRioXORxQBHIuelQnOal6dabvUCgBoIHU80VBcyAZ5ooA+ZvE3/ACMerf8AX3L/AOhmswZrT8Tf8jJq3/X3L/6GazOnFAG74eBD9Op4r0rRoyQMV5x4a3M49ulenaGvyr2oA6eziOBmtFDtTFVrYAJnNSlwelAFqGTtirsMmSARWQrYHBq1byUAbEZFOK5NU0lOOtTeYce9AEu3bRnFR7iRzThj1NAAWpVbNMfAoBA5BNAD3OO1NDGmM5LYpwHFAEvmYXpUEso5oI471DL0oAiicvLhc/hXofhu1Y2Y3dx3rldBsVmnBIrvAgtrLEZ5xQBzuuaeJJSM1z1xpJjycGuiWd5bsh89e9aU1qjRcYoA4mCx38YrTtdJJPINbUVkqsOK0BB5aZAoAzI4RAACvSrcDgkHpTCPMkxg8mtO2swyZ20AWbeXK4qnqDBQTirMMTK5AHFVdWAVCDQBz93J82e9S20uQKqXvWmQybcA5oA1jIT9KytWi3LuxV0MAoNNkIlTaaAOYDfNinsMjirF9b+UxI6VSjl5xigB3fFPGMc0yQgZ5qEzdqALDGnA88CqLSndzmpRNgUAWHamlwKz7ifDcc03z/loAtzSY5NVzMO1VJ7jK8dRUCSkjpQBdluAAeKqG5y3tVaaU5IxUIbmgC3K++imxkEdaKAPnXxP/wAjHq3/AF9y/wDoZrMBrS8Tf8jLq2f+fuX/ANDNZ3FAG94bYCQZ9cV6joHCg9a8i0SXZcqvvXrHh6T9yvFAHXxyARjimFsmo0YMoAoc7RzQBKrYq1A465rL35qxBJg0AbKycVNFKCeccVnK+RzT43waANYyg4wKcDkVnLLg1NHPQBbZsDpmkTO3movMyanBBXNADHNPTnr0puM804EKOaAJflx0pjR72AAqIyir+l4lkAxnnigDovDtqBGpwc10KQl0Kn0qrpMPlxgkcVqqw2nigDmZoBHd5qyr5OD0pdTYI5PrWeJ88igDUG089+wqccxkGs21myRmtINmM44oArrH+9GPWtu2+SLJFYqkiStWOTMBoAfbSr5x3CszXmVmO2hZyJGwaztUm3MeaAMy5xiqLOFPFOu7jBxWbJcfN170Ab9tJui5oQ/MRVOymG0Zq7Cu45FAFXVGVYTnGRXMpMPNNaXiObyUYE1yf2j5iaANe6ulBxmqqz5Oc1mSz7m60+EkgYzQBomY5zmpFlJFUgvuanXIFACXDEiq3m84qeXkc1SkXDmgB7yDIFTRnjiqDIxkBGcVeh+SPJFAFW5Pz0qAFc02f5pMigvsjJoAdLMkaHJA4orA1jUlWMriigDxnxP/AMjLq3/X3L/6Gaze9anib/kZNW/6+5f/AEM1mZHPvQBLayeVcIw9a9X8LT+ZCnOMj1ryIdRXf+CL0bUVjyMCgD1KAfKKbIeaW1kVoQevFEhBPFAEZ+QZFEU2ZACAee9OcjFRwgb6ANeAgqT0+lScdjVeMELmnxvk4oAlGSanjBAqFD84qypG3g0AKZCKnVzs64quSCRUm5dhxQBJ52B1pjTEnrVSR8GmbyTxQBbaTitfw3KDcLyODiufaQBean0q88q5BBxzQB6xFc7YgBUkd0DxmsnS5/tEAwc8VPJuiY59cUARan+8JweKzIUOcGtiQKyZPPFVPLUN6CgAhXawrSViqY5qkkZyMc1s2tviIswoAZbQmUZxirjJ5dufXFLDIoXaB0qG7ucIwoAx5ZdhJ6Vl3s25W5/GpL6clie2azppco2aAM65lyTk1QJ3OMetPuZMOaqxyHzRQBuWJzgV0lhGPKLHsK5mybhQOtdPbt5dizN6UAcJ4umDXTIDXLOCBzW9rriW8kOe9ZMqfLQBRH3hV62B4xUCpj61btu1AE24ipAxNIQDQvagBGBxzUTJuOcVM55pAcigCER81IBnikzzipMHbxQBSnARuCM1nX07CNgOuKu3bZz+VZs8e5cmgDi/EFw/zUVa8RW6+W1FAHnfif8A5GPVv+vuX/0M1mDGK0/E/wDyMerf9fcv/oZrLoAK1/Dt4LS6G44BPrWRTlYgjHBFAHtuj6mskK7fSthJWbnFeY+FdUJwufavR9PkaWEE9KAJXkJyKfaAmTrS+Vls5qzbxgMPWgC5/wAsqigPz1M/EYFQQ8SUAWxTkYjqaQA4pSMUAPZ8dKaWPY8Uzpk0oPy0ANYknGaVRgUg5JzTxjHWgCvOfeoYjtcEHmrEybhUSp8woA9A8E3m/ajHNdPqvByBivPfCc5gu1GcDNei3rCW2DDHSgDLWbAwaYZMniqc8mGxnFNEmFznNAGrbTbWG41sLfp5O0fzrjZrvYOTTLW/LN940AdYtwVLHPFU7y9DZxVRLjdH15qldZ55NAEVzcA8ZqnLLlDUEo3OeaaVOwjJNAFK4y7HFVERhIDV8RkFvSiOMFulAFyx+8mTXUXH/IMJHpXNW6bHXriuhWRZLFk9BQB5xfZF02T3qu3zDirWtR7Lth05qtCOMUAV2Ug0+JipwBUsyYFVs7WzmgCclwTk4FSxuSOtRsd8fFNiJyBQBNgs1PwQab0NS54HqaAIG4INP3/IabIOaYTjigClcqWfIqCX5UO6r5QFs1VvhhMgUAcZ4kf5GGKKj8RkkMDRQB534n/5GPVv+vuX/wBDNZdanib/AJGTVv8Ar7l/9DNZhHNACUvGKCMUKCWAXrQBv+FiwuBjpXquky4iUE15z4dtikalutd9pSsAvOfwoA6iBAVzTlGHAFQQtiMetPjf94KALpGUpsEfz0oPy1NABQBME4qvKcNVhyQKqyfMaAGFyQafuAUVEVw2ar3DlQeaALAk5wOanTnk1lW8hLVoxsSBigCYrxwaYqjOc80rMVSoFlzJigDY0YEXakdjXobzBrJQD2rh9CiyVfFdNJMREAKAM67chjTVl+Sic7iSaiGSKAGTnfximwDaamVfWmvnigC0k5GPanyOWWqJYjFWYWynXNAFN8hjkUxm2irc6cZFVSpPFADQNwp0KYNTwoACWqWNQT0oAVAQKminaP5exoVPUVFO6rQBnavaK5L9zzWCybTjFdJcyLIOtZUsWTkDigDLk3E47VXkX2rUeAkdOapTLtzxzQBAG2jFOhyTUHzF6txAAUAEkuDTUmzUV197ApkQIxkUAWgxZwO1LOAq5p0O0dajum3HC0AQoSTior0ZjP0qeFCo+YVXvsspC0AcVr6Fiwoq9qVu7bty0UAeU+Jv+Rk1b/r7l/8AQzWbjmtLxL/yMurf9fcv/oZqgsbt90UAMNX9Jh8yYZpbTTpZXAK/rXX6Foe0KSuDQBa0qzwqlRXXaZCUQetQ2WnFEAxgitO3j2cGgCwgIBFJEG8361KgHrT1UBwaALCnCc1JE+GqMkUsYBOaALjPlcVAwzSjHc0uOM5oAY5CrzWZdtnOKvXDbVOTWdLyaAG2uQOa0YpNo5qrAny8CpCrE8A0ASSyluhpbSEySjOadFbFgCetamlWwMwzzQBvaWvkQDPpVmWXjrSeUFjAqCUUAIzbjRnHeo1+9ipCnrQAqNk04rlTTUGDUyYIxQBTMZ39eKuQJgYzTDgGnI/zUATTJ8vNVVj3NWjsEiilSAKc0AVFg7HNCLsOWq5KVQcdazrmY460ATSTAd6zLyTJ+9RJJ7mo5FDjNAEAOZBkk1ZCArTI4RnNWlUAcUAVJIOM96zbq3LEjvW2/pVaVQaAOee3MZpoyOtbEkQbgiq8lquOKAM5huYHHNOZRtBxVg25U5FIyEDFAFX5qcgw3OakKYPSkxQA92G3FVZEyalKZ5p6Jng0AZF5CGB4orRlt8A5FFAHj+p6A02valKVOGupD/48ang0EqPuc/SvSJrFTczMV5aRjn8TQLJN33aAOR0/RfmXK4/Cuos9PWMDArSgtVGPlqwFVe1AFTyQOlM8vnirjjcTinRxdMigCqoIFBbFXDFgZqnMACaADzKlic4zVZVLYxVhFKjmgCbeacrnFQM3PFTRAkZFAEF1kioYomZ+nFX3i3HpU1rBg5IoAS1t+ORVtLZM9KnRMU4rQAiQKOnFT26iN8jimAkYGKXJoA1Y5dwwTSsoPPas5JSp5qyJt64FAEwQbulOl46ClicBeabMwPQ0ACjPIp6jrToT8tDdaAInoj5IpzIzAmkjQ+9AGlARt5qVnUIaogkLio3ZsdaAGzTsXI7VTlbcDmp3GRVe4GB7UAQYycUpGBgUwAlhin4IIzQA5Bg1MrVAOTUijigBXGWzVeUCpXbiqsr8mgBnFIRn6VGZBnGKcpzQA4xrtqNoQR0qyozShRnkUAZTREPz0pjoc8CtGZBk0wRAjNAFBIiTzU6xhetTrGAelBTFAFWWPJoqwVz2ooAzXUea5P8AeP8AOkG3PFXDFuYn3P8AOo/I5oAjJAHFRHNWJUIFVsN6GgADYNPE4Udeaj2EnpUghLUAMaUsKqSfO+Kum3OelCWx3ZxQBXiQpxUhNXVgyelP+yZIzQBnBcmrsCdqsC1UVKkQU0AMCYHSpoUyKeVGKVQVHFADidoppbIoakAoAkRMnrTyMHimKx5p6HJ6GgCNuTg0Rvt71JKo5NUmYqwFAGkkhxyaUSfMOahh+aPNPA5oA0bdwV5IqcqCayUcq4xWnavvNADzwuMe+acgB61c8lWTNQFQuaAGlQFyTzVaTHPNPeSqsr85xQAOxB9KhlfeMGlY55pqrk0AEEBY0+WLA461btFG4Cp5ohjpQBiqxDYqb+GmTJtm/GnEjHWgCCU4zVCVzk1ZuHw+Koytk0ANJ5yaljlA4qAg1LGnFAFhZQOhzUySBqqBasRLgigAkHzU4YC80knDULyDmgAVgTQQD3pAuCaaxOelAAUx1ooJJ6migCLAA/E/zpgI9aa5POPU/wA6jYMelACyLuPFNEIxzUgRsc5p6Ke9AECwc5qxHEB1p5XA4pysccigA2LTDHzgDrTt+KWNzuwOPU0AKkftipQAo5pDKMc81C0oJ60APZhmkzSbc8ig8UASA8UtR07NAAwJqRBwKROTzUvFADcAUqHn2pHApob5TQA+U5Q4qpj5snrVgNuBAqWG0LnNADYRgD0qfFSi1IHWlEZUjNAFfYT2q7ahoyOOKAoBzU0bCgC/aljHy3aobg4qaN18vjiqlzJluKAK0h561HuB4omNRA4oAm2/LUGMPmplY45qKQ80AW7eQDBq4siuKxg2KtW8vNAFTUnEcmRxWVJd/N1rQ1qMuu5TXNShlOeaAL8k+7vURO45zVATHOKmSUHrQBdiHPNWlx2rPimyeauRt8w9KAJhwak5CikGCKeOnNAETHNOX7tIw5ozhaAHqwxSEj0oRCRQ6fnQAxiCeKKFjZs4zRQBFgBcn1P86ABiqryEkjPAJ/nU0Bz1oAnUDFNchTQCAOtQu2TxQBOTkUIDnmoBIEUetH2gdhQBM2MkUqICaqiRmbNXoMZG48UAIycVEI+eKvgRnvT1EQHbNAFE5A4BFRnJPetFtmOMVXkKjoOaAIN3FIGpkzkZxUIdqALayYNK03fNUXZ88UjOccmgC1JcgjrUa3I6ZrMuJW5FV4GkeYCgDrbIB1zV9HCduKq6XERACw7VJI3OKALJm4qMzg5qq7UgbHWgCyHpySc4qrk1NGfWgDTgbOATSzRLjIqtbk8VfALJmgDKuExUS9KvXEWTUIhwM44oAjTGDULcvipZPl6dDSRLzk0AI0Y2UsOBRcvtGBVeOTnrQA/UyPJIrmbiugunyuDWDfKRnaKAM6UhTnNNEnfNRT78UlsTt5oAtxye9W4rnjvWcoOasRggUAa0VwGGM1Ktxu4rIVyDxV2FgACTQBophh1qXywcciqKSH+9xUyTAY5oAtldgqMtk0zzi1G4YzQBIJBH060VWd8migDObIlft8x/nSlzjio5Hw7j/aP86Zv3LwaAJhKT3p27iqqhutPJYCgCUSZ4NNdwKjIbNJJ1oAnjlAFO888YJqqiE5oYbe5oA0Un461KkoPU81mxglcg0rEqOtAGqs6CmtcIayg2T3qVU75oAtPKpqIuM8VGy4FNBGcUASPKKikbcOKeIiwzipEh9aAKLoWGKtabaF5lIFWEgyeRV+zXyWDY6UAa2BFAFAxxVQ/McmpDOJjjNNdNgoAjZMj3qu8b54NWVzzxS98UARIpxU0aMeaVBz0q7CgAoALZGyM1qpGfLFU4RhvlGcdq1bUF4+Rg+lAGZMRnmonZdlGoHZIcetUWlJHWgAmZdwqNnB6VC7knrmkBPrQAy5fJ61HACT3qSaPK+9LbrtagBzrlcHrWbdwggg9a05n21SmbcaAMWa2JHFUWhKNXQNyvaqcsO88CgClHGSeatxpgU8RbQOKei/NigCFk64pi5VqtyJjpTDHuGaAGeZinRuT0qGaMg0WxKtQBoxnAzStJxSKeKjbrQAoLN2oqVBgUUAZk3+sf/eP8zUQoooAmXpQ3aiigB3aq5+8aKKAJ4elRzdaKKAHJ0pX+7RRQAxOtWI+lFFABJUS9/rRRQBfj+4KeOtFFAEq9amHSiigB1t/rjWjL2+lFFAFcdDTf4qKKAJ4/vCrkdFFAFm3+8a2LP/VGiigDn9W/15+tZz9KKKAK4/i+tHeiigB5+6aTsaKKAIZ/ufjVR6KKAIxTD1oooAc/3aav3qKKAFk6UsfSiigCvc9T9Kr2336KKANEdKZ3oooAsj7oooooA//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This section from a thoracic CT scan shows a solitary osteolytic lesion of the sternum (black arrow) with sclerotic margins (red arrow) in a 38-year-old woman presenting with chest pain. A bone scan was positive in this area, as well. The resected surgical specimen showed Langerhans cell histiocytosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fazio N, Spaggiari L, Pelosi G, et al. Langerhans' cell histiocytosis. Lancet 2005; 365:598. Copyright &copy; 2005 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_13_20703=[""].join("\n");
var outline_f20_13_20703=null;
